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Abstract 
The number of people suffering from Diabetes mellitus in both developed and 
developing nations has increased dramatically over the past two-three decades and this 
increase is predicted. The condition can result in numerous complications in the patients 
suffering from the disease if it is not with long-term effects including retinopathy with 
potential blindness, nephropathy that may ,lead to renal failure, and/or neuropathy and an 
increased risk of cardiovascular, peripheral vascular and cerebrovascular disease. Camel 
milk consumption has been reported to have a positive effect with respect to diabetic 
severity and complications and as a treatment of diabetes with regular camel milk 
drinkers requiring lower doses of insulin to control their blood glucose levels. A number 
ofstudies have now suggested a direct link between camel milk insulin and the effect of 
drinking camel milk on diabetic suffers. In this study, insulin from dromedary camel 
(Camelus dromedaries) milk was isolated and characterized in order to investigate the 
stability and nature of the protein to begin to understand why it may have positive 
benefits on patients consuming camel milk Initially the camel insulin gene was 
amplified and sequenced from 32 camels using primers used to amplify the camel 
proinsulin eDNA. The sequenced fragment was aligned using a BLAST search and the 
sequence matched a sequence from lama with 96% homology. A number ofSNPs were 
identified in key regions of the camel gene sequence, although none in the coding 
sequence with 3 located in the C-peptide intron, 2 in the 3' .UTR and 1 after the 
termination signal. When the gene sequence was converted to the corresponding amino 
acid sequence this revealed that across the 13 species compared the camel insulin has 
two unique amino acid changes in the signal peptide, one unique amino acid change in 
the B-chain and two changes in the A-chain compared to human (which are observed in 
some other species). There is much variation across species in the C-peptide region and 
in the camel there were various changes compared to other species. Using the sequence, 
.. 30 homology modeling of camel pro insulin was undertaken which suggests the 
formation of different secondary structure compared to that for human insulin which 
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may impact upon the stability of the molecule. Using FISH, the camel insulin gene was 
also mapped to the distal (Telomeric) end of the q-arm of camel chromosome 10. In 
addition to investigating camel insulin at the genomic level, studies were undertaken at 
the protein level. For protein analysis, fresh camel milk samples were collected from the 
Emirates dairy farm. The samples were initially defatted and then treated with ethanol in 
order to precipitate casein which is the major milk protein and other large molecular 
weight proteins, before the supernatant was passed through an ion-exchange 
chromatography column of A-25 DEAE Sephadex beads. The bound camel milk insulin 
was then eluted and further purified by immuno-affinity chromatography using an anti-
human insulin antibody. The resulting insulin concentration and activity was measured 
by radioimmunoassay using a human insulin kit. The camel insulin gene was also cloned 
into a mammalian expression vector and transfected into a mammalian cell line and 
attempts made to produce cell lines stably expressing camel insulin. The thermostability 
of the insulin purified from camel milk was then compared with human and bovine 
insulin in camel and bovine milk. The results suggest that camel insulin appears to be 
stabilised due to the unique both amino acid variants in comparison to human insulin but 
these studies also suggested that camel milk itself provides protection against 
thermostability which bovine milk does not and this property contributed the most 
towards the enhanced thermostability of camel milk insulin. The exact nature of this 
protection and the agents responsible are not currently known, but further elucidation of 
the mechanism(s) may provide possible routes for the thermostabilisation of other 
proteins. 
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Chapter 1 
Introduction 
1.0 Background and Introduction to Thesis 
Motasem Ismail 
In the Middle East camel breeding is of great importance and hence infonnation and 
scientific investigations around the biology of the camel are at the forefront of science in 
general in the area. The camel is important in this area because of its economic value, as 
a source of transport, meat and milk. In addition, camel racing is a popular sport in the 
Arabian Gulf region and racing camels are worth consider sums of money with many 
valued in the millions of US dollars. The Food and Agriculture Organization (F AO, 
1996) reported that there are approxiinately 18 million camels in the world, which 
. maintain the life of millions of people in arid and semi-arid areas. The high nutritional 
value of camel milk has made it one of the most important food sources for humans in 
many parts of the world, particularly in these arid and semi-arid areas where highly 
nutritional food sources can be limited in their supply or availability (Elagamy et al., 
1998; Elagamy, 2000). Of particular interest for this thesis is milk provided by the 
camel, not for the nourishment perspective but as camel milk and the insulin provided 
within this, appears to offer benefits to diabetic patients and reduce the dependence of 
such patients upon the administration of insulin (Agrawal et al., 2007a). Hence, this 
thesis set out to investigate and characterise camel insulin in more detail. 
1.1 The Camel Family and Taxonomy 
The Camelids Came/idae family are derived from the suborder Ty/opoda (pad-footed 
animals) of the order Artiodacty/a (even-toed ungulates). Camelids are ruminating 
animals but are not classified under the Ruminantia (ruminants) suborder because of 
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differences in the foot structure, in the gastric system and because of the nonexistence of 
horns (Schwartz & Dioli, 1992; Fowler, 1998; Wernery, 2003). The Camelidae family is 
further classified into three genera: Camelus, Lama and Vicugna. In older literature the 
Camelidae family classification was restricted to the first two of these genera. The gunus 
Camelus refers to the old world camel and includes Came/us dromedaries and Camelus 
bactrianus as domesticated species. Camelus ferus, found in the Gobi desert is known as 
the wild species of the came/us genera (Wilson & Reeder, 2005). 
The Dromedary camel (Camelus dromedarius) is a one humped camel and is found in 
the hot deserts of Africa and Asia. The dromedary name is derived from the Greek word 
"dromeus" that means runner or "droma" running. The Bactrian camel (Camelus 
bactrianus), the two-humped camel, is distributed and typically found in the cold deserts 
and dry steppes of Asia. The Bacterian name is derived from Bactriana in Central Asia 
(Rao et al., 1970; Fowler, 1998; Jassim & Naji, 2002). 
The general habitat of the camel is therefore in tropical and subtropical dry zones such 
as North Africa western Asia and North West India. In last century the number of 
camels in Australia has dramatically increased, as although they are found in the large 
desert areas in this country there is plentiful food and water resources for the camel to 
survive and flourish. Camels are also present in the United States of America, Central 
America, the Caribbean, southern Africa and Europe but in much lower numbers and 
density (Wilson, 1984, Wilson et al., 1990). The camel is therefore extremely adaptable 
and able to survive extremes of climate and terrain, making this a very hardy animal able 
to populate most of those areas globally that would be inhospitable to many other 
species, but also able to populate areas more favourable to other species. 
About five thousand years ago the Dromedary camel (Camelus dromedaries) was first 
domesticated in southern Arabia. This camel has the ability to survive in the harsh desert 
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climate for up to forty days without drinking and hence has made it a recognised 
creature of the desert (Bulliet, 1975; Higgins, 1984; Hassan, 1971). For these reasons it 
became the most important domesticated animal in this region, providing milk, transport 
across expansive desert terrain, meat and companionship. 
1.2 Milk Proteins 
Milk is the material generated to feed mammalian infants with all mammals from 
humans to whales producing milk for this purpose. Around nine thousand years ago 
animals such as cows, buffalos, sheep, goats and camels were domesticated by man for 
the purpose of milk and meat production (Eddleman, 1999). The milk is not only used as 
a direct source of nourishment and protein, but also for the production of other 
foodstuffs such as cheese and yoghurts. 
There has been a huge volume of research undertaken into the milk of many different 
mammalians and the benefits and roles of the proteins and lipids/fats within these milks 
and it is beyond the scop~ of this thesis and introduction to describe these. The milk 
from many species has significant health benefits if consumed by humans, although in 
some cases allergies or conditions can result from the consumption that can be life 
threatening, for example due to lactose intolerance (Qiao et al., 2011). Protein 
biomarkers in milk have also been suggested as useful markers for disease states and for 
genomic profiling (Baumgartel and Conley, 2012). 
Milk proteins are thus well studied, although much research continues into these 
economically value proteins. The importance of milk whey proteins is due to many 
functional aspects, several of which will be discussed here. Firstly, some milk proteins 
have the ability to be modified, for example to have regions such as the phosphorylation 
sites in casein that change the properties of the protein (Beg et al., 1984; Beg et al., 
1986). Second, some milk proteins are similar to anti-proteases, neurophysins and other 
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such proteins in their structure and function that indicate the wide evolutionary and 
functional relationships between these proteins (Dandekar et a/., 1972; Hennighausen et 
aZ., 1982; Beg et aZ., 1984; Beg et aZ., 1986; Urashima et a/., 2012). Thirdly, the 
majority of milk proteins are much like other proteins that are similar in amino acid 
sequence, appearance and content between different mammalian species and hence are 
found in the milk of most mammals and are presumed to play the same role across 
mammals in sustaining infants. However, a minority of milk proteins have been reported 
as being present or absent in milk from different species and hence there are some 
species specific proteins present/absent. For example, camel milk is deficient in p-
lactoglobulin which is a major protein in other milks (Kessler, 1970; Liberatori, 1979), 
whilst a number of milk proteins have unidentified function but are suggested to be 
involved in regulatory processes (Dandekar et a/., 1982; Reeds et aZ., 2000). The 
deficiency of p-Iactoglobulin in camel milk is potentially important as this is one of the 
major allergens in cow milk and is problematic for a percentage of the population (AdeI-
Patient et aZ., 2012) who may therefore be able to drink camel milk in place of cow milk. 
For human infants, cows milk is a major source of nutrition and essential nutrients for 
growth and development, and provides essential proteins, minerals, carbohydrates, fatty 
acids, immunoglobulins and growth factors where human milk is not available (El-
Hatmi, 2007). The existance of specific growth factors in human milk and colostrum, 
and their activity on different cell types, was first identified in human milk and 
colostrum in the 1980's, and then subsequently in bovine milk, colostrum and whey 
(Sylvie et al., 2006). For example, the presence of very active growth related cytokines 
in bovine colostrum and milk have been identified and characterised by a number of 
groups in the proceeding years. For example, the G-CSF (Calhoun et a/., 1999), IL-l 
(Kelly, 2003), IL-IP (Hagiwara et aZ., 2000), IL-6 and INF-T ( Hagiwara et al., 2000, 
Kelly, 2003), TNF-a (Blum et a/., 2000, Hagiwara. 2000; Kelly, 2003; Ontsouka et aZ., 
2003) and IL-IS (Muneta et aZ., 2005) have all been identified and isolated from bovine 
milk and/or colostrum and characterised. 
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The stage of lactation, and the methods used for the quantification of growth factor 
concentrations in milk explain the fluctuations in the concentrations and presence of 
these biomolecules. The concentration of growth factors reaches the maximum levels 
during the first hours after delivery of the new born and then decrease drastically in a 
time-dependent manner. The total protein concentration in milk and colostrum also 
decreases during the first four days after delivery (Sylvie et al., 2006). A further 
important signalling moleculelhonnone with regard to this thesis that is particularly 
found in camel milk is insulin (Agrawal et al., 2005; Wemery et al., 2006). The role of 
insulin and its presence in milk are discussed in greater detail below. 
1.3 Camel Milk 
Camel milk is highly nutritious, contains less fat than cow milks, higher levels of 
potassium, iron and vitamin C and relative to other milks large amounts of insulin 
(Knoess et al., 1979). The presence of volatile acids such as polyunsaturated fatty acids 
and linoleic acid increased the value of camel milk compared to other milks and these 
acids are vital in human nutrition (Rao et al., 1970). Camel milk not only nutritional 
value, many years ago was proposed to have properties as a 'biodrug' (Rao et al., 1970). 
For nomads in arid regions camel milk is one of the most valuable food resources and in 
urban populations the consumption of camel milk is increasing (Farah, 2004). 
The visual appearance of camel milk is that of a very white colour with a foamy 
structure. About 13,500 liters of milk (or even more in some cases) is the volume of 
milk that can be produced by the typical camel during the lactation period, a period that 
can last for up to 18 months (Knoess, 1977). The type of the food that a camel eats can 
affect the taste of the milk and hence the makeup of the milk with the feeding of green 
fodder producing sweet milk, while certain shrubs and herbs in arid regions can produce 
salty milk (Rao et al., 1970). The casein content in camel and cow milk is reported to be 
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very similar, but the whey fraction in the case of the camel is larger than the whey 
fraction from cow milk. As a result, in the camel the ratio of whey protein to casein is 
higher than in cow milk but lower than found in human milk. This may explain and 
clarify the softness of camel milk coagulum compared to that found in cows (EI-Agamy, 
1983). 
As mentioned above, the composition of camel milk is considered very different from 
that of other ruminants. Haddadin et al. (2007) reported a large variation in the 
concentrations of Arabian dromedary camel milk components over the year, reporting 
that the concentration of water in camel milk was 877 ± 12.7 g\L, lactose was 39.2 ± 0.5 
g\L, fat content was 29.5 ± 2.6 g\L, protein content was 26.9 ± 1.6 g\L and ash content 
was 8.2 ± 0.3 g\L. The highest concentration of water was observer in August at the 
peak of the summer while the lowest was observed on January, whilst the concentration 
of the fat, proteins and ash were lowest in August (Haddad in et aI., 2007). 
In comparison with the human and bovine milk, the water content in one litre of bovine 
milk is 878 giL while in the human milk it is 871 giL. The total protein contents in 
bovine milk 32 giL is and in the human is 13 giL. The fat in bovine (39 giL) and human 
milk (41 giL) is more the camel milk. The lactose quantity in bovine milk is 48 giL 
while in human milk is 72 giL. Table 1.1 is showing the differences between camel, 
human and bovine milk samples in the water, fat, lactose and total protein contents 
(Emmett and Rogers, 1997). 
Table 1.1 Comparisons between camel, human and bovine main milk components. 
Nutrient Camel milk Bovine milk Human milk 
Water 877 878 871 
Lactose 39.2 48 72 
Fat 29.5 39 41 
Proteins 26.9 32 13 
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As mentioned above, camel milk is deficient in ~-lactoglobulin which is the major serum 
protein available in ruminant milk. Serum albumin, ~-lactalbumin, immunoglobulins, 
lactoferrin and peptidoglycan recognition protein are examples of key proteins in most 
mammalian milks that have been also been identified in camel milk (Kappeler et a/., 
2004). Interestingly, the immunoglobulins of camel are different to many other 
mammals in that there are heavy chain only antibodies with no light chain, so termed 
single-domain antibodies (Muyldermans et al., 2001), which are now generating much 
interest as potential biotherapeutic molecules. Finally, the pH of fresh camel milk is high 
in comparison to other milks, however the pH decreases rapidly when the milk is left to 
stand at room temperature (Agrawal et al., 2004a). 
1.3.1 Camel milk medicinal properties 
Initially, milk was only deemed to be a source for particular nutritional factors such as 
es~ential amino acids (Hambraeus, 1992). However, more recent studies have shed light 
on the nutritional and functional characteristics of milk, due to the abundance of 
bioactive substances which provide various health benefits. It has observed in different 
parts of the world that both fresh and fermented Dromedary camel milk serves as a 
potential source of remedy for various illnesses such as autoimmune diseases and 
metabolic disorders, dropsy, jaundice, tuberculosis, asthma, spleen problems, piles, 
anemia and diabetes (Rao et al., 1970; Abdelgadir et al., 1998; Shalash, 1984). For 
example, Mal et al. (2001) observed a positive role for camel milk in treating chronic 
pulmonary tuberculosis, a major disease in developing nations. Camel milk has also 
been reported to have a therapeutic effect on patients with ulcers and hepatitis. 
Furthermore, there are no reported lactose intolerance or allergies against camel milk as 
a result of its consumption (Zagorski et al., 1998; Shabo et a/., 2005), a potential issue 
observed with consumption of cows milk as described above. 
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1.3.2 Camel milk and allergies 
It has previously been shown that camel milk proteins are involved in food allergy 
prevention and treatment. B-Iactoglobulin and different l3-casein proteins are responsible 
for allergies that develop in response to drinking cows milk, however these proteins are 
absent from camel milk. Camel milk also contains some immunoglobulins that are at 
least partially ·very similar to human milk immunoglobulins, which decrease the allergic 
reactions in children and help in their future tolerance to the food (Shabo et al., 2005). 
Shabo et al. (2005) studied the effect of camel milk on allergy treatment. In this study 
were included 8 children from parents suffering from acute food allergy who had no 
response to the conventional allergy treatment, with the children aged between 4 months 
and 10 years. In the study the parents were advised to feed their children with camel 
milk and impressive results with this camel milk treatment were observed with a rapid 
improvement in the children's health and the" children being generally less 
sensitivity/allergic to various foodstuffs (Shabo et al., 2005). 
1.3.3 Antimicrobial activity of camel milk 
Many studies have described the antimicrobial activity of camel milk. Amongst these it 
has been reported that camel milk has antimicrobial effect against wide range of Gram 
negative and Gram positive bacteria, including Escherichia coli, Listeria 
monocytogenes, Staphylococcus aureus and Salmonella typhimurium (EI-Agamy et al., 
1992; Benkerroum et al., 2004). The antimicrobial activity of camel milk has been found 
to be due to the presence of lysozyme, hydrogen peroxide, lactoferrin, lactoperoxidase 
and immunoglobulin'S which together all contribute to the many described examples of 
the antimicrobial activity of camel milk (El Agamy et al., 1992). 
1.3.4 Hypocholesterolaemic effect of camel milk 
One of the foremost causes of death in the developed world, as well as in many 
developing countries, is coronary heart disease (Pereira and Gibson, 2002). One of the 
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key risk factors leading to coronary artery heart disease is the increase in levels of blood 
and dietary cholesterol (Reddy et al., 1977; Spence et al., 20 I 0). Elayan and his group 
described in 2008 that administering fennented camel milk with Bifidobacterium lactis 
(BB-12) to rats in vivo led to hypocholesterolaemic. The administration of fennented 
camel milk was effective in lowering the level of total plasma cholesterol, very low 
density lipoprotein (VLDL) and the low density lipoprotein (LDL) in the tested rats 
compared with the controls (Elayan et al., 2008). It is postulated that such a benefit 
might also be present in people who regularly drink camel milk. 
1.3.5 Hypoglycaemic effect of camel milk 
A significantly reduced occurrence of diabetes has been observed in the Raica 
community in India and it is thought that this is the result of the consumption of 
Dromedary camel milk since the prevalence of diabetes is zero among those who 
commonly drink camel milk (Agrawal et al., 2007b). Camel milk consumption also 
provides effective management for patients with type I diabetes (Agrawal et al., 2003). 
The elevated concentration of insulin in camel milk is thought to contribute towards this 
effect (Agrawal et al., 2003; Beg, 1986). The effect of camel milk on diabetics will be 
discussed further in the following sections, however why there are increased levels of 
insulin found in camel milk and if this has unique properties compared to other insulin 
molecules was not known when the work in this thesis was begun. 
With regard to the anti-diabetic properties of camel milk, Agrawal et al. (2007a) studied 
the effect of camel milk on type one diabetics in a study that included 50 patients. The 
patients were separated into two groups based on their age, body mass index, blood 
glucose, glycated hemoglobin (HbAlc), current insulin dose, plasma insulin, C-peptide 
level, and concentration of anti-insulin antibodies. For 12 months group 1 was treated 
with conventional treatments and group 2 received the conventional treatment along 
with 500 ml of raw camel milk daily. After the treatment period the camel milk 
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consuming group showed a significant decrease in glucose levels from 115.16 ± 14.50 
mg/dl to 100.20 ± 17.40 mg/dl (p = 0.002) and a dramatic reduction in the insulin dose 
required from 30.40 ± 11.97 uU/day to 19.12 ± 13.39 uU/day ( p < 0.001). There was a 
slight reduction in the percentage of HbAlc from 8.2 ± 1.44 % to 7.51 ± 0.98 % (p = 
0.06), and a slight increase in the level of C-peptide observed in the camel milk 
consuming group. There was no change in the amount of anti-insulin antibodies present 
in both groups. 
Agrawal et al. (2007b) also reported a positive effect of camel milk on p-cell function 
and suggested that there were several possible mechanisms by which this might occur. 
These were; (1) That by helping to maintain the glucose concentration within normal 
values may lead to less activity is required by p-ce1ls that ultimately conserves and 
reserves p-cell function, (2) that the high level of circulating insulin may cause tolerance 
stimulation in the body, (3) that single domain immunoglobulins in camel milk, which 
are small in size and weight, may interact with host cell proteins to induce the regulatory 
cells and eventually discourage the immune system and p-cell salvage, (4) that the 
existence of half-cysteine whey protein and lactoferrin in camel milk may stimulate p-
cell function. 
1.4 Insulin and Diabetes 
Diabetes as a disease has been recorded for more than 3,500 years, but its cause 
remained a mystery until the early 1900's. The earliest recorded case of diabetes is on 
the Papyrus Ebers of Ancient Egyptians in 1500 B.C. describing frequent urination 
(polyuria) as a symptom. In the first century A.D. Arateus described diabetes as 'the 
melting down of flesh and limbs into urine' (Lasker et al., 2010). At about the same 
time a Greek physician, Galen of Pergamum, mistakenly diagnosed diabetes as an 
ailment of the kidneys. It was not until the 11 th century that the term mellitus was added 
which comes from the Latin word for honey. The common way for diagnosing diabetes 
was by 'water tasters' who drank the urine of those suspected of having diabetes as it 
was thought to be sweet tasting (Desbandhu et al., 2011). 
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In the early 19th century, tests were derived to measure the presence of sugar in the 
urine. In 1869, Paul Langerhans, a German medical student, reported that the pancreas 
contained two types of cells; one responsible for the set:retion of normal pancreatic juice 
and the other later identified as the 'islets of Langerhans' (Lasker et al., 2010). In 1909, 
Jean De Meyer gave the name 'insulin' to the glucose lowering hormone which was still 
hypothetical at that time and he proposed that the horm,?ne is produced by the islet tissue 
of pancreas, the name was originated from the Latin word insula (insula = island) 
(Lasker et al., 2010). 
Insulin was discovered in 1921 by the Canadian scientists Banting, Best, Macleod and 
Collip, as a substance which reduced the circulating blood sugar level. They 
subsequently isolated insulin from animal pancreas islands. Until this discovery, type 1 
diabetes mellitus was often and eventually fatal for those patients suffering from it. 
Initially they tried administering a pancreas extract on dogs and then they subsequently 
used such an extract on patients with human diabetes. After several trails they were 
discovered they were able to use their extract to treat diabetes successfully for the first 
time (Banting and Best, 1922; Rosenfeld 2002; Joshi et al., 2007; Teuscher, 2007). 
In January 1922, a bovine insulin extract was injected into a diabetic human patient. The 
extract was so impure it caused a 7.5 cm callus at the injection site on the left buttock of 
the first insulin patient Leonard Thompson. James Collip therefore continued his work to 
further purify the insulin extract to make it safer for administration and more effective. 
Every sample of the early isolated insulin had a different effect as a result of the 
divergence in the purity of the sample and presumably due to differences in insulin 
concentration. As a result, the early diabetics to be treated with insulin frequently had 
hypoglycaemic responses, pain and swelling at the injection site (Bliss, 1982; Rosenfeld, 
2002; Joshi et al., 2007). Subsequently new purification procedures were developed to 
generate insulin from swine pancreas and with the advent of recombinant DNA 
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technology recombinant insulin was developed and expressed in E.coli as discussed in 
more detail below. 
Diabetes has a number of effects on those that suffer from the condition, including the 
long-tenn damage, dysfunction and failure of various organs if the disease is not 
controlled (Fowler, 2008). Patients may present with characteristic symptoms including 
thirst, polyuria, blurring of vision, and weight loss (Ringborg et al., 2009). Often the 
initial symptoms are not severe and hence pathological and functional damage may 
proceed for some time before a diagnosis is made. The long-tenn effects include 
retinopathy with potential blindness, nephropathy that may lead to renal failure, and/or 
neuropathy (Ryden et al., 2007). People with diabetes are also at increased risk of 
cardiovascular, peripheral vascular and cerebrovascular disease (Fowler, 2008; Ringborg 
et al., 2009). 
Diabetes is classified into two broad categories, type 1 and type 2. In type 1 diabetes the 
cause is a deficiency in insulin secretion and accounts for .... 10% of all cases of diabetes. 
In type 2 diabetes the cause is a combination of resistance to insulin action and an 
inadequate compensatory insulin secretory response (American Diabetes Association, 
2009). In those patients with type 2 diabetes (also referred to as age-onset diabetes), a 
degree of hyperglycemia sufficient to cause pathologic and functional changes may be 
present for a long period of time before diabetes is detected. Thus, the majority of 
diabetes patients are Type 2 diabetics (American Diabetes Association, 2009). 
It has been observed that the number of patients with Diabetes mellitus has been 
increasing dramatically over the past two decades such that the increase is described as 
an epidemic, leading to many complications in the patients suffering from this disease 
and a substantial variation in the number suffering worldwide in different countries 
(King et al., 1998; Diamond, 2003). The figure ofthe International Diabetes Federation 
showed a very high number of people diagnosed with diabetes and the number has 
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increased from 30 million people to more than 246 million people in only the last twenty 
years (Hossain et aI., 2007). In 2000 the global prevalence of diabetes mellitus was 
estimated for all age groups to be 2.8% and was predicted to rise to 4.4% in 2030 (Wild 
et al., 2004). The lions share of the drastic increase to date, and of the predicted increase 
is in developing and third world countries. The developing countries are also predicted 
to increase further as a consequence of the rapid increase in the aging population these 
countries will have with improved medication and access to foodstuffs, since the 
prevalence of diabetes increases with age. It'has thus been estimated that by 2025 among 
those aged 20 years and above the number of diabetics will increase by 35%. India is 
predicted be the country that will have the largest number of diabetics and the incidence 
is rising especially in urban areas (Ramchandran et al., 2001). Socio-economic, cultural 
and behavioural parameters influence the prevalence as well as the proportion of 
undiagnosed diabetics and thus the number of undiagnosed patients cannot be. 
extrapolated to the whole population (Agrawal et al., 2004a). 
The insulin hormone is important for growth and metabolism in most eukaryotes. It is 
particularly required for normal glucose homeostasis as described above. Insulin 
deficiency causes diabetes mellitus and due to its clinical significance it is considered an 
important model protein for structural studies (Steiner et al., 1985). Insulin enhances the 
uptake of glucose in muscle and adipose tissue by translocating glucose carriers to the 
cell surface from the intracellular pool (Nelson and Alkon, 2005). Mature human insulin 
consists of two separate chains, namely the A-chain which consists of 21 amino acids 
and the B-chain which consists of 30 amino acids. Both chains are joined by specific 
disulfide bridges and are within a single polypeptide chain from a single gene, which is 
matured and processed by proteolytic processing to proinsulin and then to mature 
insulin. The C-peptide is removed from the polypeptide in the process of generating 
mature insulin, and is the portion of the polypeptide that directly connects the A- and B-
chains (Chang et al., 1998). The biosynthesis of insulin therefore includes as the last step 
the proteolytic conversion of a single chain precursor pro insulin to the double chain 
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product of insulin (Steiner & Oyer, 1967). A specific number of amino acids, for 
example 33 and 35 respectively in the cases of porcine and human proinsulin, are 
excised from the middle of the proinsulin during this process to generate the C-chain or 
C-peptide (Chance et al., 1968; Ko et at., 1971). 
Goeddel et al. (1979) synthesized the human insulin gene by recombinant DNA 
technology. The A- and B- chains were cloned separately, the pBR322 plasmid being 
used as the cloning vector, to afford efficient transcription and translation and the 
recombinant genes merged to an Escherichia coli p-galactosidase gene. The mature 
insulin protein was· spliced from the p-galactosidase. The insulin chain material was 
then purified and identified by radioimmunoassay. A complete purification for the 
individual A-chain and an incomplete purification for the B-chain was then performed, 
both chains were mixed, reduced and reoxidized to generate human insulin. 
1.5 Insulin Biosynthesis 
The insulin gene encodes a preproinsulin molecule as a single chain polypeptide; the 
preproinsulin is proinsulin with the signal peptide that directs the molecule to the 
endoplasmic reticulum (ER). The ER is where the initial maturation of the insulin 
biosynthesis process takes place (see Figure 1.1) (Harding and Ron, 2002; Joshi et al., 
2007). Once the preproinsulin is synthesised in the cytoplasm, it is translocated into the 
lumen of the ER through an interaction between the signal recognition particle (SRP) 
and the signal peptide on the insulin polypeptide, the SRP then binding to the SRP 
receptor on the ER membrane (Huang and Arvan, 1994). 
The signal peptide of preproinsulin gets cleaved off in the ER to produce the proinsulin 
molecule. In the lumen of the ER, proinsulin completes the process of protein folding 
and the formation of three disulphide bonds, theses disulphide bridges being essential for 
insulins stability and bioactivity (Narhi et at., 1993; Dai and Tang 1996; Hober et al., 
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1997; Weiss et al., 2000; Guo and Feng., 2001; Yan et al. , 2003). The properly folded 
proinsulin is then carried to the Golgi apparatus for packaging in the secretory granules 
(Huang and Arvan, 1994). 
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Figure 1.1. Insu lin biosynthesis steps from preproinsulin to proinsulin and finally the mature insulin 
(Joshi et at. , 2007). 
Proinsulin binds only weakly to the insulin receptor and the bioactivity of the insulin 
hormone increases massively after proteolytic processing to generate mature insulin 
(Galloway et aI., 1992). The conversion of proinsulin to insulin takes place inside the 
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secretory granule of the pancreatic p-cell during its maturation after passing through the 
Golgi apparatus and entering the immature secretory granules (Huang and Arvan, 1994). 
At this stage the C-peptide is cleaved by a specific prohonnone convertase to genertae 
the mature insulin which is then released by exocytosis along with the C-peptide (Grant 
and Coombs, 1970; Steiner, 1998; Weiss, 2009). The cleavage takes place at two 
conserved digestion sites, the first between the B-chain and the C-peptide and the other 
between the C-peptide and A-chain junctions (Weiss, 2009). 
As mentioned above, the insulin folding process in the ER requires the fonnation of 
three disulphide bridges. Two of these bridges are between the A and B-chains (A7-B7 
and A20-B 19), the third bond is an intrachain bridge within the A-chain between the 6th 
and the 11 th amino acids in the chain (see Figure 1.2) (Hua et al., 2006; Narhi et al., 
1993; Dai and Tang 1996; Weiss et al., 2000; Guo and Feng., 2001; Van et al., 2003; 
Teuscher, 2007). To obtain and maintain the final structure of insulin each disulphide 
bond should be correct and maintained. Disulphide isomers between the A and B-chain 
are less stable and have low biological activity (Hua et al., 1995; Hua et al., 2002). 
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Figure 1.2. The amino acid sequence of human, porcine and bovine insulins and the location of the inter-
and intra-chain disulphide bridges in the three insulins (Teuscher, 2007). 
1.6 Insulin Hormonal Regulation 
The insulin molecule as a hormone has various effects and functions in the body. Within 
seconds following the sensing of insulin in the blood stream by insulin receptors, 80% of 
body cells raise glucose uptake and cell membranes become more penetrable to various 
amino acids, phosphate and potassium ions (Guyton and Hall, 2006). Leftover 
carbohydrates, which cannot be put into storage as glycogen, are also turned under the 
171Page 
Molecular Identification and Characterization of Camel Milk Insulin Motasem Ismail 
stimulation of insulin into fat and accumulate in the adipose tissue (Guyton and Hall, 
2006). Indeed, the rate of glucose uptake in adipose and muscle cells is regulated by 
insulin. Insulin also stimulates and thereby is involved in the regulation of many 
pathways. The insulin receptor is embedded in the plasma membrane and is composed 
of two extracellular alpha subunits and two beta subunits embedded in the plasma 
membrane (see Figure 1.3 for a schematic representation). The receptor is a tyrosine 
kinase receptor and once insulin binds to the receptor alpha subunit, the beta subunit 
catalyses the substrates tyrosine phosphorylation (Chang et al., 2004; Shepherd, 2005; 
Nadendla, 2008). 
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Figure 1.3. The alpha and beta subunits of the insulin receptor and their intra and extracellular locations 
(Nadendla, 2008). 
Tyrosine phosphorylation of the insulin receptor substrate (IRS) results in the 
stimulation of the phosphatidylinositol3-kinase (PI-3K) pathway. The PI-3K pathway is 
responsible for the production of the phosphatidylinositol 3,4,5-tris-phosphate (PIP3) in 
the plasma membrane. PDKI protein (3-phosphoinositide-dependent protein kinase) is 
activated by the presence of PIP3. Then, the PDK-l phosphorylates and stimulates both 
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atypical protein kinase C (aPKC) and the protein kinase B (PKB) proteins, which are 
required for the glucose transporter (Glut 4) translocation to the cell membrane, this 
process being summarised in figure 1.4 (Chang el al. , 2004; Shepherd, 2005; Eriksson, 
2007). Protein kinase B (PKB) is a key regulatory protein as it promotes the 
phosphorylation of many proteins, including pro-apoptotic protein (BAD), glycogen 
synthase kinase-3 (GSK3P) involved in cellular growth and glycogen synthesis, and also 
the subclass 0 of the forkhead family transcription factors Foxo I which are involved in 
regulating gene expression (Bhatt el al., 20 I 0 ). Furthermore, insulin binding to its 
receptor results in the phosphorylation of the adapter protein APS which activates the G 
protein TC 10 that is foound in the lipid rafts. TC lOis involved in the control of a 
number of cellular mechanisms including changing the actin in the cytoskeleton, 
controlling the adapter protein CfP4, and building of the exocyst complex. Together 
these pathways are important in controlling and recovering the glucose transporter Glut4 





Figure 1.4. Insulin signalling via the Pl3K-dependcnt pathway in adipocytes and skeletal muscle 
(Eriksson, 2007) 
191 P agc 
Molecular Identification and Characterization of Camel Milk Insulin Motasem Ismail 
GLUT4 is the insulin responsive glucose transporter and is mainly responsible for 
insulin motivated/stimulated glucose transport processes in the muscle and adipose 
tissues (Herman and Kahn 2006; Furtado et a/., 2002; Bryant et a/., 2002). It is found in 
intracellular vesicles in the absence of insulin and relocates to the plasma membrane in 
the presence of insulin stimulation to increases the uptake of glucose (Dugani and Klip 
2005). GLUT4 facilitated glucose transport is a rate limiting function in glucose 
utilization in the muscle and adipose tissues (Zisman et a/., 2000; Kim et a/., 200 I). 
When insulin stimulation stops, GLUT4 proteins leave the plasma membrane by 
endocytosis to the intracellular storage compartment and hence are recycled (Dugani and 
Klip, 2005, Ornata et a/., 2000; Ramm et a/ 2006; Zhao and Keating, 2007). Along with 
the translocation regulation of GLUT4, insulin raises the GLUT4 expression in 
adipocytes in the presence of glucocorticoids (Hajduch et a/., 1995; Hernandez et a/., 
2003; Zhao and Keating, 2007). 
1.7 Insulin Variation between Species 
A study by AI-Swailem and colleagues (2008) showed that the amino acid sequence of 
camel proinsuIin B showed 100% homology when compared with other species such as 
pig, dog, horse, sheep and ox. It showed 95.2% homology with man, cemacaque, rabbit, 
elephant, chihamster and opossum which was not considered a significant variation 
while mouse and rat showed a highly significant variation (66.6%). On the other hand, 
the A-chain showed 100% homology with ox, 95.2% with sheep, and a significant 
variation with man, cemacaque, rabbit, pig, dog and elephant (90.5%). The camel A-
chain had a significant variation upon comparison with horse, rat 1, chihamster and 
opossum (85.7% homology) and a considerably high variation upon comparison with 
squirmonk and guinea pig (76.2% homology). The above-mentioned differences were 
considered relevant enough for the authors to suggest that a study into the molecular 
mechanisms and responses of such different insulins should be undertaken (AL-Swailem 
et a/., 2008). 
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In terms of amino acids, there are three amino acid changes from porcine insulin to 
bovine insulin at positions 8, 9 and lOin the A-chain (Figure 1.2). The immunological 
reactivity may vary due to these amino acid differences. Human and porcine insulin 
have a change of a single amino acid at position 30 of the B-chain and it has no known 
effect on insulins immunological reactivity (Trenkle, 1972). 
1.8 Milk Insulin 
At the time of early lactation, insulin interacts with the bovine somatotropin (bST) to 
improve the milk yield and protein synthesis in dairy cows. These effects are most likely 
mediated through a combination of effects of bST on gluconeogenesis and nutrient 
mobilization, bST-induced insulin peripheral resistance, and bST/insulin synergism on 
insulin growth factor-I (lGF-I) secretion and on the metabolic activity of the mammary 
tissue. Insulin's ability to increase milk protein content, even with a modest increase in 
the insulin level observed, requires further studies to obtain the goal of manipulating the 
diet of animals to increase the pancreatic stimulation that leads to increased endogenous 
release of insulin. Such strategies to get increased insulin secretion in cows with high 
plasma bST concentrations are of interest to the agricultural industry (Molento et al. J 
2002). 
To obtain lipogenesis similar to those observed during early lactation the co-culture with 
three hormones insulin, corticosterone and prolactin is required (Strong et al., 1972). 
The effects of these hormones on cell division and protein synthesis in vitro in the mid-
pregnant mouse mammary gland are well documented (Topper, 1970; Mills & Topper, 
1970; Shushanov, 2011). The epithelial cells are stimulated while culturing with the 
insulin to synthesize DNA and further division. The daughter cells are then highly 
sensitive to cortisol which leads to the production of enormous amounts of rough 
endoplamic reticulum. Only then can the epithelial cells respond to the synergistic 
actions of insulin and prolactin by synthesizing casein (Forsyth et al' J 1972). 
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1.8.1 Camel Milk Insulin 
Wernery et al. (2006) reported the mean concentration of insulin in camel serum as 
12.77 ± 7.62 ~U/ml while the mean insulin concentration in camel milk is 41.9 ± 7.38 
~U/mJ. Insulin is existing in the milk of other mammalians but in lesser amount, the 
insulin mean concentration in human milk is 211JTU/ml (Kulski and Hartmann, 1983) 
while in bovine milk is 16 IJIU/ml (Shehadeh et al., 2001) and 17 IJIU/ml in porcine 
milk (Westron et al., 1987). The following chart (figure 1.5) shows the differences in 
milk insulin concentration among species. 
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Figure 1.5 Differences in milk insulin concentration (~IU/ml) among camel, human, bovine and porcine. 
Agrawal et al. (2004b) studied the oral hypoglycemic effect of camel milk on diabetic 
rats induced by streptozotocin. The study included five different groups. The first 3 
groups group were offered raw camel milk, pasteurised camel milk and lactoferrin 
spiked camel milk, respectively, the 4th group was offered pasteurised raw cattle milk 
and the 5th group was the control group on a normal diet without streptozotocin 
treatment. This study showed that in those taking the raw camel milk the mean glucose 
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levels were found in the normal range of 70 to 90 mgldJ. It was further found that the 
blood glucose level of all the untreated groups getting raw milk showed a decrease in 
glucose levels, however .the rate of decline was higher in the first group of animals 
getting camel milk when compared with the groups getting raw cattle milk. From such 
observations it has been suggested that camel milk can be used as a therapeutic 
adjunctive option for diabetes melJitus in humans. This study shows that in diabetic rats 
getting raw camel milk there was a significant decrease in the mean blood glucose level, 
however there was no apparent added advantages of adding lactoferrin in the raw camel 
milk. The study also importantly showed that after pasteurization hypoglycemic activity 
decreases. 
Agrawal (2004a) observed a low frequency of impaired fasting glucose (IFG), impaired 
glucose tolerance (lGT) and diabetes (OM) in the Rica population consuming camel 
milk routinely. This study in the Raica community in North-Western Rajasthan was 
informative with regard to the potential beneficial effects of drinking camel milk 
regularly. The age-adjusted prevalence of diabetes (0.0%), IFG (3.2%), and IGT (8.6%) 
of camel milk consuming Raica subjects was significantly lower than those consuming 
other milks where the p~evalence is 4.6%, 7.8%, and 20.6% respectively. 
Agrawal et al. (2007b) also referred to the hypoglycemic activity of camel milk and 
assigned this property to different factors including, the high concentration of insulin or 
insulin like substances in camel milk, the positive immune effect on beta cell function 
and the absence of coagulum formation under the acidic conditions. This also suggested 
that the nature of the intake of food may have effect on the secreted milk composition. 
Camels prefer natural vegetation food such as salty plants, desert bushes and herbs like 
neem. Some herbs may permit secretion of some phyto-chemicals that have anti-diabetic 
activity. 
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In a further study the Soroka Teaching hospital collected colostrum and milk from 
camels, cows, goats, sheep and women two days after birth as part of their normal 
routine examinations. All samples were kept frozen until subsequent analysis. 
Additionally, samples of store brought milk (cows) and camel-milk ice cream were 
obtained and frozen. The insulin concentrations in the milk samples were then 
determined by specific RIA. The insulin content of the ruminating animals blood was 
considerably higher than those of their milks. Woman colostrum contained insulin but at 
levels similar to those of milk of the other animals. The lowest insulin level was found in 
cow milk. Store milk had the lowest insulin content of all the samples. The study of 
camel milk on blood glucose levels was informative. In fasted animals administered 
camels milk, blood glucose levels started to decline after 6 minutes (P<O.OOI) and 
declined 24% within 8 minutes, then began to rise again to the initial levels after 10 
minutes (Zagorski et al., 1998). 
Wemery et af. (2007b) measured the insulin concentration in camel milk and colostrum 
over a lactation period for 310 days .. The highest insulin concentration was observed in 
the first 48 hours of lactation with a mean of 286.5 J.1IU/ml then the concentration 
decreased to reach a mean value of 40.5 ± 10.7 J.1IU/ml after 160 days. Before, dry off the 
insulin concentration increased again, suggesting different regulatory mechanism at play 
and the potential for different levels of insulin in the feed for the calves. 
Another more recent study (Agrawal et al., 2009) was carried out to determine the 
efficacy of camel milk in controlling diabetic nephropathy. Its nature is microvascular 
and it is an important complication usually found in diabetic patients. In this study the 
authors managed to study the role of camel milk in controlling microalbuminuria levels 
in type I diabetic patients. For this study they recruited 24 type I diabetes patients 
randomly and observed that after adding camel milk to their diet there was a 
considerable decrease in the rate of micro albuminuria (119.48 ± 1.68 to 22.52 ± 2.68; 
p<O.OO I). It was suggested that this change may be due to the direct effect of camel milk 
or due to the better glycemic control as a result of taking camel milk. The actual 
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mechanisms behind these observations however, are yet to be uncovered. Associated 
with this, and possibly because of the good nutrition value of camel milk, there was a 
slight increase in mean Body Mass Index (BMI) (18.52 ± 0.73 to 19.43 ± 0.81) after 
camel milk consumption, and there was a significant reduction of insulin dose required 
to maintain glycemic control. The mean dose of insulin/day was reduced to 28.32 ± 2.66 
after addition of camel milk into patients treatment regimen, from a mean of 41.61 ± 
3.08 before treatment. It was assumed from this study that these changes are the 
consequence of the insulin or insulin like protein content found in the camel milk. It was 
also found that there was a countable change in cholesterol, high-density lipoprotein 
(HDL), low-density lipoprotein (HDL), very-low-density lipoprotein (VLDL) and 
triglycerides after consuming camel milk. This observation may be due to the low fat 
content in the camel milk (Agrawal et at., 2009). The fat content in camel milk is 2.49-
3.1 g %, while it is 3.79 g % in cows milk (Surwit et aT., 1992). 
1.9 Stability and Special Features of Camel Proteins 
Camel milk proteins themselves have been reported to be unusually stable, possibly as a . 
result of components of the camel milk itself acting as stabilisers. The effect of 
pasteurization, heat treatment and different storage temperatures on the concentration of 
insulin in camel milk have been studied by Wemery et at. (2006a). A minor decrease of 
about 7% in the insulin concentration was observed after pasteurization and storage at 
4°C for 24 hours with a slightly larger decrease of approximately 13% observed after 
longer storage at 4°C for 4 days. A much higher reduction of approximately 26% was 
observed after boiling at 95°C for 5 min. However, overall these studies showed that 
camel milk insulin us heat stable. 
The immune system of camel is different from all other mammals. This has been 
described by Casterman et at. (1993). In the camel, antibodies lack the conventional 
light chain and the antibody molecule consists only of the two heavy chains (Riechmann 
et at., 1999) that reduced their average molecular weight to 95 kDa instead of 150-160 
kDa for the conventional molecule from other species (Waron et at., 1987). The camel 
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antibody consists of one single antigen binding domain called the VHH, this domain 
created by merging the variable domains of two heavy chains (VH) (Figure 1.6). The 
VHH has a strong antigen-binding capacity and offers the potential of interacting to 
epitopes that are undifferentiated by conventional VH-VL pairs. The absence of the 
variable light chain is balanced by the existence of the long complementary determining 
region (CDR3) loop (Muyldermans et ai. , 2001). The camel HVV site has high 
neutralizing activity to enzyme antigens (antigens that binds to the enzymes and inhibit 
their function) , whilst conventional antibodies are less likely to have this property. A 
camel hypervariable domain is a strong and selective inhibitor to hepatitis C enzyme 
system (Martin et ai., 1997). 
Light chain (b ) 
Heavy chain 
Classical Ab Heavy-chain Ab 
Figure 1.6. Schematic image of (a) classical antibody, (b) heavy-chain antibody of camelid . 
Abbreviations: Ab, antibody YH, variable domain of heavy chain; YHH, variable domain of heavy chain 
ofheavy-cbain antibody; YL, variable domain of light chain (Muyldermans et 0/., 2001 ). 
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Camel and human antibodies have a similar antigen affinity but the camel antibodies are 
smaller in size and this facilities the antibody access to the target (Jassim & Naji, 2001). 
Figure 1.5 shows the difference between the classical and camel antibodies. 
Elagamy et af. (2000) also found that cow and buffalo milk whey proteins are less heat 
resistant than camel ones. Among camel whey proteins, p-Iactoglobulin is more stable 
than serum albumin and less stable than a-lactalbumin. The concentration of 
antimicrobial factors like lysozyme (LZ), lactoferrin (LF) and immunoglobulin G (IgG) 
in camel milk is higher than cow and buffalo milk. It has also been found that the heat 
resistance of lactoferrin is greater than immunoglobulin G but less than lysozyme. In 
general the concentration of the antimicrobial factors in camel milk are higher than cow 
and buffalo milk. The authors concluded that the biological activity of protective 
proteins in heat-treated cow and buffalo milk proteins at 75°C for 30 minutes is less than 
that of camel milk. 
1.10 Recombinant Proteins 
In the past, clinically used therapeutic proteins were purified from natural sources, being 
isolated from human or animal sources. For instance, the human follicle stimulating 
hormone (FSH) was purified from womens urine (Dickey et al., 2002), human growth 
hormone (GH) was isolated from human bodies (Rappaport and Graham, 1987) and 
insulin hormone from cows and pigs (Feldman et af., 1963). Treatments using such 
sources had many safety doubts (Rappaport and Graham, 1987; Feldman et al., 1963). In 
the present day, the animal origin of isolated proteins is rare for biotherapeutic purposes 
because of the advent of recombinant DNA technology. 
In the last thirty years the advancement in the biotechnology filed has resulted in the 
production of therapeutic proteins from recombinant genetic material using either 
prokaryotic (bacteria like Escherichia cob) or eukaryotic (yeast or mammalian cells) 
expression systems. The term recombinant is used in order to differentiate them from 
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naturally produced proteins and to indicate that they are expressed and produced by 
recombinant genes. The first recombinant protein permitted for human use was insulin 
produced in E.co/i in the United States of America in 1984 (Walsh, 2005). Tissue 
plasminogen activator (tPA) was the first recombinant protein produced by transfected 
Chinese hamster ovary (CHO) cells as a mammalian cell host in 1986 (Wurm, 2004; 
Bertschinger, 2006). 
Mammalian cells, particularly CHO cells, and E.coli cells are the most widely used 
expression systems for biotherapeutic proteins with almost half the therapeutic protein 
products available in the market being produced in mammalian cells (Wurm, 2004 and 
Walsh,2006). 
1.10.1 Production of recombinant protein in Bacteria: 
Protein expression in bacterial cells is considered the most commonly utilized 
expression system for recombinant protein synthesis. The main reasons of this is because 
that the bacterial cells are quite easy to manipulate, low cost to culture, and the time 
needed to synthesis a recombinant protein using it is short and it's easy to scale up the 
protein production (Sahdev et al., 2008). Though, as it is a prokaryotic system, the 
expressed eukaryotic proteins in this system are not modified properly, hard to facilitate 
the secretion of enormous amounts of the recombinant protein. Additionally, the largely 
expressed proteins can may precipitate and form the inclusion bodies (Hunt, 2005; 
Khow and Suntrarachun, 2012). 
Escherichia coli bacterial system is the most frequently used expression system for 
recombinant industrial and pharmaceutical protein production and large scale production 
systems are established. However the E. coli may accumulate a pyrogenic 
lipopolysaccharide for humans and animals. Thus the recombinant therapeutic proteins 
should be purified twice to produce endotoxin free products (Petsch and Anspach 2000; 
Terpe, 2006) 
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1.10.2 Production of recombinant protein in yeast cells: • 
Yeast combines the advantage large amount production of recombinant protein in short 
period of time and the ability to perform the eukaryotic posttranslational modifications, 
like glycosylation, disulfide crosslinking and phosphorylation. Saccharomyces 
cerevisiae is the first yeast species to be used for the recombinant protein production 
(Holz and Lang, 2005). The yeast expression systems are well developed and the 
genetics and physiology of this organism are extremely studied. The yeast expression 
systems were widely used to understand the function and properties of many of 
mammalian proteins (Romanos et aT., 1992). Different Saccharomyces cerevisiae 
expression systems are available to increase the protein production by eliminating the 
main proteases or enhance the transcription and expression level (Harashima, 1994). The 
recombinant proteins generated by this technology either be produced in the cytoplasm 
or secreted through the secretory pathway (Holz and Lang, 2005). 
1.10.3 Production of recombinant protein in mammalian cells 
CHO cells are the most widely used mammalian cells for the generation of 
biotherapeutic proteins for medical applications, however other cell lines such as the 
human embryo kidney (HEK293), mouse myeloma cells NSO and the baby hamster 
kidney (BHK-21) cell lines have also been used for recombinant protein production 
(Wurm, 2004). 
Although the mammalian cell cultures are more expensive and complicated than 
microbial cells, the mammalian cells are more desired in some cases because of their 
capability to perform specific post-translation modifications of proteins, mainly 
glycosylation and disulphide bond formation (Walsh, 2006, Walsh and Jefferis, 2006). 
Yeast is also able to make disulphide bonds and glycosylate proteins, however the 
glycosylation in this host differs from that of mammalian cells (Walsh, 2006) therefore 
efforts have been undertaken to "humanize" the process of glycosylation in non-
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mammalian hosts (Wildt and Gerngross, 2005). Table 1.2 summaries the differences 
between the prokaryotic, yeast and mammalian expression systems. 
Table 1.2 Differences between the prokaryotic, yeast and mammalian expression systems 
Expression system Prokaryotic cells Yeast Mammalian cells 
Commonl) used cells Escherichia coli Saccharomyces cerevisiae Chinese hamster ovary ce ll s 
Handling Straightforward Straightforward Requires expertise 
Post-translational 
No moderate Yes 
modifications 
Cost Cheap Cheap Expensive 
References Sahdev el al., 2008 Wildt & Gerngross, 2005 Walsh & Jefferis. 2006 
1.10.4 Transfection methods 
The generation of recombinant proteins from mammalian cells requires the transfection 
of DNA, usually in a plasmid, into the target host cell. This may then be expressed 
transiently or stably if the material is incorporated into the cellular genome. Many 
different transfection methods have been established for the delivery of DNA into 
mammalian cells. The se lection of the transfection method depends on the cell type and 
purpose of use. The ideal approach must have low cell toxicity, high transfection 
efficiency, the least effect on the cell physiology, it should be reproducible and easy to 
use. The three different methods used are biological , chemical, and phys ical mediated 
methods (Kim and Eberwine, 2010). 
1.10.4.1 Biological Method 
Viral transfection is the most frequently used method in clinical studies and is also 
termed transduction (Pfeifer and Verma, 2001). Viral transfection is easy to achieve, 
extremely competent and the expression us ing thi s method is sustained due to the viral 
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nature of integration into the transfected cell genome. For instance, retrovirus murine 
leukemia virus has been used as a viral vector for stable trans gene expression in human 
(Hacein-Bey-Abina et al., 2002; Roesler et al., 2002 ). The major disadvantages of this 
transfection method are immunogenicity and cytotoxicity. The integration of the viral 
vector could cause an inflammatory reaction and mutation, this being due to the random 
integration of the viral vector into host genome which may activate oncogenes, disrupt 
tumour suppressor genes or interrupt vital genes (Woods, 2003). From a recombinant 
protein perspective, the use of viral vectors carries the potential threat of introducing 
viral material into the final product. 
1.10.4.2 Chemical Method 
Chemical transfection methods are the most extensively used methods (Schenbom and 
Goiffon, 2000). Chemical methods· use cationic polymer like calcium phosphate, 
cationic lipids and cationic amino acids (Schenbom and Goiffon, 2000; Holmen, 1995; 
Washboume and McAllister, 2002). The mechanism of all chemical methods is thought 
to be similar. The positively charged chemicals attract negatively charged nucleic acids 
to form nucleic acid/chemical complex. This positively charged complex is then 
attracted to the negatively charged cell membrane. The exact mechanism of cell 
membrane integration is unknown; it is thought that a endocytosis and phagocytosis 
processes may playa rule in this process. The transfected DNA must then be delivered 
to the nucleus to be expressed and once again the exact nature of this process is 
unknown (Luo and Saltzman, 2000; Kim and Eberwine, 20 I 0). Many factors control the 
transfection rate when using chemical methods, the efficiency of this method being 
largely dependent on factors such as nucleic acid/chemical ratio, pH value of the media 
and the type of cell, hence the method results in less transfection efficiency. However, 
this technique has advantages of generally low cytotoxicity and no mutagenesis (Kim 
and Eberwine, 2010). 
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1.10.4.3 Physical Methods 
Direct microinjection and electroporation are commonly used methods in physical 
transfection. The direct microinjection method is an effective technique in injecting the 
genetic material into cultured cells or nuclei by fine needle (Cappechi, 1980). This 
technique was used to produce transgenic organisms after directly transfecting the 
embryonic stem cells with the required genes (Bockamp et al., 2002). The device used 
for this method is quite expensive and the technique requires expertise and it is not a 
method of choice for studies that need a large quantity of the transfected cells (Mellott et 
al.,2012). 
Wong and Neumann in 1982 were the first to use the electroporation technique for gene 
transfer into mouse cells. The mechanism of this method is based on using an electrical 
pulse to disturb .the cell membrane and form pores to allow the nucleic acid to enter the 
cell (Shigekawa and Dower, 1988). The technique requires optimisation to balance 
between pulse duration and strength for each type of cell used. Furthermore, 
electroporation often requires more cells than the chemical methods because of the 
enormous cell death during the procedure and the extensive optimization that must be 
undertaken and is essential to control the transfection efficiency and cell viability. 
Therefore the physical transfection method is reliable but it needs expensive instruments 
and causes physical damage to samples (Mellott et al., 2012). However, this is widely 
used in the generation of cell lines for the industrial production of biotherapeutic 
proteins. 
1.10.5 Transient Transfection 
The transient transfection and expression of target proteins is a useful method that 
allows fast investigation and generation of small amounts of the recombinant protein. 
The cells are transfected with the gene of interest and then cultured for a limited time to 
allow for the gene to be expressed (Reeves, 2006). Because the gene is not integrated 
into the genome, the target protein usually reaches a peak concentration 2-3 days after 
321 P age 
Molecular Identification and Characterization of Camel Milk Insulin Motasem Ismail 
transfection, then the cells and culture medium are collected to assay and purify the 
expressed protein. The transient expression is more often used because it is a fast and 
simple method (Reeves, 2006). As mentioned previously, the transiently transfected 
genes are not integrated with the host genome (Figure 1.6B) and are only expressed for a 
short period of time (Recillas-Targa, 2006). The transiently transfected genetic material 
can be lost due to environmental factors, digestion of the material, and during the 
mitosis/cell division (Kim and Eberwine, 2010). 
1.10.6 Stable Transfection 
The purpose of stable transfection is permanent integration of the gene of interest into 
the host cell genome (Figure 1.6A). The integration into the genome is a random 
process, so the expression is influenced by the site of integration and.also the number of 
copies of the targeted gene that stably integrated into the genome (Reeves, 2006). The 
Flp-In system is a recent technology in this field produced by Invitrogen. This 
technology allows targeted integration of the gene of interest into the host genome by 
DNA recombinase. This technology is a quick process and generates reproducible and 
highly productive cell lines (Sauer, 1994). 
To establish a stable cell line, a plasmid cloned with the target gene should be deliver to 
the host genome and integrated into it. The transfected cells undergo antibiotic resistance 
selection (the antibiotic resistance gene is carried on the plasmid), hence the 
untransfected cells and the inefficiently transfected cells will be killed by the antibiotic, 
while the antibiotic resistant cells will form colonies on the surface of a culturing flask 
(Kunaparaju et al., 2005). CHO cells are well characterised genetically, and the stable 
cell lines generated with them have been extensively used for many years to synthesis 
many of the commercially important recombinant proteins. Bioreactors for large scale 
cultivation of CHO cell are also well established and hence these are the current gold-
standard mammalian expression system used in industry (Reeves, 2006). 
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Figure 1.6. The proces of two different transfection approaches. (A) Stable transfection. Foreign D A is 
carried to nucleu through the cell and nuclear membranes then integrated with the host genome and 
become expressed continuou ly. (B) Transient transfection. Foreign D A is deli vered into the nucleus to 
be expre ed for a hort period of time without genome integration. From (Kim and Eberwine, 2010) with 
slight modification 
1.11 Protein Stability: 
Throughout preparation, processing, storage and shipping of the pharmaceutical peptide 
products, the physical and chemical integrity of the peptide is subjected to many 
circumstances which may have substantial effects on its. Therefore, many peptides 
should be transported and warehoused under cold conditions (Zahn et al., 2006). 
The unfolding and aggregation of proteins have been involved in some diseases like 
Alzheimer'S and Creutzfeldt Jakob ' s diseases (Harper and Lansbury, 1997; Dobson, 
2001) . Thus, understanding the protein stability in solution is significant to assure proper 
handling for pharmaceutical biotherapeutics (Cheung and Raverkar, 2006). 
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The main pathways of peptide degradation are generally classified into: chemical and 
physical instability. Chemical instability is any process altering the peptide by 
formatting or cleaving covalent bond, creating new chemical objects (Manning et 01., 
2010). Chemical instability pathways are oxidation, hydrolysis, isomerization, 
racemization, disulfide exchange, deamidation, and p-elimination (Li et 01., 1995). Any 
changes to the higher order structure can be considered as Physical instability like 
dimerization and aggregation (Frokjaer and Hovgaard, 2000). 
1.11.1 Factors affecting protein stability: 
1.11.1.1 Temperature 
High temperatures not only result in physical denaturation but also can cause a chemical 
degradation (Zhang et (II., 1995). In some proteins the denaturation that induced by heat 
is reversible while the most of the protein denaturation cases are irreversible at high 
temperatures, the reversibility of unfolding can be strongly affected by modifying 
solution conditions (Mulkerrin and Wetzel, 1989). The used buffer, pH, and protein 
concentration also can affect the stability against the high temperature denaturation 
(Mulkerrin and Wetzel, 1989). The cysteine containing proteins fail to form free thiol 
groups when heated at 100°C (Volkin and Klibanov, 1987). 
1.11.1.2 Freeze-Thawing 
Some proteins are sensitive to the frequent freeze and thaw ~hich result in extensive 
aggregation (Chang et 01., 1996; Jameel et 01., 1997; Papandreou and Fenouillet, 1997). 
It has been suggested that the frequent freeze and thaw processes is causing interfacial 
adsorption at ice liquid interfaces which enhance the protein aggregation (Kreilgaard el 
01., 1998). 
1.11.1.3 Agitation and Exposure to Denaturing Interfaces 
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The proteins in aqueous solution are exposed to agitation or shaking through the 
handling and shipping of the product (Henson et 01., 1970). The protein denaturation and 
also aggregation that induced by agitation is probably due to protein interactions with 
surfaces (air or storage vial) (Charman et 01., 1993; Henson et 01., 1970; Kreilgaard et 
01., 1998; MacRitchie, 1986; Sluzky et 01., 1991). 
1.11.1.4 Pressure 
The high pressure can induce unfolding intermediates of the protein (Clery et 01., 1995; 
Muller et 01., 1981; Wong and Heremans, 1988; Yamasaki et 01., 1998). Within certain 
pressure limits, the denaturation induced by pressure induced is reversible (Zhang et 01., 
1995). It has been suggested that the pressure denaturation is a result of the 
destabilization in the hydrophobic core due to the water transfer into it (Hummer et 01., 
1998; Wolfenden and Radzicka, 1994). 
1.11.1.5 The value of pH 
The protein stability in aqueous solution is greatly depends on pH. It has been found that 
at pH value of 1-3 the triptorelin protein generally go through acid catalysed hydrolysis 
due the deamidation of the C terminal amide and produce free acid deamidated peptide. 
While in the pH of 5-6, the peptide backbones of triptorelin are hydrolyzed at the N-
terminal side of the serine residue [Hoitink et 01., 1997 ; Strickley et 01., 1990). At pH 
values above 7, base- catalyzed epimerization is the main pathway of degradation. 
Serine is most likely involved in base-catalyzed epimerization through a carbanion 
intermediate (Hoitink et 01., 1997) 
1.11.1.6 Deamidation of Asn and GIn residues 
Deamidation is considered as common chemical degradation pathway for proteins. 
Peptides consisting glutamine (GIn) and asparagine (Asn) amino acids can go through a 
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spontaneous deamidation to form glutamic acid (Glu) and aspartic acid (Asp) amino 
acids under certain physiological environments (Manning et a/., 2010). 
1.11.1.7 Auto, Photo and Metal ion catalyzed Oxidation pathways 
Peptide oxidation is a chemical degradation pathway. The organic molecules oxidation 
is either a decrease in hydrogen content or an increase in oxygen (Solomons, 1992). The 
peptides that contain methionine (Met), tyrosine (Tyr), histidine (His), tryptophan (Trp) 
and cysteine (Cys) amino acids can ~e impaired due to their extreme interaction with 
many reactive oxygen species (ROS). Oxidation process can be prompted by light 
exposure and the contaminating oxidants. Metal ions can enhance the oxidation process 
during handling and storage. Temperature, pH and buffer composition can influence the 
oxidation reaction (Payne and Manning, 2009). 
In 2007, Kerwin and Remmel studied the light induced degradation in 
biopharmaceuticals. Photo induced oxidation starts when the protein absorbs a certain 
light wavelength, this gives energy to raise the molecule to an excited state. The excited 
molecule can then move that energy to molecular oxygen and convert it to responsive 
singlet oxygen atoms. By this mechanism the tryptophan, histidine, and tyrosine can 
modify by oxidation in the presence of light (Li et a/., 1995, Grosvenor and Morton, 
2010). 
1.11.1.8 Disulfide exchange reactions 
Disulfide exchange reactions contribute to the formation of dimers and larger 
aggregates. These reactions may occur at the cysteine-cysteine link. (Windisch et a/., 
1997). 
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1.12 Aims of this Study 
This project sets out to more fully investigate and define camel milk insulin and test the 
hypothesis that camel milk insulin is unique in terms of the makeup of the proinsulin 
molecule, the C-peptide and its sequence, and mature insulin, which is in tum reflected 
in its stability and structure. 
The aims of the project are as follows: 
• To identify and sequence the camel insulin gene. 
• To undertake SNP analysis and confirm the sequence of the gene encoding camel 
insulin. 
• To map the chromosomal position of camel insulin gene using FISH technique. 
• To undertake bioinformatic analysis to compare the camel insulin gene and 
protein with other species. 
• To purify camel insulin from camel milk and investigate the properties of 
purified camel insulin. 
• To express the camel insulin protein in a Chinese hamster ovary (CHO) cell line 
using recombinant DNA technology. 
• To investigate the biophysical properties of camel milk insulin and the protective 
nature of camel milk on insulin and other protein stabilities upon temperature 
stress and compare this to other species insulin. 
The scope of the project coveres all the aspects mentioned in the proposal, in addition to 
this; the protein was expressed Mammalian cell line instead of the bacterial expression 
cells to provide the expressed protein the correct folding and to avoid any insulin 
isomers. 
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Chapter 2 
Materials and Methods 
2.1 Materials 
All camel milk and colostrum samples were collected from the Emirates Industry for 
Camel Milk and Products farm. The blood samples were collected from the camel pen of 
the Central Veterinary Research Laboratory (CVRL). The pancreatic tissue was 
collected from the CVRL post-mortem from newly deceased camel carcasses ~fter 
analysing and determining the reason for death and before sending them for incineration. 
All collection of samples at the CVRL was undertaken using authorised protocols 
following the required guidelines. 
2.2 Camel Insulin Protein Isolation from Camel Milk 
Camel milk samples were defatted and treated with rennet enzyme in order to remove 
casein which is the major milk protein and problematic in subsequent purification 
schemes if left in place when trying to purify less abundant proteins. The purification 
procedure developed for insulin purification involved 4 steps of which the first was 
defatting, the second casein treatment, the third ion exchange chromatography and 
finally an immunoaffinity chromatography step. Each of these is described in more 
detail below. 
2.2.1 Defatting of Camel Milk Samples 
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Camel milk samples were defatted by centrifugation at 4000 g for 10 min at 10°C. A 
commercial cream separator (Motor Sich-80, Latvia) was used for large scale defatting. 
2.2.2 Casein Treatment of Milk and Colostrum 
Three different methods were then used to remove the casein from the defatted milk, 
casein being the major milk protein component. The first method used was acid 
precipitation. In this method the whey was obtained after acid precipitation of caseins at 
pH 4.6 by adding 1 ml of 10% acetic acid (v/v) and 1 ml of 1 M sodium acetate to 10 ml 
of milk or colostrum followed by incubation at 37°C for 10 min and centrifugation at 
4000 x g for 10 min at 10°C (EI-Hatimi et al., 2007). 
The second method used was rennet enzyme treatment. This method is undertaken using 
rennet enzyme tablets (Hundsbichler, Austria), these tablets being used commercially for 
cheese making. Rennet tablets (25 mg) were dissolved in 0.1 ml of water then mixed 
well with one litre of defatted milk before the samples were incubated at 37°C for 1 
hour. The whey was then separated by centrifugation at 4000 g for 5 min. 
The third method used was the ethanol precipitation method. Ethanol (50% final 
concentration) was used to precipitate the casein and other higher molecular weight 
proteins. The whey fraction was isolated by filtration using Whatman filter papers 4 
(Cat. No. 1004-240). The insulin concentration in the whey fraction was measured and 
determined by radioimmunoassay (RIA) as described below. 
2.2.3 Radioimmunoassay (RIA) for the Determination of Insulin Concentrations 
Radioimmunoassay (RIA) was undertaken throughout this study to determine the 
concentration of insulin present using a commercially available human insulin kit. 
During the purification studies all milk fractions were analysed using the human anti-
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insulin antibody from the human insulin RIA kit (INS-Irma, KIP1251-KIP 2154, 
Diasource Europe, Belgium) following the manufacturers instructions. Six insulin 
controls with a range of activity from 0 to 440 JlIU/ml and the samples were briefly 
vortexed and 50 JlI of each sample and control were transferred to the respective 
antibody coated tubes. Fifty microliters of the tracer e25Iodine labelled anti-insulin) 
were dispensed into each coated tube. To release any trapped air bubbles, the rack 
containing the tubes was shaken gently by hand. After 2 hours incubation at room 
temperature, the total content of each tube was aspirated. The tubes were then washed 
twice with 2 ml of Working Wash solution (supplied with the kit). The content of each 
tube was aspirated after each wash. The radioactivity was then counted for 60 sec using 
a gamma counter LKB wizard 1470 (LKB, Sweden). The standard curve was prepared 
based on the control results and the concentration of each sample calculated using the 
generated standard curve. Samples with an insulin concentration above the highest 
standard were diluted with the zero concentration control and reanalysed. 
2.2.4 Western Blotting 
The sensitivity of Western blotting to detect human insulin was determined by running 
serial dilutions of human insulin on a 12% SDS-PAGE gel from 10 IU/mL-10 J.1IU/mL. 
The primary antibody used was the commercially available anti-human insulin antibody 
(Diasource Cat. 51.125.26, Belgium). Ten JlL of protein were added to 10 JlI of loading 
butTer (Laemmli buffer, Bio-Rad, USA) and incubated at 70°C for 10 minutes. After 
incubation, the samples and a protein pre-stained standard marker (SeeBlue Plus2, 
Invitrogen, USA) were loaded into a 12% NuPAGE gel (Invitrogen) in NuPageMES 
running butTer (Invitrogen) for protein separation by SDS-PAGE in a XCell SureLock™ 
mini-cell apparatus (Invitrogen). The gel was run for 75 minutes at 150 V and then 
blotted onto 0.2 JlM polyvinylidene difluoride (PVDF) membrane (Invitrogen) by 
electro-blotting in an XCell IITM Blot Module (Invitrogen). After 1 hour of blotting at 30 
V the membrane was washed in phosphate buffer saline (PBS). The membrane was then 
incubated in blocking solution (0.1 % Tween and 5% non-fat dry milk in PBS) for 1 h 
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and then incubated overnight at 4°C with the anti-insulin antibody which had been 
diluted at a ratio of 1 :500 in PBS buffer containing 0.1 % Tween and 0.1 % non-fat dry 
milk. The following day the membrane was washed 3 times with PBST (0.1 % Tween 20 
in PBS) buffer for 10 minutes each, and then incubated in secondary antibody (Horse 
raddish peroxidase conjugated rabbit-anti-mouse JgG, Dako) diluted 1:1000 for I hour, 
then washed 4 times with PBST for 10 minutes each. The membrane was then developed 
with 2 ml ofimmobilon Western chemiluminescent HRP substrate (Millipore, USA) and 
incubated in the dark for 4 minutes. Finally, the immunocomplexes were exposed to 
lumi-film chemiluminescent detection film (Roche). The films where developed in a 
compact X4 system (Xograph imaging systems). 
2.2.5 Gel Filtration Chromatography 
Gel fihration chromatography was ·undertaken using G-25 Sephadex beads (GE 
healthcare, USA) using decaseinised colostrum samples where 2.5 ml of sample was 
passed manually through a 5 ml column. The column was washed with 12 ml of 0.1 M 
NaCI in 0.02 mM Tris buffer and fractions collected every 1 ml. 
2.2.6 Ion Exchange Chromatography 
Ion exchange chrom.atography was performed using A-25 DEAE Sephadex beads (GE 
healthcare, USA). Several trails were initially undertaken in order to maximise the 
recovery of insulin. Initially the purification was undertaken at a small scale with a small 
amount (as detailed below) of milk and colostrum in a 5 ml column, and then the 
purification expanded to process 100 litres of milk using a 1 litre chromatography 
column. The trails were carried out in order to optimise the washing and elution 
conditions. Rennet enzyme treated samples, supernatant 50% ethanol precipitated 
samples and untreated defatted raw milk and colostrum samples were all investigated to 
find the best feedstock to load the column for maximum recovery of insulin. 
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In all, six different ion exchange chromatography trails were performed. In all ion 
exchange chromatography runs the column was equilibrated with 3 column volumes of 
50 mM NaCI in 0.02M Tris buffer and all washing and elution buffers were prepared in 
0.02 M Tris buffer. Fractions of 100 I.d were collected throughout and stored at -20°C 
for subsequent insulin quantitation by RIA. In one trail the LP biologic chromatography 
automated system (BioRad, USA) was also used. 
In the first trail, diluted decaseinised colostrum was used where 3 ml of decaseinised 
colostrum was diluted with 11 ml of equilibration buffer and loaded onto a 5 ml column 
of DEAE A-25 Sephadex beads. The column was then washed with 6 ml of 10 mM 
NaCI washing buffer and eluted with three different concentrations of elution buffer (10 
ml of 50 mM, 10. ml of250 mM and 12 ml of 1 M NaCI respectively). 
In the second trail 11 ml of decaseinised colostrum sample was used without dilution in 
the same column as used in the first trail, the column washed with 15 ml of 100 mM 
NaCI washing buffer and eluted with two different concentrations of elution buffer (20 
ml of 500 mM and 20 ml of 1 M NaCI respectively) followed by a 20 ml wash with 1 M 
acetic acid. In third trail, 45 mt of defatted raw milk was used in the same column as 
used in the first and second trails, the column washed with 20 ml of 50 mM NaCI 
washing buffer and eluted with three different concentrations of elution buffer (250 mM, 
500 mM and of 1 M NaCI respectively) using 20 ml of each for elution. 
The fourth trail was undertaken using 250 ml of defatted decaseinised raw whole milk 
using a 5 ml column of A-25 DEAE Sephadex. The sample was loaded in 5 batches with 
5 washes of 15 ml of 50 mM washing buffer (l after loading each batch). After loading 
the entire amount of sample, the column was washed with 30 ml of 250 mM NaCI 
washing buffer and then eluted with 70 ml of 1 M NaCI.· 
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The fifth trail was undertaken on an ethanol treated defatted raw milk sample in a 5 mL 
column of A-25 DEAE Sephadex beads. To obtain a 50% ethanol final concentration, 
100 ml of absolute ethanol was added gradually to 100 ml of defatted raw milk while 
stirring. The sample was then incubated at 4°C overnight. The clear supernatant layer of 
a volume of 100 ml was separated and loaded onto the pre-equilibrated column. The 
column was then washed with 35 ml of 50 mM NaCI washing buffer and then eluted 
with 25 ml of250 mM NaCI elution buffer followed by 65 ml of 1 M NaCI buffer. 
The sixth and final trail was also undertaken on an ethanol treated defatted raw milk 
sample using the biologic LP automated chromatography system (BioRad, USA). For 
ethanol precipitation the sample was treated as described in the fifth trail. After attaching 
a 20 ml column of DEAE A-25 Sephadex beads to the chromato~aphy system, the 
column was equilibrated with 60 ml of equilibration buffer. The sample was then loaded 
using a flow rate of2 mVmin. The column was then washed with 80 ml of 80 mM NaCI 
washing buffer, then eluted with 20 ml of 1 M NaCI elution buffer. Two peaks were 
observed on the LP data viewer (A280 nm) during the washing step and 3 strong peaks 
during the elution. The fraction(s) corresponding to each peak were collected and 
analysed to determine their insulin concentration by RIA. 
2.2.7 Immunoaffinity Chromatography Purification of Camel Milk Insulin 
The immunoaffinity chromatography column was designed using anti-human insulin 
antibodies, specifically a monoclonal antibody IgG anti-human recombinant insulin 
(Diasource Cat. 51.125.26, Belgium) linked to Sepharose 4 beads. The initial 
immunoaffinity chromatography trail was undertaken on 22 ml of decasienised 
colostrum which had been treated with rennet enzyme to remove the casein. A three mL 
column was equilibrated with 12 ml of 50 mM glycine pH 8.0; 0.1% NaN03 (w/v) and 
the sample loaded onto the column at a flow rate of approx. 30 mllhour at 4°C. The 
column was then washed 10 times with 4 ml of 1.25 M NaCI in 50 mM glycine pH 8.0 
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before the insulin was eluted with a buffer consisting of 50 mM glycine and 1.5 M NaCI 
at pH 2.3. For the second and third immunoaffinity purifications, the NaCl concentration 
was reduced to 0.5 M in the elution buffer. The eluted product was collected in 10 
fractions of 2 ml each. The pH was adjusted immediately after every elution with 60 J.l1 
of 1 M Tris-buffer for every 2 ml sample. 
2.2.8 Purification of Camel Milk Insulin from large quantity of camel milk 
The first purification was undertaken with 100 L of camel milk. The milk was defatted 
by centrifugation in 50 ml tubes at 4000 g for 10 min and the samples then loaded onto a 
pre-equilibrated 1 L column of DEAE A-25 Sephadex beads. After 11 hours of 
continuous sample loading the column was washed with 3 L of 0.2 M NaCI and then 
eluted with 6 L of 1 M NaCI in 3 batches. 
In the second purification the supernatant of the 50% ethanol treated sample was used. 
After defatting of the milk using the cream separator (Motor Sich-80, Latvia), chilled 
absolute ethanol was added gradually to the sample in a 1:1 ratio with stirring in a 4°C 
room. After adding 60 L of ethanol to 60 L of defatted milk (two hours), the sample was 
then incubated overnight at 4°C. The following day the sample was separated into two 
layers. The transparent upper layer was separated carefully using a pump and then 
filtered through a 1 J.lm filter. The sample was then loaded onto an equilibrated 1 L 
column of DEAE A-25 Sephadex beads over a 6 hour period. The column was then 
washed with 2 L of 80 mM NaCI buffer and then eluted in 12 fractions where the first 8 
fractions were eluted with 700 mM NaCI elution buffer and 1 M NaCI elution buffer 
used to elute the last 4 fractions. 
In the third purification, 45 L of defatted milk was used. The milk was defatted using the 
cream separator machine (Motor Sich-80, Latvia). The sample was loaded in 6 batches 
where 7.5 L of the defatted milk was loaded in each batch. After each batch the column 
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was washed with 2 L of 50 mM NaCI buffer and then eluted with 1 L of200 mM NaCI 
followed by 2.5 L of 500 mM NaCI in 5 fractions. The insulin concentration in all 
. fractions was analysed and determined by RIA. 
Chromatography fractions with the highest insulin concentrations as determined by RIA 
were pooled and together the volume was 5.5 L. The sample was then filtered through a 
0.2 Jim filter unit and then concentrated 38 times using a Pellicon XL 50 ultrafiltration 
cassette with a 5 kDa. molecular weight cut off (Cat. No. PXB005A50, Millipore, USA). 
The sample concentration process was undertaken in a 4°C room for 2 days and resulted 
in 145 ml of concentrated sample. 
The concentrated sample (145 ml) obtained from the 2nd and 3rd purifications was 
divided into two portions (80 and 65 ml) and passed through the immunoaffinity 
chromatography column separately. The conditions were as described in the trail 
experiments except for a modification in the salt concentration of the elution buffer 
which was decreased from 1.5 M to 0.5 M NaCI. 
The two purification schemes for the isolation of camel milk insulin are described below 
in Figure 2.1. 
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Figure 2.1 The steps of camel milk insulin purification from raw camel milk. 
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2.3 Analysing the Isolated Camel Milk Protein 
Western blotting was undertaken on purified camel milk insulin according to the 
procedure described in section 2.2.4. The 3rd, 4th and 5th immunoaffinity chromatography 
elution fractions from the first portion (80 ml concentrated sample) were analysed by 
western blotting. As a monomer insulin band couldn't be visualized by western blotting, 
and to con finn the presence and the size of the camel insulin, 50 JlL of the 3rd 
immunoaffinity chromatography elution fractions from' the first portion (80 ml 
concentrated sample) were initially analysed by SDS-PAGE. The resulting gel was cut 
into 13 horizontal sections and each gel section was cut separately into tiny pieces and 
then incubated overnight with shaking in passive diffusion buffer consisting of 20 mM 
TrisHCl (pH 7.5), 150 mM NaCI, 0.1% SDS and 2 mM EDTA. Following day the liquid 
was separated from the gel pieces and the insulin concentration determined by RIA. To 
recover more insulin from gel pieces, a second technique was performed using the 
protocol described by Steven et al. (2007) where 100 JlI of buffer containing H20/2-
propanol (2: 1 v/v) was used to recover protein from 11 horizontal sections of the SDS-
PAGE gel. 
2.3.1 In-gel Digestion of the Isolated Camel Insulin 
One mL from the immunoaffinity chromatography where the insulin concentration was 
90000 JlIU/ml, was divided into two tubes and concentrated in a speedvac to a volume 
of 10 Jll. Each sample was then mixed with the same volume of Laemmli sample buffer 
(Bio-Rad Laboratories). The samples were then run on a 12% Tris base (Invitrogen) 
precast gel and electrophoresed at 150 V. After protein separation, the gel was stained 
with Bio-Rad Coomassie Brilliant Blue Staining solution for 1 h with constant shaking. 
The bottom of gel where the insulin band was expected was horizontally sectioned into 
four sections. The sections were labelled from A to D starting from bottom as in figure 
2.2. Each gel section was then placed in a separate 1.5 ml tube. 
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Figure 2.2. Location of the gel ections u ed for in-gel digestion after SDS-PAGE separation. The 
pre ta ined tandard SeeBlue Pl us2 marker (In itrogen, USA) is on the extreme right side of the image. 
The gel piece were de tained with acetonitrile/200 mM ammonium bicarbonate (1 : 1 
ratio) for 15 min at room temperature before the destaining solution was removed and 
the gel lice washed with fresh destaining solution by pipetting up and down. The 
solution was then di carded and the gel pieces dried in a SpeedVac for 30 min. The gel 
section were then rehydrated with 30 ilL of 10 mM dithiothreitol (DTI) dissolved in 5 
mM ammonium bicarbonate and the protein reduced for 45 min at 56°C. The OTT wa 
then carefully removed from the sample and di carded. Thirty ilL of 50 mM 
iodoacetamide in 5 mM ammonium bicarbonate was then added and the protein was 
alkylated for 45 min at r om temperature in the dark. The iodoacetamide was then 
carefully remo ed from the sample and di carded . The gel pieces were then washed with 
5 mM ammonium bicarbonate for IS min with gentle agitation and the solution 
removed . One wash with 50% acetonitrile was then performed with gentle agitation and 
the olution replaced with 30 J..LL of acetonitrile/25 mM ammonium bicarbonate (I : I 
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ratio) and the gel sections dried in a SpeedVac. Forty J.1L of sequencing grade trypsin 
solution (Promega) was then added to the sample and the gel pieces were allowed to 
rehydrate at 4°C for 1 h. Excess trypsin solution was carefully removed from the sample 
and discarded. Thirty J.1L of 50 mM ammonium bicarbonate was then added to the 
sample and incubated overnight at 37°C. On the following day the solution from the gel 
tubes was removed and stored. 30 J.1L of 50% acetonitrile was then added to the gel 
pieces and sonicated for 15 min at room temperature. The solution was then aspirated 
and added to the solution stored from the previous step. Another 30 J.1L of 50% 
acetonitrile with 5% formic acid was then added and sonicated for 15 min at room 
temperature and the solution was also added to the isolated mixture from the previous 
two steps. Finally, the pool solution from the last 3 steps was completely dried in a 
SpeedVac. The dried peptides were then reconstituted with 20 1.1I of 0.1% trifluroacetic 
acid and analysed by liquid chromatography-mass spectrometry. The mass spectrometry 
analysis was conducted using a microTOF-Q machine (Bruker DaItonics) using the 
electrospray ionization mass spectrometry technique. 
2.4 PCR Amplification and Sequencing of the Camel Insulin Gene 
2.4.1 DNA Extraction 
DNA was extracted from camel blood and pancreas tissue using the commercially 
available MagNA pure LC system (Roche, Germany) using the MagNA pure LC DNA 
large volume isolation kit (Roche Germany) according to the manufacturer's 
instructions. 
2.4.2 PCR Amplification of the Camel Insulin Gene 
The camel insulin gene was amplified using Cam-INS-F2 (5'· TTT GTG AAC CAA 
CAC CTG TGC GGC TC-3') and Cam-INS-R2 (5'-CGT CTA GTT GCA GTA GTT 
CTC CAG CTG-3') primers, which were optimized to amplify the camel proinsulin 
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cDNA (AL-Swailem et 01., 2008). The PCR reaction volume was 25 JlL and consisted of 
400 J.1M dNTPs, 500 nM of appropriate primers, 2 units of Fast start Taq DNA 
polymerase (Roche, Germany) and 2.5 JlL of lOX PCR buffer. A Tetrad thermal cycler 
from BioRad was used to run all PCR reactions. The cycling conditions were as follows: 
40 cycles of denaturing at 94°C for 30 s, annealing at 64°C for 45 s and polymerization 
at 72°C for 45 s, followed by a final extension at 72°C for 5 min. The PCR products 
were analysed on a 1.5% agarose gel and the presence of the expected 768 bp band 
confirmed. 
2.4.3 DNA Sequencing of the Camel Insulin Gene 
Each 2 JlL o~ PCR product was treated with 0.1 U of exonuclease I and 1 U of shrimp' 
alkaline phosphatase (both from USB, USA) before sequencing the amplified fragment. 
The amplified fragment was sequenced using the BigDye terminator v3.1 kit (Applied 
Biosystems, USA) according to the manufacturer's recommendations. Three ilL of the 
treated PCR product from the last step were mixed with 0.3 JlL primer and 2 JlI BigOye 
terminator and the reaction volume made up to 5 III with d.d.H20. The samples were 
cycled in the thermal cycle as follows; 1 cycle at 96°C for 1 min and 25 cycles of 96°C 
for lOsee, 50°C for 5 sec and 60°C for 4 min. 
To clean the sequencing reaction products from the excess BigDye terminator and 
primers, 1.25 III of 125 mM EDT A was mixed with sequencing reaction product and 25 
III of cold absolute ethanol was added to each sample and centrifuged at 1650 X g for 30 
min, and then the ethanol was removed by quickly spinning the sequencing plate upside 
down at 185 X g force. The washing step was repeated with 70% ethanol for 15 min 
followed by centrifugation. Finally, the plate was dried and the sequencing reaction 
product of each sample was reconstituted in 10 JlI of Hi-di Formamide (Applied 
Biosystems, USA) and loaded into the ABI 3730XL sequencing machine. 
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The sequencing results were analysed using DNA sequencing analysis software version 
5 (Applied Biosystems, USA). Using a BLAST search the sequenced fragment was 
matched to a BAC clone sequence from Llama pacos CH246-515B 17 clone with 96% 
homology. Primers Fl (5'- CAC TGG TCC TTG AGC CTA GC -3') and R2 (5'- CAG 
GAA AGG TGC AGA TTG GT -3') to amplify the upstream and downstream regions of 
the insulin gene were then designed using the matched clone, the primers being designed 
using the primer 3 online software tool (http://frodo.wi.mit.edulprimer3/). The fragment 
of 1960 bp was amplified using the designed primers in a 25 J.lL PCR reaction volume, 
500 J!M dNTPs, 500 nM of appropriate primers, 3 units of Fast start Taq DNA 
polymerase (Roche, Germany) and 2.5 ilL of lOX PCR buffer and with cycling 
conditions 40 cycles of denaturing at 94°C for 45 s, annealing at 62°C for 45 sand 
polymerization at noc for 2 min's, followed by a final extension at noc for 10 min. 
The PCR products were then analysed on a 1.5% agarose gel. The amplified fragment 
was then sequenced using the protocol described above. To sequence the entire fragment 
internal primes R3 (5'-GGC CTT GGG TOT GTA GAA GA-3') and F867 (5'-CTT CGC 
T AA CCA OCA CCT OT -3') were designed using Llama pacos CH246-515B 17 clone 
and the primer3 online software tool (http://frodo.wi.mit.eduJprimer31). 
2.5 Identifying the Insulin Gene Regions and Single Nucleotide Polyrnorphisms 
(SNP's) of Camel Insulin 
The insulin gene regions (signal peptide, A- and B-chains and C-peptide) were identified 
based on the previous publication of the insulin gene of other species (Bajaj 1986, 
Brown 1955, Kwok 1983) and by Basic Local Alignment Search BLAST comparison 
with published sequences. In order to identify the single nucleotide polymorphisms 
(SNP's) in the camel insulin gene, thirty two different camel samples were sequenced 
and the resulting sequences then aligned by DNAMAN software version 5.2.2. The 
SNP's were then identified from the insulin sequence differences among the 32 camels. 
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2.6 Taxonomic Alignment and 3D Homology Modelling 
The complete DNA sequence was analysed with Basic Local Alignment Search Tool 
BLAST search (http://blast.ncbi.nlm.nih.govlBlast.cgi). DNAMAN software (Lynnon 
corporation, Canada) was used to convert the DNA sequence to an amino acid sequence 
and subsequently align the amino acid sequence across 13 different species. This 
software was also used to construct a homology tree between the Dromedary camel and 
. the 13 different species compared. The 3-dimentional structure of the camel insulin 
protein was generated using· 3D-JIGSAW protein Comparative Modelling Server 
(http://www.bmm.icnet.ukl-3djigsawl). The resulting model was viewed with RasMol 
software version 2.6 and PyMOL software version 1.3. 
2.7 Camel Insulin Gene Localization with Chromosomes 
The insulin gene localization was undertaken using Fluorescence in situ hybridization 
(FISH) on cultured lymphocyte metaphases. Two methods were used to localize the 
camel insulin gene on camel chromosomes. The first method used was by hybridizing 
the amplified PCR product of the camel insulin gene on the camel chromosomes. The 
second method used was by hybridizing a BAC clone that included the insulin gene. The 
clone was selected by BLAST search and the presence of the insulin gene was 
confirmed by PCR. 
2.7.1 Cell Culture 
Peripheral blood was collected from 3 camels. 8 ml of sterile complete growth medium 
(RPMI-1640) and 1.5 ml of inactivated fetal calf serum were then put into a 25 cm2 
sterile culture flask and then 0.1 ml of p·okeweed mitogen (PWM) added to the flask. 0.5 
ml of blood was added to the flask, mixed and incubated in 5% C02 and 80% humidity 
for 96 hours. 70 JlI of colcemid (10 Jlg/ml) was then added to the culture 1 h before 
harvesting. The cultured cells were then mixed vigorously and transferred to a tube and 
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centrifuged at 200 g for 10 min. The supernatant was then removed and the cells 
resuspended in 7 ml of 0.075 M KCl and incubated at 37°C for 30 min before the cells 
were fixed with 3: 1 methanol:glacial acetic acid 3 times for 30 min for each fix. 
2.7.2 Probe Labelling 
2.7.2.1 PCR product labelling 
Two labelling procedures were adapted to label a 1960 base pairs PCR fragment that 
includes the insulin gene. The fragment was amplified using the primers Fl (5'- CAC 
TGG TCC ITG AGC CTA GC -3') and R2 (5'- CAG GAA AGG TGC AGA TTG GT-
3'). The first method is the nick translation labelling method using Biotin labelled 16-
dUTP by Biotin-Nick Translation mix (Cat. No. 11745824910, Roche, Germany), where 
1 J.lg ofthe PCR product was made up in a 16 J.l1 volume of d.d. H20 and mixed with 4 
J.lI of Biotin neck translation mix. The mixture was then incubated at 15°C for 90 min. 
The labelling reaction was terminated by heating at 65°C for 10 min and by adding I J.lI 
of 0.5 M EDT A (pH 8). The second method was the PCR labelling procedure using the 
PCR DIG Probe Synthesis Kit (Cat. No. 11636090910, Roche, Germany). In this 
method the primers Fl and R2 were used to amplify and label the fragment of camel 
insulin and the surrounding regions with digoxigenin (DIG) labelled dUTP. The 
labelling PCR reaction was prepared and undertaken according to the manufacturers 
instructions. 
2.7.2.2 BAC clone labelling 
BAC clone number CH246-515B17 from Llama pacos was selected by BLAST search 
using the high throughput genomic sequencing (HTGS) database. In order to subculture 
the BAC clone, a sterile tip was dipped into the original BAC broth culture and 
transferred to 30 ml of LB broth (lOg Bacto-tryptone, 5 g yeast extract and 109 N aCI to 
1 L H20) containing chloramphenicol antibiotic at 20 J.lg/ml concentration and then 
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incubated in 37°C shaking incubator overnight at 225-250 rpm. On the following day, 
the cultured tube was centrifuged at 4000 rpm for 10 min to pellet the cells and the 
supernatant discarded. BAC DNA was isolated using FlexiPrep kit Cat. No 27928101 
(Amersham bioscinces, USA). The pellet was resuspended in 4 ml Buffer PI. To lyse 
the cells 4 ml of Buffer P2 was added, the tube inverted 6 times and then incubated for 5 
min at room temperature. The mixture was then neutralized with 4 ml of P3 buffer, 
inverted 6 times, and incubated on ice for 10 min. To precipitate the bacterial genomic 
DNA the tubes were centrifuged at 12,000 g for 15 min at room temperature and the 
supernatant carefully isolated and transferred to a 15 ml tube. The BAC DNA was then 
precipitated with 8.4 ml of isopropanol, which was added to the isolated supernatant 
DNA and then centrifuged at full speed for 30 min. The supernatant was then removed 
and the pellet reconstituted with 100 J.11 of H20. The presence of the insulin gene in the 
clone was confirmed by PCR using Cam-INS-F2 and Cam-INS-R2 and the random 
priming method. The BioPrime Array CGH kit catalogue number 18095-011 
(Invitrogen, USA) was used to label the BAC DNA indirectly using biotin labelled 
dUTP. 300 ng of BAC DNA was used for the labelling procedure to prepare a 15 J.11 
reaction. The random primers and BAC DNA were denatured at 95°C for 5 min and then 
immediately chilled on ice for 5 min, the dntp's mix containing biotin labelled dUTP and 
klenow enzyme were then added according to manufacturer recommendation and the 
volume adjusted to 15 J.11 by DEPC-treated water. The labelled product was then run on a 
2% agarose gel to check the labelling efficiency. 
2.7.3 Fluorescence in situ Hybridization (FISH) 
2.7.3.1 FISH with the PCR product of the insulin gene 
The FISH technique was used to localize the insulin gene on camel chromosomes. Slides 
were air-dried, then dehydrated with serial alcohol (70%, 90% and 100% ethanol) using 
5 min for each. A 3 J.11 probe cocktail containing indirectly labelled DNA probes and 9 
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JlI of hybridization buffer (Chrombios, Germany) was then overlaid on the slides. A 
coverslip was placed on each slide and sealed with rubber cement. Slides were then 
placed on an 85°e hot plate for 6 min and incubated overnight at 37°e in a humidified 
chamber. Following this, the slides were washed 2 times in 2X SSC solution containing 
50% formam ide (Q-Biogene, USA) for 5 min at 45°e, soaked in 2X sse for 5 min at 
45°e followed by 2 washes with 4X sse containing 0.1 % Tween 20 for 5 min at room 
temperature. After blocking by soaking in 4X sse solution containing 5% non-fat dry 
milk at room temperature for 5 min, slides were incubated with 100 JlI streptavidin-FITC 
and anti-DIG TRITe cocktail, the dye selected based on the labelling procedure used, 
then incubated at 37°e in a humidified chamber for 30 min. The slides were then washed 
3 times with 4X sse solution containing 0.1 % Tween 20 at room temperature for 5 min 
each time. After the slides were air-dried, antifade with DAP! (Vectashield, Germany) 
was applied to the slides. The slides were then visualized using an Olympus BX61 
fluorescence microscope (Olympus, Japan). Images were captured using Applied 
Imaging eytovision 3.1 software (Applied Imaging, UK). 
2.7.3.2 FISH using BAC clone contains the insulin gene 
A drop of 12 JlI of the fixed cell suspension was spread on a slide exposed to hot steam. 
The slide was then exposed again to the hot steam for 4 sec and then placed immediately 
on a heating block at 65°e and the slides dehydrated in serial alcohol (70%, 85% and 
96% ethanol) and then aged at 65°C for 1 hour, then overnight at room temperature. The 
hybridization buffer was prepared and consisted of 5 ml formamide, 1 g dextran sulfate, 
1 ml 20xsse before the volume was adjusted to 7 ml with ddH20 and pH to 7.0. For 
probe preparation, 1 JlI of the labelled probe was mixed with 7 JlI of hybridization 
buffer, 1 JlI salmon sperm DNA and 1 JlI ddH20. The slides were denatured in 
denaturation solution which contains (70% formamide I 2xSSC) and then immediately 
chilled in an ethanol series 70%, 85% and 96% at -20oe. The probe was denatured at 
73°e for 10 min and then chilled on ice immediately. 5 JlI of the prepared probe was 
then overlaid on the slides. A cover slip was placed on each slide, and sealed with rubber 
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cement and allowed to hybridize overnight at 3 rc in a moist hybridization chamber. 
The slides were then soaked in 2XSSC to drop off the cover slips. Following this, the 
slides were washed with O.4x SSC/0.3% Igepal, pH 7.0 - 7.2 for 2 min at 73°C, then 
soaked into storage buffer (4x SSC / 0.05% Igepal) for 15 min at room temperature. 
After blocking by' soaking in storage buffer containing 2.5% bovine serum albumin at 
room temperature for 25 min, 90 III of the detection mix (prepared from 50 III of 
blocking buffer, 50 JlI storage buffer and 0.5 J.lI streptavidin-Cy3) was added to each 
slide, covered with a cover slip and incubated at 3rC in a dark humidified chamber for 
35 min. The cover slips were then removed and the slides washed 3 times in storage 
buffer for 3 min each wash with agitation. After rinsing with ddH20 the slides were air-
dried and then antifade DAPI solution (Vectashield, Germany) was applied. The slides 
were then visualized using an Olympus BX61 fluorescence microscope (Olympus, 
Japan). Images were captured using Applied Imaging Cytovision 3.1 software (Applied 
Imaging, UK). To identify the chromosomes, 1 mg ofpropidium iodide (Sigma-aldrich) 
was dissolved in 1 ml of phosphate buffered saline (PBS) and 2 III from the propidium 
iodide solution were then added to I ml DAPI. Finally, 50 J.l1 of the propidium 
iodidelDAPI solution were dropped onto each slide to produce a banding pattern similar 
to the GTG banding. 
2.8 Synthesis of Recombinant Camel Insulin 
2.8.1 Recombinant Insulin Synthesis from Mammalian Cell Lines 
To produce camel insulin from a mammalian cell line, recombinant clones using the 
commercially available pcDNA3.lV5 and pcDNA5 FRT vectors (Invitrogen) were 
prepared and then transfected into a Chinese hamster ovary (CHO) cell line. Initially 
separate clones coding for the A-chain and B-chain of insulin were generated using 
synthetic fragments containing stop codons and phosphorylated sticky ends. The 
fragments were cloned into the Not! and XhoI sites of each vector. In addition, the pre-
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pro-insulin and pro-insulin genes were amplified by PCR using primers with Notl and 
Xhol restriction sites and subcloned into the same sites of the pcDNA3.1 and pcDNA5 
FRT vectors. Due to low recombination efficiency using this pair of sites, the 
subcloning was repeated using HindlII (which is further upstream in the multiple 
cloning site (MCS), see Figures 2.3 and 2.4 ) instead of NotI along with the Xhol 
restriction site. Following this the pcD A3.1 VS constructs were used to transiently 
transfect the appropriate Chinese Hamster Ovary (CHO) cell line as described further 
below. It was also attempted to produce CHO cell lines stably expressing camel insulin 
using the commercially available Flp-In CHO cell system (Invitrogen) by transfection of 
the Flp-In cells with pcDNAS FRT constructs using the Flp recombinase mediated 
integration system. All transfection procedures were performed using Lipofectamine 
2000 transfection reagent (Invitrogen). 
pcDNA5/FRT 
5070 bp 
Figure 2.3: The map of pcDNA5 FRT vector adapted from the Invitrogen website, 
http://tools.invitrogen .com/content! sfs/vectors/pcd naS frt _map. pdf. 
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Figure 2.4 : The map of pcD A3.1 V5His vector adapted from the Invitrogen website, 
http ://tools .invitrogen.comlcontentlsfs/manuals/pcdna3. 1 topota _man . pd f. 
2.8.2 Primer and Gene Fragment Design 
The gene sequences and fragments were initially designed without the insulin signal 
peptide and phosphorylated after synthesis. The fragments for both the A- and B-chain 
(see Table 2.1) and subsequent phosphorylation were undertaken commercial ly by 1 st 
BASE Custom Oligos, Singapore. The sense and antisense DNA strands were 
synthe ized eparately and annealed using the following conditions; 1 ~I containing 10 
nmo) of each strand was mixed in the presence of 1 J.l1 of lOX T4 ligase buffer 
(Prom ega, USA). This mixture was then heated at 75°C for 10 min before being left to 
cool to room temperature for 1 h. The fragments were designed to have a Notl sticky site 
at the 5' end and a Xhol sticky site at the 3' end. Start and stop codon sequences were 
added to both fragments. 
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Table 2.1. The gene sequences of the sense and anti-sense strands of the camel insulin A and 8 chain 
fragments. The start and stop codons are labelled with red while the sticky ends are labelled with green. 
Name Sequence 5'->3' 
A -cha in-Sense GGCCGCATGGGCATCGTGGAGCAGTGCTGCGCCAGCGTCTGCTCGCTCTACCAG 
Strand CTGGAGAACTACTGCAACTAGC 
A-chain-Anti TCGAGCTAGTTGCAGTAGTTCTCCAGCTGGTAGAGCGAGCAGACGCTGGCGCAG 
Sense Strand CACTGCTCCACGATGCCCATGC 
B-cha in-sense GGCCGCATGTTCGCTAACCAGCACCTGTGCGGCTCACACCTGGTGGAGGCGCTG 
Strand TACCTGGTGTGCGGGGAGCGCGGCTTCTTCTACACGCCCAAGGCCTAGC 
B-chain-Anti TCGAGCTAGGCCTTGGGCGTGTAGAAGAAGCCGCGCTCCCCGCACACCAGGTAC 
sense Strand AGCGCCTCCACCAGGTGTGAGCCGCACAGGTGCTGGTTAGCGAACATGC 
The gene sequence of the preproinsulin (proinsulin with signal peptide) and proinsulin 
cDNA were amplified from pancreatic cDNA as described in section 2.8.3 below. 
2.8.3 Synthesis of Camel Prepro- and Pro-insulin from cDNA 
2.S.3.1 Extraction of Total RNA from Pancreas 
Total pancreatic RNA was isolated as follows . 100 mg of fresh pancreatic tissue was 
frozen in liquid nitrogen and pounded into powder using a mortar and pestle. After 
transferring the tissue powder to a 2 ml tube, 1 ml of TRIzol reagent (Invitrogen, USA) 
was added, mixed thoroughly with the sample and incubated at room temperature for 5 
min. A volume of 0.2 ml of chloroform was then added to the suspension and the tube 
was agitated for 15 sec followed by 3 min incubation at room temperature before being 
centrifuged at 12,000 g for 15 m in at 4°e. The upper aqueous phase was then transferred 
into a new 1.5 m] tube. To precipitate the RNA, 0.5 ml of isopropanol was then added 
and the solution mixed by inversion before being incubated for 10 min at room 
temperature and then centrifuged at 12,000 g for 15 min at 4°e. The supernatant was 
then discarded and the pellet washed with 1 rol of 70% ethanol before being centrifuged 
at 12000 g for 5 min and the supernatant discarded again. The pellet was fmally air dried 
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before being dissolved in 50 III of diethylpyrocarbonate (DEPC)-water. The extracted 
. RNA was then stored at -20°C until required for experiments. 
2.8.3.2 Reverse Transcription cDNA Synthesis 
Insulin eDNA was prepared using the commercially available ImProm-II Reverse 
transcription system (Cat.No. A3800, Promega, USA) by mixing 1 Ilg of isolated 
pancreatic RNA with 1 III of random primer, 20 nmol of each deoxynucleoside 
triphosphate (dNTPs), 4 III of ImProm-II 5X Reaction buffer, 3 mM magnesium 
chloride, O.S III of recombinant RNasin ribonuclease inhibitor and 1 III of ImProm-II 
reverse transcriptase in a total volume of 20 Ill. The reaction mix was then incubated for 
5 min at 25°C followed by a further 1 h at 42°C and then finally at 70°C for 15 min. In 
an initial trial experiment 1 III of Oligo (dT) primer was used instead of the random 
primer. 
2.8.3.3 Polymerase Chain Reaction to Synthesise Prepro- and Pro-insulin 
The gene sequences of the Preproinsulin (proinsulin with signal peptide) and Proinsulin 
eDNA were amplified from pancreatic cDNA generated as described in section 2.8.3.1 
using the primers described in Table 2.2 below. 
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Table 2.2. The sequences of the primers used to amplity the camel prepro-insulin and pro-insulin. All 
primes have a restriction site compatible with the vector into which the subsequent PCR product was to be 
cloned into and extra nucleotides at S' end (overhang) for the restriction enzyme. 
Oligo Name Sequence (5'-->3') 
SP-INS-F AA T GCG GCC GCA TGG CCC TGT GGA CAC GCC 
Proinsulin-F AA T GCG GCC GCA TGT TCG CTA ACC AGC ACC 
Proinsulin-R AA TeTe GAG GTT GCA GTA GTT eTe CAG eTG 
SPHind-F ACG AA T AAG CIT A TG GCC CTG TGG ACA CGC CTG 
PROHind-F ACG AA T AAG CIT A TG TTC GCT AAC CAG CAC CTG 
INSSCXho-R ACG AA T CTC GAG CT A GTT GCA GTA GTT CTC CAG 
To enhance the restriction enzyme digestion efficiency, the primers used to amplify the 
prepro- and pro-insulin were designed to have 3-6 extra bases prior to the restriction site. 
Primers SP-INS-F and Proinsulin-R (Table 2.2) were used to amplify the camel 
preproinsulin gene while Proinsulin-F and Proinsulin-R (Table 2.2) were used to amplify 
camel proinsulin. Both forward primer sets had a Notl restriction site whilst the reverse 
primers had a Xhol restriction site. The primers SPHind-F and PROHind-F (Table 2.2) 
were used separately with the INSSCXho-R primer to amplify the camel preproinsulin 
and camel proinsulin respectively but with a Hind III restriction site at the 5' end and 
stop codon and Xhol site at the 3' end. The primers SPHind-F and PROHind-F were also 
used with Proinsulin-R to amplify preproinsulin and proinsulin fragments without a stop 
codon in order to express the protein with a His tag when cloned into the pcDNA3 . 1 
vector. The total PCR reaction volume was 100 ilL and consisted of 500 11M dNTPs, 500 
nM of each of the appropriate primers, 5 Units of Fast start Taq DNA polymerase 
(Roche, Germany) and 10 ilL of lOX Roche PCR buffer. A Tetrad thermal cycler from 
BioRad was used to run all PCR reactions. The cycling conditions were as follows : 
initial denaturation at 95°C for 5 min, 40 cycles of denaturing at 94°C for 30 sec, 
annealing at 58°C for 30 sec and polymerization at 72°C for 35 sec, followed by a final 
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extension at 72°C for 5 min. 5 ilL of the resulting PCR products were analysed on a 2% 
agarose gel and the presence ofa band of the expected size confirmed in this way. Prior 
to restriction digestion, all samples were purified using the commercially available 
wizard® SV gel and PCR clean-up system (Cat. No. A9281, Promega, USA) following 
the manufacturers instructions. 
2.9 Restriction Enzyme Digestion oCPlasmid DNA and peR Products 
Double digestion with Notl and XhoI restriction enzyme (New England Biolabs (NEB), 
UK) was initially undertaken. However, the restriction site was later changed and Notl 
replaced with HindIII to inc~ease the digestion efficiency. One microgram (1 Ilg) of 
purified PCR product was digested with 10 units of each restriction enzyme in the 
recommended buffer (buffer 3 was used for Notl and XhoI double digestion while buffer 
2 was used for HindIII and Xh~I) in the presence of IX bovine serum albumin (BSA) 
(NEB, UK) in a 50 III volume and incubated for 3 h at 37°C. The enzymes were then 
heat inactivated at 65°C for 15 min. 2 Ilg of vector DNA (pcDNA3.1 and pcDNA5 FRT 
vectors from Invitrogen, USA) were digested with 20 units of restriction enzyme in the 
recommended buffer in a 100 III volume overnight at 37°C followed by an enzyme 
inactivation step at 65°C for 15 min. The correct digestion of plasmid DNA was 
confirmed by conventional agarose gel electrophoresis. The digested PCR products and 
plasm ids were then gel purified on a 1.5% agarose gel. DNA from the gel pieces was 
recovered using the commercially available wizard® SV gel and PCR clean-up system 
(Cat. No. A9281, Promega, USA). The gel pieces were dissolved in a 1:1 ratio v:wt 
membrane binding solution by heating at 55°C for 15 min until they melted completely 
before applying the resulting solution to the column provided in the kit. The column 
with the mixture loaded was then centrifuged at 12,000 g for 1 minute. The flow through 
was discarded and the DNA was washed with 750 III of membrane washing solution 
provided with the kit for 1 min. The washing step was repeated with a 500 III volume for 
5 min and the column was again centrifuged at 12,000 g. The column was then placed 
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into a sterile 1.5 mL microfuge tube and the DNA was eluted from the column using 
warm (50°C) dd. H20. 
2.9.1 Ligation of Plasmid DNA and PCR Products 
All ligation reactions were undertaken in a total volume of 10 J.lI using 3 Units of T4 
DNA ligase (Promega, USA) in 2X rapid ligation buffer (Promega, USA). The molar 
ratio of insert to vector was 3 to 1. Ligation reactions were then left to proceed at 4°C 
overnight. 
2.9.2 Transformation of Ligation Mixtures into Competent E.coli Cells 
Four microliters (4 J.lL) of ligation mix w~s used to transform JMI09 E.coli competent 
. cells (Promega, USA). Bacterial transformation was performed using the heat shock 
method at 42°C for 30 sec then immediately chilling the mixture on ice for 5 min. The 
cells were then left to grow in 400 J.lI of SOC media (Invitrogen, USA) for 1 h before 
spreading the transformed cells onto Luria-Bertani (LB) plates which contained 
ampicillin antibiotic (GIBCO, USA) at a 100 J.lg/ml final concentration . 
. 2.9.3 Colony Selection and Screening Following Transformation 
Colonies were picked from the culture plates and sub-cultured individually in 1 ml of 
Luria-Bertani LB culture media containing ampicillin at a concentration of 100 J.lglml. 
These cultures were incubated at 37°C for 6 h with shaking at 200 rpm in microfuge 
tubes. The plasmid DNA from all colonies was isolated using a crude DNA method 
whereby 10 J.l1 of 0.2 M sodium hydroxide was added to 10 J.l1 of the cultured cells, 
incubated for 5 min at 95°C, and the solution then neutralized with 35 J.l1 of Tris-Hel 
(pH 7.4) before the solution was centrifuged for 30 sec at 12000 g. One microliter from 
the supernatant was then used for the subsequent peR to confirm the presence of the 
expected gene insert. All colonies were screened by peR using a T7 forward primer 5'-
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TAATACGACTCACTATAGGG-3' and a BGH reverse primer 5'-
TAGAAGGCACAGTCGAGG-3'. The total PCR reaction volume was 20 JlL and 
consisted of 100 JlM of dNTPs, 100 nM of each of the appropriate primers, 1 Unit of 
Fast start Taq DNA polymerase (Roche, Germany) and 2 JlL of lOX Roche PCR buffer. 
A Tetrad thermal cycler from BioRad was used to run all PCR reactions. The cycling 
conditions were as follows: initial denaturation at 95°C for 5 min, 35 cycles of 
denaturing at 94°C for 30 sec, annealing at 53°C for 30 sec and polymerization at noc 
for 35 sec, followed by a final extension at noc for 5 min. Five microliters of the PCR 
products were then analysed on a 2% agarose gel. The positive colonies were identified 
by the PCR product size difference in comparison with the control wild type vector 
band. The cloning site and insert of the selected positive clones were sequenced using a 
T7 forward primer and following the sequencing procedure described in section 2.4.3. 
The sequencing results were also confirmed by a second sequencing reaction using the 
BGH reverse primer. The positive colonies were then sub-cultured and plasmid DNA 
generated and purified from these for subsequent experiments as described below in 
section 2. I O. 
2.10 Generation of Recombinant Plasmid DNA for Transfection Experiments 
Following the generation of the cloned camel insulin plasmid material, it was necessary 
to generate sufficient material for transfection into mammalian cells. 
2.10.1 Small Scale (Mini-Prep) and Large Scale Preparation (Maxi-Prep) of 
Plasmid DNA for Transfection Experiments 
For all plasmid DNA preparations, anion ion exchange columns were used, in both small 
and large purification scales from commercially available kits as described below. The 
first construc~s were purified at a small stale using mini-prep columns, later maxi-prep 
columns were used to produce large amount of the construct. 
651 P age 
Molecular Identification and Characterization of Camel Milk Insulin Motasem Ismail 
For plasmid small scale purification (mini-prep), 100 JlI of culture was initially used to 
inoculate 5 ml of a Luria-Bertani LB culture containing ampicillin and the subsequent 
solution incubated at 37°C for 16 h. On the following day the plasmid DNA was 
isolated using the commercially available Wizard® Plus SV Miniprep DNA Purification 
System (Promega, USA) following the manufacturers instructions. Briefly, the bacterial 
cells were pelleted by centrifugation at 4000 g for 10 min and the pellet then 
resuspended in 250 JlI of cell resuspension solution. The cells were then lysed by adding 
250 JlI of Cell Lysis Solution and the tubes inverted 4 times for mixing. After 5 min at 
room temperature, proteins were digested using 10 JlI of alkaline protease solution. The 
tubes were incubated for 5 min at room temperature after 5 inverts. Following this, 350 
JlI of neutralization solution was added and the tubes inverted immediately 6 times for 
mixing. The cell debris and genomic DNA were then pelleted by centrifugation at 12000 
g for 10 minutes. The supernatant was transferred onto a Spin Column provided with the 
• 
kit and centrifuged at 12,000 g for 1 min to bind the plasmid DNA to the column. The 
bound DNA was washed twice using the Washing Solution (using 750 JlI initially for 1 
min and the second wash was with 250 JlI for Smin) and then the DNA eluted with 100 
JlI of warm (50°C) Nuclease Free Water by centrifugation at 12000 g for 1 min after 5 
min incubation at room temperature. 
A similar procedure was undertaken for the large-scale purification but using the 
commercially available Qiagen kit. For large scale purification (maxiprep), 500 JII of a 
positive culture was added to 200 ml of Luria-Bertani LB culture medium containing 
ampicillin at a concentration of 100 Jlglml and incubated at 37°C for 16 h with shaking 
at 200 rpm. On the following day the plasmid DNA was isolated using QIAGEN 
Plasmid Maxi Kit (cat. No. 12162, Qiagen, USA) following the manufacturers 
instructions. Briefly, the bacterial culture was harvested by centrifugation for 10 minutes 
at 4000 g at 4°C. The supernatant was then discarded and the pellet was resuspended in 
10 ml of Buffer PI (Resuspension Buffer containing RNase A). A volume of 10 ml of 
Buffer P2 (Lysis Buffer) was then added to the resuspended pellet, mixed gently and 
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incubated for 5 min at room temperature. Ten millilitres of chilled Buffer P3 
(Neutralisation Buffer) was then added and mixed immediately. The lysate was then 
poured into a QIAfilter Cartridge, which had been closed with a cap on its outlet noozle 
and left for 20 min at room temperature. Using 10 ml of QBT Buffer the QIAGEN-tip 
500 had been equilibrated by applying the buffer and letting the column empty by 
gravity flow. The plunger supplied with the kit was then gently inserted into the 
QIAfilter Cartridge and the lysate filtered through the previously equilibrated QIAGEN-
tip 500. The QC buffer was then used to wash the QIAGENtip 500 twice with 30 ml 
used for each wash. Subsequently the DNA was eluted with 15 ml of Buffer QF (Elution 
Buffer) and then precipitated using 10.5 ml of isopropanol (Merck). After mixing the 
precipitated DNA was centrifuged immediately at 4000 g for 30 min at 4°C and the 
supernatant removed carefully. To remove the precipitated salt, 5 ml of room 
temperature 70% ethanol (Merck) was added to the pellet and the tube was then 
centrifuged at 4000 g for 20 minutes at 4°C. The supernatant was then completely 
removed and the pellet air dried and re-dissolved in 500 J.lI of nuclease free H20. To 
check the purification efficiency, approximately 5 J.l1 of the sample was run on an 
agarose gel. The remaining sample was stored at -20°C until required for further 
experiments. 
2.11 Transfection of CHO Cells with Plasmid DNA 
A Chinese hamster ovary cell line (CHO-Kl, sourced from ECACC) was transiently 
transfected with camel insulin A-chain and B-chain, proinsulin and preproinsulin 
recombinant pc DNA vectors in order to determine if insulin could be produced from 
these constructs The commercially available Flp-In CHO cell line (Invitorgen) was also 
transfected to try and generate stably expressing cell lines. 
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2.11.1 Transient Transfection ofCHO-Kl Cells 
Insulin A-chain and B-chain constructs with stop codon in the pcDNA3.1 V5 vector were 
used in this transfection procedure. The procedure was repeated with prepro-insulin and 
pro-insulin pcDNA3.1 V5 constructs with and without stop codon. Prior to transfection 
2.0 x 105 CHO-KI cells were seeded in each well of a 6-well tissue culture plate in 2.5 
ml of CHO-KIID~EM medium (which contained Dulbecco's Modified Eagle's 
MediumlNutrient F-12 Ham (DMEMlFI2) (Invitrogen), 10% Fetal calf serum, 6 mM L-
Glutamine, Ix non-essential amino acids (Gibco), 7 mg/L each of adenosine, guanosine, 
cytidine, uridine, 2.4 mgIL of thymidine and 60 mgIL each of L-glutamic acid and 
asparagine) and cultured overnight at conditions of 5% CO2, 37°C. The foIlowing day, 
the ceIls were transfected using the commercially available Lipofectamin 2000 
(Invitrogen, USA) cationic lipid reagent whereby two solutions were initiaIly prepared -
(a) 250 J-ll OptiMEM and 12 J-ll Lipofectamine 2000 were mix,ed in a microfuge tube and 
(b) a further 250 J-ll ofOptiMEM was added to 4 J-lg of vector construct DNA and mixed. 
Both mixes were then incubated at room temperature for 5 min. Following this 5 min 
incubation, the two solutions were mixed and incubated for an additional 20 min at room 
temperature. Subsequently, the solution was added to the cells gently and drop wise. The 
cultures were then left for 5.5 h at 37°C, 5% C02. Afterward this period the medium was 
replaced with 2.5 mL of fresh CHO-KII DMEM media and the ceIls incubated at 37°C, 
5% C02 until harvested to analyse for insulin. 
2.11.1.1 Cell lysis and Collection following Transfection 
Forty eight hours after transfection, the medium from transient transfection experiments 
was collected and transferred to 15 ml tubes. The tubes were centrifuged at 200 g for 5 
min to separate any cells and the supernatant then stored at -80°C. Each well of the 
adherent transfected cells was washed with 3 ml of phosphate buffer saline (PBS). After 
removing the PBS, 200 J-ll of extraction buffer (20 mM HEPES, 100 mM NaCl, 1 % 
Triton_X 100, 10 mM p-glycerol phosphate, 50 mM sodium fluoride, 50 mM sodium 
vanadate and one tablet of Complete Protease Inhibitor Cocktail (Roche) per 10 ml 
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buffer) were added to each well. The cells were then scraped using a cell scraper and the 
scraped cells transferred to mircrofuge tubes, vigorously vortexed and incubated on ice 
for 30 min. The tubes were then centrifuged at 4000 g for 10 min at 4°C, the 
supernatant/lysate separated and stored at -80°C until required for further experiments. 
2.11.2 Stable Transfection of CHO Flp-In Cells 
Constructs of the pcDNA5 FRT vector with prepro-insulin and pro-insulin were used in 
the transfection procedure of the commercially available FRT Flp-In cells from 
Invitrogen. Each construct was designed to have and to lack a stop codon (that lacking 
reading into a distal his-tag), therefore a total of 4 vectors were used in this procedure. 
An additional two controls were also used, one was transfection of the Flp-In cells with 
POG44 vector alone and the other was the cell line without transfection. Flp-In CHO-
Kl cells were maintained in Flp-In medium which contain Ham's F12 medium (Cat. No. 
21765-029, Invitrogen, USA) containing 10% Fetal Bovine Serum (FBS) (Cat. No. 
16000-044, Invitrogen, USA) and 0.1 % zeocin. Prior to transfection, 5· x 105 cells were 
seeded into a T25 culture flask with Flp-In medium without Zeocin cultured in 5% C02 
at 37°C. Twenty four hours later, the cells were transfected using Lipofectamin 2000 
(Invitrogen, USA) more-or-Iess as outlined in 2.11.1 above. Briefly, 625 J!lofOptiMEM 
and 30 J!I of Lipofectamine 2000 were mixed in a microfuge tube whilst in another tube 
625 J!I of OptiMEM was used to dilute 9 J!g of the pOG44 vector and 1 Ilg of the vector 
construct DNA. Both mixes were then incubated at room temperature for 5min before 
these were themselves mixed and incubated for an additional 20 min at room 
temperature. Subsequently, the solution was added to the cells in the T25 flask that were 
prepared the previous day. The cultures were then allowed to transfect for 5.5 h at 37°C, 
5% C02. Following this incubation period, the cells were washed with PBS and the 
transfection medium was then replaced with 6 ml of Flp-In medium without zeocin. 
After 48 h the Flp-In medium was replaced with fresh medium supplemented with 
Hygromycin of 500Ilg/ml final concentration. The medium was aspirated and replaced 
with Hygromycin containing medium every 48 h hours. Eight days after transfection 
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when distinct colonies clearly appeared the cells were washed with 5 ml PBS, followed 
with 3 min trypsin-EDTA (Invitrogen) treatment with 500 III volume per T25 flask at 
37°C. Twenty millilitre of hygromycin containing Flp-In medium was added to 
inactivate the trypsin. Cells were then split into 2 T25 flasks and cultured at 5% CO2, 
37°C. The hygromycin containing Flp-In medium was changed 3 days later and the cells 
were transferred to a T75 flask and after another 3 days the cells were transferred to a 
T175 flask with fresh hygromycin containing medium. During each transfer half of the 
cells were cultured and one quarter taken for analysis and the remaining quarter was 
stored in liquid nitrogen as below. 
2.12 Cryopreservation of Cells in Liquid Nitrogen 
To preserve CHO cells in liquid nitrogen, the cell cultures were centrifuged at 250xg for 
5 minutes. The supernatant was then removed and the cells were resuspended in the Flp-
In medium consisting of 10% FCS and 90% Ham's F-12 at a cell density of 5xl06 
cells/mt. The cryoprotective agent, dimethyl sulfoxide (DMSO) was then added to the 
cell suspension at a ratio of I :9. The cell suspension was then dispensed into sterile, 
screw capped, plastic cryotubes in I ml aliquots. The ampoules were placed in a -80°C 
freezer for 3 h before being transferred to liquid nitrogen storage. 
2.13 Cell Lysis using RIP A Buffer 
One quarter of the stable transfected cells were analysed after each trypsin treatment. 
The trypsin treated cells were transferred to 15 ml tubes and then to remove the culture 
medium centrifuged at 200 X g for 5 min. Cells were then washed with 5 ml of sucrose 
containing solution. After removing the sucrose, 400 III of RIPA buffer (Brenner, 1997) 
(25 mM HEPES, 0.2% SDS, 0.5% deoxycholic acid, 125 mM NaCI, 1% Triton_X 100, 
10 mM sodium fluoride, IOmM sodium pyrophosphate, 10 mM sodium orthovanadate 
and one tablet of protease inhibitor per 10 ml buffer) was added to lyse the cells. The 
cells were passed through a needle and syringe several times to breakdown the cells and 
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DNA, followed by incubation at 4°C for 30 min. The tubes were then vortexed and 
incubated again for another 30 min at 4°C and finally centrifuged at 4000 g for 10 min at 
4°C, the supernatant was separated and stored at -80°C until required for analysis 
2.14 Analysis of Material from Transfeded CHO Cells 
In order to investigate the transfected cell lines western blotting and radioimmunoassay 
were undertaken. 
2.14.1 Western Blotting 
All supernatants and cell lysate were analysed by western blotting for the presence of 
insulin. Ten microliters of protein were added to 10 JlI pf loading buffer (Laemmli 
buffer, Bio-Rad," USA) and incubated at 70°C for 10 minutes. The western blotting was 
undertaken following the western blotting procedure described in section 2.2.4. 
2.14.2 Radioimmunoassays 
The cell lysate and the culture supernatants were analysed using a human anti-insulin 
antibody using the human insulin RIA kit (INS-Irma, KIPI251-KIP 2154, Diasource 
Europe, Belgium). The radioimmunoassay was undertaken according to the procedure 
described in section 2.2.3. 
2.15 Chemical Synthesis of the Insulin Peptides 
Human and camel insulin A and B-chains were chemically synthesized using a peptide 
synthesizer and the resulted polypeptides analysed by liquid chromatography mass 
Spectrometry (LCIMS) and purified using reverse phase high performance liquid 
chromatography (HPLC). 
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2.15.1 Solid Phase Peptide Synthesis 
Four different peptides were synthesised by solid phase peptide synthesis which was 
conducted on PSSM-8 peptide synthesizer from SHIMADZU Corporation, Japan . The 
peptides synthesised are described in Table 2.3 below. 
Table 2.3. Am ino acid sequences of the 4 synthetic peptides generated during th is study 
Peptides N - tcnninus ~ C - tenninus Species 
Insulin A-Chain GIVEQCCASYCSLYQLENYCN Camel 
Insulin A-Chain GIYEQCCTSICSLYQLENYCN HLD11an 
Insulin B-Chain FANQHLCGSHLYEALYLYCGERGFFYTPKA Camel 
Insulin B-Chain FYNQHLCGSHLYEALYLYCGERGFFYTPKT Human 
Peptides A and B of camel and human insulin were synthesized at 20 Ilmol scale using a 
0.2 mmol/g of NovaSyn®TGT resin (Novabiochem) and 0.16 mmol of 9-
fluorenylmethoxycarbonyl (Fmoc) amino acids (8 equivalents). In the synthesis process 
3 different types of cysteine were used, each cysteine was protected with different side 
chain protecting groups. The first cysteine in B-chain and the second cysteine of A-chain 
were protected with the acetamidomethyl (Acm) protecting group, while the last in both 
chains cysteine was protected with a triphenylmethyl (Trt) protecting group. A-chains 
have two more cysteine residues involved in intrachain disulphide bridge formation , 
therefore A-chain peptides were synthesised to have the first and the third cysteine 
residues with tert-butyl (tbu) protecting groups. Prior to synthesis the resins were 
washed with DMF for 3 minutes. To start the synthesis, the first resin-bound amino acid, 
Fmoc was deprotected using piperidine where two resin volumes of freshly prepared 
20% piperidine in DMF were recirculated through the resin two times for 7.5 min each. 
The reaction mixture was drained and the resin washed five times for 1 min each with 
excess DMF. For the next amino acid to be coupled, 160 Ilmol of the relevant Fmoc 
amino acid was added along with 500 Ilmol of each of the coupling reagents (both 
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coupling and activating reagents were prepared in DMF) N-
Hydroxybenzotriazole(HOBt)/ 2-(1 H-Benzotriazole-I-yl)-I, I ,3,3-tetramethyluronium 
(HBTU) and 1 mmol of the activating reagent N, N-diisopropylethylamine (DIPEA). 
The reaction mixture was incubated for 45 min to couple the amino acid. Between each 
coupling and deprotection step the excess amino acids were removed by 5 washes with 
600 J-ll DMF for each wash, then washed with 5 ml of DMF (See Appendix 2 and 3 for 
more details about the synthesis calculations). 
To release t~e final peptide product from the resin, the synthetic peptides were treated 
with Trifluroacetic Acid (TF A) and two scavengers, ethanedithiol and triisopropylsilane, 
to react preferentially with the free radical and other reactive species released during the 
cleavage reaction. At the end of the synthes.is, the resins were washed twice with 
methanol and allowed to dry in a speed vacuum concentrator for I h. To cleave the 
peptide from the resin, 750 III of freshly prepared ice-cold cleavage mixture (I % 
triisoproplysilane, 2.5% ethanedithiol, 2.5% H20, 94% TF A) was added, and the 
mixture was incubated for 1 h, then another 750 J-ll of the ice-cold cleavage mixture was 
added and incubated again for 1 h. The reaction mixture was collected from the resins by 
draining it into 30 ml of cold diethyl ether in a 50 ml centrifuge tube and the resins were 
washed again for 5 minutes with 1 ml of undiluted TF A. The washing solution was 
collected from the resin by draining it again into the cold diethyl ether which was used 
for the previous collection. The peptide was precipitated immediately by centrifugation 
at 4000 g for 10 min. The supernatant was decanted and precipitates were washed twice 
with 10 ml of diethyl ether for each wash. The peptides were then dried in the air to 
remove diethyl ether and redissolved in 1 ml of 80% acetonitrile containing 0.1% TFA 
and mixed well with 1 ml more of 0.1 % TF A added. For insulin A-chain peptides, 1.2 g 
of urea was added to enhance the solubility of the peptide. Five microliters of each of the 
4 synthetic peptides were diluted in 45 III of 0.1% TFA and analysed by liquid 
chromatography-mass spectrometry. The mass spectrometry analysis was conducted 
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using a micrOTOF-Q machine (Bruker Daltonics) using the electrospray ionization mass 
spectrometry technique. 
2.15.2 HPLC Purification of Synthetic Insulin Peptides 
High pressure reverse phase liquid chromatography was used to purify the cleaved crude 
peptides from the scavengers and other synthesis by-products. HPLC was undertaken 
using a Waters 600 HPLC system and a CIS reversed phase column. Each synthetic 
peptide was diluted in a I: I ratio with 0.1 % TF A to reduce the concentration of the 
acetonitrile to 20% and then injected in 8 separate injections with a batch volume of 0.5 
ml. The peptides were injected onto the CI8 reversed phase preparative column and then 
eluted at a flow rate of 4 ml/min using a gradient of aqueous acetonitrile containing 
0.1% formic acid. The elution fraction of the B-chain peptide was collected 27 min after 
injection while the A-chain peptides were collected after' 31 min. The fractions of each 
peptide were pooled and stored at -20°C after Iyophilisation. 
2.16 Investigating Insulin Stability in Milk 
Bovine and human insulin were dissolved in 50 mM Tris-glycine buffer (pH 2.5) and 
incubated for 2 min at room temperature whereupon the solution was immediately 
neutralized with I M Tris buffer. The two insulin solutions, along with the isolated 
camel milk insulin (the fraction where the insulin concentration was 90000 J.lIU/ml) 
were then diluted in bovine and camel milk samples to give a final insulin concentration 
between 250-300 J.lIU/ml. Prior to the thermal stability experiment, the insulin 
concentration in the diluted samples was measured by RIA to assure the required 
concentration. All samples, along with plain milk (unspiked), were divided into two 
aliquots. One was incubated at 60°C and the other at noc, both for one hour. Following 
the thermal (heat) stress, the insulin concentration was measured by RIA after the 
thermal treatment and compared with original concentration. 
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Chapter 3 
Camel Insulin Gene Sequencing, SNP, and 
Chromosome Localization Analysis 
3.1 Introduction 
The insulin gene is present in a single copy in most species, however in the mouse and 
the rat there are two copies of the insulin gene present. The human insulin gene is 
local ised on the short arm of chromosome II at position p 15 (Harper ef 01., 1981). On-
the-other-hand, both copies of the rat insulin gene are located on chromosome 1 at the q-
arm and the genes are approximately 100,000 kilobases distant from each other (Soares 
et al., 1985), while in mouse one copy of the insulin gene (insulin 1 gene) is localised on 
chromosome 19 (Davies et al., 1994) and the second copy of the insulin gene (insulin 2 
gene) is positioned on chromosome 7 (Duvillie et al., 1998). The human insulin gene 
and the rodent insulin 2 gene contain three exons and two introns, while the rodent 
insulin 1 gene lacks the second intron (Melloul et al., 2002) (see Figure 3.1). 
100bp 
5' 0.5 kb 6.0 kb 3' 
l'ns2 1 ......... - If-......... + •••••••• .......... z- ::::::::: 
1.3 kb 
... 
l'ns1 I ... -If-... ... !;! 
UTR Signal B C A UTR 
peptide Chain peptide chain 
Figure 3.1 The gene structure oflns2 and Ins l genes in the mouse, Boxes show the exon regions while 
the so lid lines indicate the intronic and the flanking regions of the gene ( hiao el a/. , 2008). 
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The insulin protein is present in invertebrates all the way up to humans making the study 
of it's evolution an important and interesting subject (Falkmer and Ostberg, 1976). 
Studies on the structure of crystalline Hagfish (Myxine glutinosa), thought to have 
diverged from the main line of vertebrate evolution about five hundred thousand years 
ago, have shown that even with 37% difference at the amino acid level (Peterson et al., 
1975) the main peptide chain sequence matches porcine insulin (Cutfield et al., 1979). 
This shows that the basic structure of insulin evolved was in the early vertebrates and 
has subsequently been largely unchanged with only small changes during subsequent 
evolution leading to man (Shu et al., 1981). The existence of insulin like molecules in 
insects, molluscs and echinoderms (Falkmer and Ostberg, 1976) as well as the presence 
of other insulin like proteins in vertebrates, all suggest that insulin is an ancient protein 
(Shu et al., 1981). 
It has been suggested (de Haen et al., 1976) that insulin and other structurally related 
proteins like relaxin, NGF (nerve growth factor) and IGF (insulin-like growth factor) 
may have evolved from the serine protease proteins such as trypsinogen and 
chrymotrypsinogen. This route of evolution is supported by a number of observations; 
(1) the presences of an intron within the C-peptide region of the insulin gene that 
corresponds to the removal of approximately 140 residues from the central region of the 
serine protease structure to leave a shortened connecting peptide similar to that found 
between the B- and A-chains of insulin (Shu et al., 1981); (2) it is well known that some 
proteases can act in an insulin like manner and can stimulate many of the cellular 
functions that insulin stimulates such as like cell replication (Holley, 1975; Glenn and 
Cunningham, 1979; Shu et al., 1981). 
As described earlier in this thesis, the insulin protein is produced as a single precursor 
molecule termed preproinsulin. The preproinsulin is post translationally processed and 
modified to produce pro insulin and finally cleaved to produce the mature insulin 
hormone (Wentworth et. aI., 1986). Glucose is the main regulator of insulin gene 
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expression. Insulin biosynthesis is mainly regulated by glucose levels (Tillmar et al., 
2002) with insulin biosynthesis being controlled at the level of protein synthesis and 
elongation rates (Wesh et al., 1986). In addition, glucose can also enhance the 
production of insulin mRNA (Brunstedt and Chan, 1982) by the selective stimulation of 
the transcription of the insulin gene (Nielsen et al., 1985) and by increasing the stability 
of insulin mRNA (Wesh et al., 1985; Tillmar et al., 2002). The half-life of insulin 
mRNA is approximately 29 h at low glucose concentration while at high glucose 
concentration the mRNA is stabilized such that the half-life is extended to 
approximately 77 h (Wesh et al., 1985). Such studies have therefore proposed that the 
insulin mRNA levels in insulin generating cells is rapidly increased upon an increase in 
glucose concentrations by the stimulation of insulin gene transcription and changes in 
mRNA stability (Leibiger et al., 1998; Leibiger et al., 2000; Tillmar et al., 2002). 
The control of insulin expression and its regulation is therefore a complex process that 
includes the stimulation and control of transcriptional and post-transcriptional 
mechanisms (Permutt and Kipnis, 1972). The insulin gene in adults is expressed only in 
the /3-cells of pancreatic Langerhans islands (Marshak et a/., 2001). Insulin production is 
controlled at the transcription level of the gene encoding preproinsulin (the insulin 
gene), rather than at the level of preproinsulin mRNA translation (Iype et al., 2005). 
Hence it is transcriptional activity and its control that regulates the levels of insulin 
made and there is little translational control. The amount of insulin produced is governed 
by the levels of mRNA present, which in tum are regulated by transcriptional control 
elements as discussed above. 
With regard to the genetics of the camel insulin gene, very few studies have investigated 
this. The karyotypes of different camelid species have been studied previously by many 
groups (Taylor et al., 1968; Koulischer et al., 1971; Bunch et al., 1985; Bianchi et al., 
1986; Graphodatsky, 2006; Di Berardino et a/., 2006). All studies indicated that the 
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diploid number of chromosome in camelid species is 74, but no conformity on 
chromosome nomenclature has been reached (Balmus et al., 2007). 
Balmus and co-workers (2007) prepared a set of chromosome painting probes from the 
dromedary camel (Came/us dromedarius) using flow sorting and degenerate 
oligonucleotide primed peR techniques. The painting probes were used to identify the 
karyotypes of the dromedary camel (c. dromedarius), the bactrian camel (c. 
bactrianus), the guanaco (L. guanicoe), the alpaca (L. pacos) and the hybrid of 
dromedary and guanaco karyotypes. In these studies Blumus and colleagues established 
a GTG banding karyotype and idiogram for C. dromedaries as shown in Figure 3.2. 
Furthermore, the cross species chromosome painting between camel, cattle, pig and 
human wit.h painting probes from the camel and human allowed. the establishment of 
genome wide comparative maps (Balmus et al., 2(07). The study showed that the 
dromedary karyotype consists of one metacentric, three sub-metacentric and 32 
acrocentric autosomal chromosomes. Both X and Y chromosomes are metacentric but X 
is a large chromosome while Y is a small chromosome. With the small chromosomes 
(from 22 to 36) the correct pairing and identification can be established only by FISH, 
this being because the GTG-banding patterns are too similar to clearly differentiate these 
'. 
chromosomes (Balmus et a/., 2007). 
This chapter investigates and discusses the composition of the camel insulin gene. In this 
chapter, for first time, the full camel insulin gene was sequenced along with part of the 
upstream and downstream regions. Five different single nucleotide polymorphisms 
(SNP's) were identified by sequencing the insulin gene of 32 camels. The camel insulin 
sequence was compared with the insulin sequence from 13 different species and the 
potential structure of camel proinsulin investigated and predicted using 3D-JIGSAW 
software. Ultimately the gene was mapped onto camel chromosomes by the use of 
fluorescence in situ hybridisation (FISH) technique. 
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Figure 3.2. GTG banding karyot)'pe and the idiogram of Dromedary camel indicating the chromosomal 
homology with human (HSA) (Balmus el al.. 2007). 
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3.2 Aims: 
• To amplify the camel insulin gene and part of the upstream and downstream 
regions of the gene. 
• To identify the regions of the functional regions of the camel insulin gene. 
• To sequence the camel insulin gene across muhiple camels to confirm the 
sequence and identify the SNP's within the camel insulin gene. 
• To undertake bioinformatic analysis to compare the camel insulin gene and 
protein with other species and identify the sequence differences. 
• To the 3D structure of camel proinsulin protein and compare it with human 
model. 
• To localise the camel insulin gene on camel chromosomes using FISH technique. 
3.3 Results 
3.3.1 peR Amplification of the Insulin Gene from Camel Genomic DNA 
Primers CAM-INS-F2 and CAM-INS-R2, which had been previously used (AL-
Swailem et 01., 2(08) to amplify camel proinsulin cDNA, successfully amplified a 
fragment of approximately 772 bp from camel genomic DNA as determined by agarose 
gel electrophoresis analysis of the resulting PCR products (see figure 3.3). In 
comparison with the published cDNA fragment, the intronic region accounts for 507 bp 
of the whole fragment and a single and specific PCR product was achieved after 
increasing the PCR stringency. The PCR stringency was increased by increasing the 
annealing tempreture to 64°C and reducing the MgCh concentration in the PCR reaction 
Figures 3.3A and 3.3B show the electrophoresis analysis of the CAM-INS-F2 and 
CAM-INS-R2 primer PCR reactions before and after optimizing the PCR conditions. 
Before optimising the PCR reaction a series of up to 5 bands or products were observed 
(figure 3.3A), the most prominent of which corresponded to the desired product. This 
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was the only band observed after the peR conditions were optimised as described above 
(see figure 3.38) 
Ikb Ikb 
500bp 500bp 
Figure 3.3 A) Lanes 1-5 ditTerent camel DNA amplified by CAM-INS-F2 and CAM-INS-R2 primers lane 
6 is the negative control and lane 7 is the molecular 100 bp size marker. A: shows the result by using the 
cD A ampli fication conditions for genomic DNA. B) the results after optimizing the PCR conditions. 
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3.3.2 DNA Sequencing of the PCR Amplified Camel Insulin Gene 
The 772 bp PCR amplified fragment described in section 3.2.1 above was sequenced and 
aligned using BLAST search. The sequence is provided in Appendix 1 ofthis thesis. The 
sequenced fragment matched a BAC clone sequence of Llama pacos CH246-515B 17 
clone with 96% homology. Figure 3.4 shows the BLAST result and alignment. Primers 
FI and R2 (see section 2.4.3 for sequence of these primers) were designed from the 
matched clone amplified fragment of 1960 base pair and 1849 base pair sequence of the 
pancreatic insulin and surrounding regions and have been sequenced from the camel 
genomic DNA. Figure 3.5 shows the agarose gel electrophoresis analysis when using 
primers F 1 and R2 to amplify the genomic DNA. whereby a band of 1960 bp in size was 
clearly present. 
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~b I AC233144.2 1 
p1ece:s 
Length=220107 
Lama p aco:s clone CH246-515B17, WORKING DRAFT SEQUENCE, 11 ordered 
Score = 1024 b 1ts (554), Expect = 0 . 0 
Ident1t1e:s = 619/ 649 (96\ ), Gap:s = 9/ 649 (1 \ ) 
Strand=Plu:s / Minu:s 
Query 1 TCAGGGTGAGAccc ~ac~g~ccccac~gccccccggccccGGA7CCCAGCTGGCGCCCA 60 
11I11111111 1111111111111111111 II 11111111111111111111 1111 
SbJct 11601 6 TCAGGGTGAGA-CCCCACTGTCCCCACTGCCTCCTAGCCCCGGATCCCAGCTGGCGCCCA 115958 
Query 61 GGGGGCGGTCAGGAGGGGTTTTAAAAAGGAGAATGATTCCCTCTTGGTCACATCCTCAAG 120 
11111111111111111111111 1111111 111111 I 1111 111111111111 11 1 
Sbj ct 115957 GGGGGCGGTCAGGAGAAAAAGGAAAA7GATGCTCTCTTGGTCACATCC'l'CAA- 115899 
Query 121 C-GGCCAGCTcnTGGGGGC'l'GAGCCCTGACAACACCCCAAGGGTGGGCTCGCCGTCCCC 179 
I 111111 111111111 11111111111111111 1111111111111 11 J 1111 1111 
Sbj ct 115898 CTGGCCAGATCTTTGGGGAC'l'GAGCCC'l'GACAACACCCCAAGGGTGGGCTCGCCG'l'CCCC 115839 
Query 180 TCCAC'l'CCCATCTTACCCC'l'C'l'CAGCCCCATTCCTTCC'l'C'l'CC'l'CCGACAAGAGCGGCT'r 239 
II I I I 11111 1111 111111111111111111 111 11111 111 111 1111111 11 11 
Sbjct 115838 TCTACTTCCAXCTTACCCCTCTCAGCCCCATTCCTTCCTCTCCTCC~ 115779 
Que ry 24 0 CAGGGA-GGGTTTTATGAAGTGAGTCAAGCCC'l'GGGGGCTGAGGGTCTCGGGGGTGCCCC:2 98 
111111 11111111 11111111111111111111111111111 11 1111111 11 11 
Sb j ct 115778 CAGGGAGGGGTTTTAGAGTCAAGCCCTGGGGGCTGAGGGTCTTGGGGGTGCCCC 11571 9 
ery 299 AfCCTCCTGCCTGCATGCCTGTGGGAGACACC'l'CAC'l'GCCCTGAGGGGAcc :;ccc cACAC 358 
111111111111111111111111111111111111 11 11111111111 III I I I 
Sbjct 11571 8 AfCCTCC'l'GCCTGCATGCCTGTGGGAGACACCTCACTGCCCTGAGGGGA--- - CCC- CAC 1 566-'1 
Query 359 ACACAGCCCGAGGCAg~gggagggg3 ~cg ~ ~ g acag3c~9cg33gagg~g93~9; -'118 
111111111111111111111111111111111111111111111 11111111111111 
Sbj ct 115663 ACACAGCCCGAGGCAGTGGGAGGGGGCTCGGTCCTGCACAGGCTGCGGGGAGGTGGGTGG 11560 4 
Query 419 gggtggggg~gggcggg~CC~GCCCGCCCGrTCAG 478 
III 11111111111 1111 I II II II 11111 1111 111111 III 1111111111 I III II 
Sbj ct 115603 GGGTGGGGGTGGGCAGG1'AACAGGCCCCGCGACGGGCACAGAGCCCGCCCGTrCAG 115544 
Query 479 GGTCCCGCTCCAGGGCTGGCTGTCTCTCGGCAGTGGGCGGCGTGGAGCTGGGTGGAGGCC 538 
111111111111111111 111111111111111111111 1111111111111111111 
Sbjct 115543 GGTCCCGCTCCAGGGCTGACTGTCTCTCGGCAGTGGGCGGTGTGGAGCTGGGTGGAGGCC 115484 
Query 539 CGGGTGCGGGCGGCC'l'GCAGCCCCTGGGCCCGGAGGGGCGCCCGCAGAAGCGCGGCA 598 
111111 1 111 111111111111111111 1 11111111111111111111111111111 
Sbj ct 115483 CGGGTGCAGGCGGCCTGCAGCCCCTGGGCCTGGAGGGGCGCC~GCGGC.ArCG 115424 
Query 599 'lGGAGCAG'l'GCTGCGCCAGCGTCTGCTCGCTC'l'ACCAGC'lGGAGAACTA 647 
11111111111111 111111 1111111111111111111111111111 
Sbjct 115423 'lGGAGCAGTGCTGCACCAGCG7CTGCTCGCTC'l'ACCAGC'lGGAGAAC'l'A 115375 
Figure 3.4 First hi t in BLAST result of the equence of CAM-l S-F2 and CAM-I S-R2 primers 
product. The re u1t how 96% homology between the equenced dromedary camel insulin gene and the 
clone number H246-5 15B 17 from Lama paco . 
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Figure 3.5 Agarose gel electrophoresis analysis of the PCR fragmenta generated from genomic camel 
DNA as described in section 3.2.1 above. Lane I and 4 are 100 bp size marker, lane 2 and 3 the insul in 
gene band of 1960 base pair fragment. 
3.3.3 Identifying and Characterising the Camel Insulin Gene Regions 
The insulin gene was PCR amplified from the genomic DNA of 32 camels and the 
resulting sequence compared across the camel samples to determine the camel insulin 
gene start and stop regions and to identify any potential single nucleotide 
polymorph isms (SNPs). Figure 3.6 shows the sequencing results of the insulin gene and 
the surrounding regions from the 32 camel samples. The gene regions were identified 
based upon the BLAST results by comparing the obtained camel sequence after 
alignment of the 32 sequences with other published results (Bajaj et aI., 1986, Brown el 
al., 1955; Kwok et aI., 1983; Buck et al., 2001; Hay and Docherty, 2006; Stoy el al., 
2D 10). Figure 3.6 highlights the signal peptide, A and B chains, C-peptide, Goldberg-
Hogness box (TAT A Box), cleavage site, stop (TAG) codon, and termination signal. 
The results show that the camel insulin gene contains a 72 bp length signal sequence, a 
90 bp insulin B-chain, a 93 bp C-peptide, a 63 bp insulin A-chain and a 507 bp intron 
within the C-peptide. A 217 bp sequence was present between the TATA box and the 
ATG start codon while a 48 bp length of sequence was present between the stop codon 
and the termination signal. The sequence between the stop codon and termination signal 
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is rich in guanine and cytosine nucleotides (Figure 3.6). The data confirms that sections 
of the insulin gene are conserved, in camel insulin with other species as shown by 
comparison with conserved regions in the A and B-chains as reported in previously 
published data (Bajaj et al., 1986; Brown et al., 1955; Kwok et al., 1983; Buck et al., 
2001 ; Hay and Docherty, 2006; Stoy et al., 2010). 
In addition to defining the regions of the camel insulin gene, the data generated from the 
genomic DNA sequence across the 32 camels allowed the identification of potential 
SNPs. Five single nucleotide polymorphisms were observed within the camel insulin 
gene across the sequence data from the 32 camels (see Figure 3.6 which highlights the 
SNPs observed). Three SNP's were located within the intronic region of the C-peptide 
sequence whilst a further 2 SNP's were located in the 3' untranslate~ region (UTR) after 
the stop codon and before the termination signal (Figure 3.6). One additional SNP was 
locah~d after the termination signal (Figure 3.6). Thus there were no SNPs located within 
the coding exon regions across all the camels investigated and the camel insulin coding 
sequence was highly conserved. The SNPs found within the intron will be absent in the 
mature mRNA and therefore whether these have any biological effect is unknown. 
However, the SNPs in the 3' UTR could potentially influence mRNA stability, turnover 
and translational efficiency (proudfoot, 2011) although this was not studied in this 
investigation. One more SNP was found after the termination signal. 
For the three identified SNP's within the intronic region of C-peptide; out of the 32 
sequenced camels the first SNP was found heterozygous (GA) in 12 samples and 
homozygous (AA) in 5 samples, the second SNP was heterozygous (CT) in 11 samples 
and homozygous (TT) in 2 samples and for the third SNP 16 samples were heterozygous 
(AC) and only one homozygous (CC). Less SNP frequency was observed for the 3'UTR 
SNP's in comparison with C-peptide intron SNPs; in the first SNP only 5 samples were 
heterozygous (AC) and one homozygous (CC) while in the last SNP only 4 samples 
were heterozygous (CT) and no homozygous samples were observed. 
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Figure 3.6. The full equence of camel in ulin gene as determined by alignment of the sequence data from 
32 camel . The equence i annotated u ing colour to define the signal peptide (blue), which contains the 
tart ATG codon, the NSf chain , the TAG stop codon, the termination signal and the TAT A box. The 
S Ps ob erved are al 0 highlighted with 5 being located within the insulin gene and one beyond the 
termination ignal. 
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3.3.4 Taxonomic Alignment and 3D Homology Modelling of Camel Insulin 
Based on the genomic sequence of the camel insulin gene obtained and reported in 
section 3.2.3 above, the cDNA sequence of camel preproinsulin (signal peptide, A-
chain, B-chain and C-peptide) was compared with human (Sures et af., 1980) and bovine 
(D'Agostino et af., 1987) preproinsulins using DNAMAN software (Figure 3.7). The 
analysis showed a number of changes at the DNA level between the three species. 
Interestingly, the changes in the A- and B-chains are mainly non-sense and occurred 
mostly in the third nucleotide of the codon and did not change the corresponding amino 
acid sequence. Thus, in the B-chain there is only a single amino acid difference between 
camel and bovine while 4 nucleotides differences exist and there were 12 nucleotide 
differences between camel and human but only 2 amino acid changes. At the protein 
level of the A-chain there is no amino acid difference between the camel and bovine 
chains while the alignment shows 2 nucleotides differences (Figure 3.7). Two amino 
acids differences are present between the human and camel A-chain and seven 
nucleotides changes are present. 
In the case of signal and C-peptides there were changes distributed among and across the 
sequence. In the signal peptide there are 15 nucleotide differences between human and 
camel with 6 amino acid changes and 9 nucleotide differences between camel and 
bovine with 4 amino acid changes. In the C-peptide there are 20 nucleotide differences 
between human and camel with 8 amino acid changes. It is noted that the bovine C-
peptide is 5 amino acids shorter than the human and camel equivalent due to a 15 
nucleotide deletion (D'Agostino et al., 1987) within the C-peptide sequence. Because of 
this the bovine sequence was not included in the C-peptide alignment with human and 
bovine shown in figure 3.7. 
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Figure 3.7. DNA sequence alignment of pre pro insulin chains (Signal peptide, B-chain, C-peptide and A-chain) between camel, bovine and human, the 
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Knowing the camel insulin genomic sequence it was possible to predict the camel 
insulin DNA sequence by undertaking and in silico transcription and translation 
prediction using the online available software package http://insilico.ehu.es/translate/. 
The resulting predicted amino acid sequence for the camel insulin gene is reported in 
figure 3.8. The data in figure 3.8 reports the amino acid sequence of camel 
preproinsulin in comparison to other species. As found in the other species, the camel 
insulin signal peptide was 24 amino acids in length. The signal peptide is the first 
section of the nascent polypeptide chain that emerges from the ribosome and is bound by 
the signal recognition particle (SRP) which arrests translation elongation and directs the 
ribosome and polypeptide to the ER by recognising SRP receptors on the ER 
(Hatsuzawa et al., 1997). Signal peptides are characterised by their highly hydrophobic 
nature and usually contain a high number of leucine residues (Zanen et al., 2005) as is 
found in the case of the camel insulin signal peptide and the other sequences this was 
compared to (see Figure 3.8). Interestingly, there were a large number of differences 
between the camel insulin signal peptide and the other insulin signal peptides this was 
compared to. The camel has a unique alanine residue at position 9 in the signal peptide 
whereas all other signal peptides had a proline in this position (Figure 3.8). 
There were a number of other obvious differences between the camel signal peptide and 
the other species investigated. At position 17 the camel sequence has a glycine residue 
that was not present in any other species, most of which had a tryptophan (W) residue in 
this position although rabbit and squirrel had a cysteine (C) and leucine (L) residue 
respectively. At position 20 the camel sequence has a threonine (T) residue which in the 
other species was an alanine (A), aspartic acid (D) or asparagine (N) residue, thus the 
camel again being unique in having a threonine (T) residue at this position. At position 
22 the camel had the same residue as in dog, cat and bovine (an arginine (R) residue) but 
this was different to that found in all other species where either a glutamate (Q), alanine 
(A), proline (P) or serine (S) residue was found. Finally there were also other differences 
between species across the signal peptide, notably at positions 5 and 18. There was 
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therefore considerable diversity in the insulin signal sequence amino acid sequence with 
the camel signal sequence having several unique residues compared to the other spec~es 
investigated. 
Compared to the variability observed in the signal peptide sequence of insulin, the 
sequence of the B-chain was highly conserved across the species compared (Figure 3.8). 
The B-chain is 30 amino acids in length with the most obvious change being a single 
unique change between camel and all other species investigated at position 2 of the B-
chain whereby the camel sequence contained an alanine (A) residue and all other species 
a valine (V) residue (Figure 3.8). The other notable feature of the B-chain was that 
camel, as in bovine, dog, cat and pig insulin contained the presence of an alanine residue 
in the last amino acid of the B-chain which was either a threonine (T) or serine (S) 
residue in all other species. The A-chain, like the B-chain was highly conserved across 
the species investigated. The A-chain is 21 amino acids in length and there are two sites 
that show prevalence for change in this section of the protein. These two differences in 
the A-chain are found at positions 8 and 10 (threonine to alanine in camel) and 
(isoleucine to valine in camel), these 2 differences also existing in cat and bovine insulin 
(Figure 3.8). 
Finally, there was much diversity in the amino acid sequence of the C-peptide across the 
species investigated (Figure 3.8). The C-peptide is 31 amino acids in length and among 
the many differences in C-peptide there were 5 unique to the camel C-peptide sequence. 
, These were an alanine to glycine and leucine to proline substitutions at the 25th and 26th 
positions of the C-peptide, respectively. In the camel C-peptide there are also threonine 
(T), glycine (G) and R residues found at positions 5, 9, and 29 respectively whilst 
various other residues were present in these positions in the other species investigated 
(Figure 3.8). At residue 30 in the camel there was a proline (P) residue, also found in 
bovine and pig whilst this was a different residue in all other species. There were various 
other sequence differences across the C-peptide between the species investigated 
showing that the C-peptide, much like the signal peptide, is not well conserved across 
the species present and shows considerable species specificity. 
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Figure 3.8. The amino acid sequence, domain/chain regions of preproinsulin and the sequence alignment of the deduced camel sequence with 13 different 
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ing the equence data pre ented in Figure 3. a homology tree was created using 
oft-ware er ion 3.2.2) and the resulting diagram is shown in figure 3.9 
below. Ba ed on the r ult of the drawn homology tree (Figure 3.9) of camel 
preproin ulin, the dog preproin ulin i the clo e t to camel while rabbit preproinsulin has 











~ .. .. 
~ 
Figure 3.9 The bomology tree oflhe peci de cribed in figure 3. , prepared u ing D AMAN 
oftware. Tb p rcentage numbers r fer 10 the percentage homology at the amino acid level 
between peci . 
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Using the amino acid sequence deduced from the genomic DNA sequence of camel 
insulin the 3-dimensional structure of the molecule was predicted using commercially 
available software (figures 3.10; 3.11; 3.12). The ~D-JAIGSAW software works by 
comparing with protein models available in the Protein Data Bank (PO B), PF AM and 
structural classification of Protein (SCOP) databases. The predicted 3-dimentional 
structure of both camel and human proinsulin, based upon the amino acid sequences, 
highlights predicted structural differences between the two species. The predicted 
structures show camel proinsulin to have more alpha helical structure in comparison 
with the human. In the human insulin structure the residues which are involved in the 
interactions between insulin and the insulin receptor are the 4th and 5th of the A-chain 
and residues number 12, 16,17,24, and 26 of the B-chain (OeMeyts et al., 1990; White 
and Kahn, 1994; Mynarcik et al., 1997 ; Yip and Ottensmeyer, 2003). None of these 
amino acids is different in the camel insulin molecule. 
Unlike human pro insulin, the camel proinsulin molecule has a predicted a-helix 
structure that can be clearly seen in the upper loop of camel proinsulin (amino acid 
residues 27 to 61) whilst this is unstructured or f3-sheet like in in human equivalent (see 
figure 3. I 0 ). As shown in figure 3. I 0, this could potentially have a very dramatic effect 
on the behaviour of these two molecules and their stability. Figure 3.11 shows the A and 
B-chains and C-peptide predicted 3D structure of human and camel proinsulins were the 
C-peptide appears to have mainly an alpha helical structure. Figure 3.12 shows that the 
existence of alanine in the junction between the B-chain and C-peptide in camel instead 
of threonine in human generates a predicted proinsulin molecule with more coiled 
structure. Furthermore, the alanine in the second position of the camel proinsulin results 
in a predicted structure that is twisted at the beginning of the camel proinsulin more than 
the human. 
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Figure 3.10. The predicted three dimensional (3D) structure of human proinsulin (upper figure) and camel 
proinsulin (lower figure) using 3D-JIGSAW comparative modeling server. The models were generated and 
viewed using the freeware RASMOL software. 
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Figure 3.11. The predicted three dimensional (3D) structure of human proinsulin (left) and camel 
proinsulin (right) using 3D-JIGSAW comparative modeling server, the models being viewed by pymol 
software. In both proinsulins, the A-chain is hown in blue, C- peptide in gray and B-chain in red. 
Figure 3.12. The predicted three dimensional (3D) structure of human proinsulin and camel 
proinsulin (right) using 3D-nGSAW comparative modeling erver, the models being viewed by pymol 
software. The predicted difference in the A- and B-chains between human and camel are hown in blue 
for the A-chain and red for the B-chain. 
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3.3.5 Camel Insulin Gene Localization Studies 
3.3.5.1 Cell Culture of Camel Cells and Metaphase Preparation 
A suspension of camel cells was prepared as described in the methods section and 
metaphase cells harvested. The cells were then placed on slides and stained with Giemsa 
stain to score the number of cells in metaphases. More than lOwell spread metaphases 
were found on each slide and seventy four chromosomes were counted in each 
metaphase (see figure 3.13 for an example). 
Figure 3.13 Metaphase chromosomes of dromedry camel. 
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3.3.5.2 FI H Anal 
Probe 
of the Camel In ulin Gene with a PCR Amplified Product 
The P R product of the camel in ulin gene was labelled by two method for FISH 
analy is. The first method u ed a biotin nick translation technique. When this labelling 
method wa u ed, for ub equent hybridisation with the labelled probes there was more 
than 2 signal on the telomeric regions of a number of chromosomes (Figure 3.14), 
howe er after increa ing the wa h tringency, no ignals were observed what oever. As 
uch till approach wa not considered appropriate to visualise and analyse the 
po itioning of the camel in ulin gene. A econd labelling approach was also attempted 
with a DIG-P R lab lied probe and in till ca e no signals were once again observed. 
Thi approach to th mapping of the camel insulin gene was therefore not successful in 
identifying th location ofth insulin gene. 
Figure 3. 14 FI H re ult using FIT avidin labeled by nick tran lation technique . 
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3.3.5.3 FISH Analy is of the Camel Insulin Gene using a BAC Clone 
As the PCR probe approach to the FISH analysis of the insulin gene was not successful, 
FISH was repeated using Llama pacos CH246-S1SB 17 BAC clone. Thirty micrograms 
of BAC ON was isolated and used for FISH analysis. A band matching the camel 
insulin gene band was observed after amplifying the BAC DNA using camel specific 
insulin primers, confirming the presence of the camel insulin gene in the BAC clone 
(figure 3.IS). When the DNA was used for labelling, 0.3 ~g was used for the labelling 
procedure. After labell ing and agarose gel electrophoresis analysis the resulting bands 




Figure 3.15 Agarose gel electrophoresis anlysis of the PCR ampli fication of the camel insulin gene 
from the SA (lane I and 2) clone and control genomic (lane 3) DNA. Negative control loaded in 
lane 4 and 100 bp size weight marker in lane 5 
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Figure 3. 16 Agaro e electrophore i of random priming labeled product. Lanes 1-3 the product 
labelled, lane 4 i the 100 bp ize marker. . 
A good number of well spread metaphase camel cells were then observed on the slides 
which were u ed for the FISH experiment. After hybridizing the slides with the labelled 
BAC probe, two strong and sharp specific cy3 signals were observed on the interphase 
lymphocytes (figure 3.17 and 3.18). 
Figure 3.17 F1SH analy is for camel insulin gene using a BAC probe showing two interphase cells of 
dromedery camel lymphocytes labled with cy3 avidin. 
100 I P age 
Molecular Identification and Characterization of Camel Milk Insulin Motasem Ismail 
Figure 3.18 FISH analy is for camel insulin gene using a BAC labelled probe on interphase cells of 
dromedery camel lymphocytes labled with cy3 avidin. 
Strong and sharp Cy3 signals were also observed on one homologous pair of 
chromosomes as shown in figures 3.19A, 3.20, 3.21 and 3.22A. Once appropriate 
labelling and FISH images had been obtained it was necessary to identify upon which 
Chromosome(s) the probe was hybridising to and hence identify the chromosome 
location of the camel insulin gene. To identify the chromosomes slides were stained 
after the FISH analysis with propidium iodide and DAPI. The two dyes gave a uniform 
fluorescence of chromosomal arms and heterochromatin regions which produced a 
banding pattern similar to the GTG banding as in figures 3.19b, 3.20, and 3.22b. 
To identify the chromosome where the camel insulin gene is located, the karyotype of 
the fust 16 camel chromosomes along with the X-chromosome (figure 3.l9c) was 
prepared using Adobe Photoshop software according to the published camel karyotype. 
By comparison with the published camel karyotype, and according to the chromosome 
size, banding pattern, and centromere position, it was deduced that the insulin gene of 
dromedary camel is localized on the distal (Telomeric) end of the q-arm of chromosome 
10. 
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c 
Chr.1 Chr.2 Chr.3 Chr.4 Chr.5 Chr.6 Chr.7 
Chr.8 Chr.9 t Chr. 1D '\ Chr.11 Chr.12 Chr.13 Chr.14 
Chr.15 Chr.16 Chr. X 
Figure 3.19 (a) FISH analy i on metapha e of dromedery camel lymphocytes labelled with cy3 avidin. (b) 
banded metaphse chromosomes tained and banded by propidium iodidefDAPT. (c) the karyotype of flfst 
16 camel chromo omes of (b) metapha e, chromosome X is also identified. The arrow shows the location 
of the insulin gene. 
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Figure 3.20 FISH analysi on banded metaphase chromosomes of dromedery camel lymphocytes labelled 
with cy3 avidin, chromo ome banded by propidium ioclidelDAPI. 
Figure 3.21 FISH analy is on metaphase chromo omes of dromedery camel Iympbocytes labled with cy3 
avidin. 
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Figure 3.22 (a) FISH analysis on metaphase of dromedery camel lymphocytes labled with cy3 avidin. (b) 
the banded metaph e chromosome as shown by propidium iodidelDAPI. Arrows show the insulin gene 
location. 
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3.4 Discussion 
In this chapter the genomic DNA sequence of the camel insulin gene was deduced and 
compared to other species. Following this FISH approaches were used to characterize 
and locate the chromosomal positioning of the camel insulin gene. 
In 2008 AI-Swailem and colleagues amplified the camel proinsulin cDNA using primers 
designed initially to amplify the human insulin gene (AI-Swailem et al., 2008). AI-
Swailem used a forward primer which hybridized to the B-chain and a reverse primer 
which hybridized to the A-chain. Due to the sequence difference in the B-chain between 
human and camel, the start region of the camel published sequence (see figure 3.7 and 
section 2.4.2) is of human origin. 
In this project, the primers described by AI-Swailem et al. (2008) were initially used to 
amplify and sequence the camel insulin gene. Based on the sequencing results obtained, 
which matched the sequenced BAC clone of Llamapacos number CH246-515B17, new 
primers, which flanked the insulin gene were designed to identify the full insulin gene 
and the surrounding regions. The result ofthe new primers showed sequence differences 
with the published data (AL-Swailem et al., 2008). This is probably due to the use of 
human primers in the published study as described above. 
The results of DNA comparison showed a number of non-sense nucleotide changes that 
did not affect the amino acid composition of the molecule when compared to other 
species. Insulin is an important cellular protein and changes in the protein structure that 
affect the function of the insulin molecule would have potential function consequences. 
This probably explains why the A and B-chains are conserved among species while the 
signal and C-peptides (which are not directly affecting the binding and the function of 
the protein) are polymorphic among the species investigated. 
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To confinn the sequencing results and to identify any single nucleotide polymorph isms 
(SNP's), the camel insulin gene along with the flanking regions of 32 camels was 
sequenced andaIigned for cO'.TIparison. After aligning the insulin sequences of the 32 
camels, five SNP's were discovered, three of them in the intronic region of the C-peptide 
and two SNP's in the 3' untranslated region of the gene. After the stop codon and before 
the tennination sequence, these two SNP's may' play a role in gene expression, 
particularly at the level of translational control. 
The predicted translated amino acid sequence of camel insulin gene showed a number of 
differences when compared with other species as shown in Figure 3.8. The existence of 
alanine instead of valine in 2nd amino acid of the B-chain only in camel may playa role 
in the stability of the mature insulin molecule. For example, Dao-Pin et al. (1990) 
showed higher thennostability of protein T4 phage lyoszyme after valine had been 
substituted to alanine. The authors suggested that the gain in thermostability could be 
due to reduction in strain which is caused by the rigidness of an alpha helix containing 
valine and found that the alaine T4 phage lysozyme mutant is more thennostable than 
the wild type. In a further study Lyu and co-workers (1990) studied the stability of 
alpha helical structures fonned by different amino acids. The study was performed by 
substituting a single residue in a polypeptide sequence with different amino acids using a 
chemical peptide synthesis technique. In all cases the alpha helical stability was higher 
in alanine containing helicies than in valine containing helices. This unique amino acid 
change in camel insulin might therefore result in a more stable insulin molecule than in 
other species and could, at least partially, explain the higher stability of camel insulin 
observed in other studies compared to that from other species (Wemery et al., 2006a). 
The stability of the zwitterionic fonn of different amino acids has been extensively 
studied, but of particular interest is an investigation by Wu and McMahon (2007). The 
authors studied isomers of each amino acid and of relevance to this study concluded that 
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the thermochemical stability of alanine isomers is higher than valine isomers (Wu and 
McMahon., 2007). 
In comparison with human insulin (B-chain and A-chain), camel insulin has 4 amino 
acid differences. Of these differences three out of the four are changes to alanine 
residues. The first substation is in the 2nd residue of the B-chain and is a change from 
valine to alanine as has been discussed above. The second and third differences are in 
the last amino acid of the B-chain and in 8th residue of A-chain and both are threonine to 
alanine substitutions. According to Lyu et ai. (1990), alanine residues are more alpha 
helically stable than valine and threonine. Only the 4th camel substitution results in a 
change to a less alpha helically stable amino acid (isoleucine in human to valine in the 
camel). The incI~sion of 3 additional alanine residues in camel insulin compared to the 
human insulin sequence suggests that camel insulin contains more alpha helical stable 
residues and hence the structure of camel insulin may be more alpha helical and that 
these helices are of a greater stability. This would be required to be tested further and 
could be done so by sequential point mutation of the human amino acids to alanine and 
to complement this mutate the camel residues sequentially to valine residues and 
determine the effect on helix formation and insulin thermostability. Further, the alpha 
helix structure is known to be more stable than beta sheets (Chakrabartty & Baldwin, 
1995), (Serrano & Fersht, 1989) (Nicholson et ai., 1991) and hence these observations 
may, at least partially, explain the greater stability of camel insulin compared to its 
human counterpart. 
Many publications have reported on studies around the interaction between human 
insulin and it's receptor (DeMeyts et ai., 1990; White and Kahn, 1994; Mynarcik et ai., 
1997 ; Yip and Ottensmeyer, 2003). The results obtained here for camel insulin indicate 
that none of the unique amino ac~ds that exist only in camel insulin are involved in the 
interaction between the insulin and insulin receptor and hence this function is most 
likely conserved in camel as in other species. The second and last amino acids in the B-
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chain may have an important role in stabilising the insulin molecule by providing the 
insulin molecule more helical structure. 
In agreement with the substitution with alanine residues discussed above, the predicted 
3-D structure of camel proinsulin showed more alpha helical structure than beta sheet in 
. comparison with the human pro insulin structure (Figure 3.12). Pro insulin is the 
precursor of insulin and plays an important role in controlling the structure of the mature 
insulin protein (Orci, 1986). The .C-peptide plays a vital role in insulin biosynthesis as it 
links the A- and B-chains in a manner that allows correct folding and assists the 
formation of disulphide bri~ges (Steiner and Tager, 1995, Wahren et al., 2000). The C-
peptide region falls between two conserved regions of insulin A- and B-chains. The 
DNA sequence of the C-peptide was found to be polymorphic aJ?ong the species 
investigated. The alpha helical predominant structure ofthe C-peptide in camel may play 
a role in protecting the proinsulin protein. Thus, if the camel has a more stable precursor 
molecule this may result in more mature insulin being produced with the correct folding 
although this hypothesis remains to be tested. Finally, insulin production is a complex 
process that includes the control of transcriptional and post-transcriptional mechanisms 
(Permutt and Kipnis, 1972; Bhatt et al., 2010). 
With regard to the signal peptide, the 9th amino acid in the signal peptide of camel 
preproinsulin is alanine. The signal peptide binds to the signal recognition particle (SRP) 
which arrests translation elongation and directs the ribosome and polypeptide to the ER 
by recognising SRP receptors on the ER (Hatsuzawa et al., 1997). Signal peptides are 
characterised by their highly hydrophobic nature (Zanen et al., 2005). Alanine is a 
hydrophobic amino acid while proline is ambivalent so this could enhance the signal 
peptide binding to the SRP receptor (Biswas et al., 2003). Furthermore, alanine residues 
can help form a stable alpha helical structure (Lyu et al., 1990), while the proline 
restricts the conformation and disfavour the alpha helical structure (Williamson, 1994) 
and it is well-known that the signal peptides can insert impulsively into lipid membranes 
1081 P age 
Molecular Identification and Characterization of Camel Milk Insulin Motasem Ismail 
and adopt a predominately alpha helical structure (Zheng and Nicchitta, 1999). Thus, the 
alanine change in the camel signal peptide may have an influence on how the 
polypeptide is transported to and transferred into the ER.· 
Here, FISH analysis was also undertaken to determine the localization of the camel 
insulin gene on camel chromosomes. Initially, an amplified PCR product was used as a 
probe to hybridise with camel chromosomes. The results showed many nonspecific and 
weak hybridisations onto the camel chromosomes. This could be due to the length of the 
PCR product being too small to give a strong signal. Using this PCR product it was also 
observed that there was strong signals on four chromosomes. These extra signals could 
be the result of the hybridisation of insulin psedogenes or insulin like growth factor. 
Ther~fore, FI.SH was performed using a Llama pacos BAC clone CH246-515B 17 
(longer DNA sequence). which contained the insulin gene. The hybridization with this 
BAC clone gave a specific and clear result. Sharp and unambiguous signals were 
observed on the telomiric region of the q arm of camel chromosome 10. The human 
insulin gene was previously localised on the distal end of the short arm of human 
chromosome 11 (Harper et al., 1981). Balmus et al. (2007) studied the camel 
chromosomes and compared between camel, cattle, pig and human chromosomes by 
using a cross-species chromosome painting technique. Interestingly, the results showed 
that chromosome 11 in human is similar to chromosome lOin camel. This finding 
supports the results presented here for the localization of the camel gene and provides 
further evidence that the gene location has been correctly identified in camel i.e. the 
insulin in human is at the distal end of p-arm while in camel it is at the distal of the q-
arm. 
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3.5 Conclusion: 
From the results obtained in this chapter it can be concluded that, the full length of 
camel insulin gene is 772 bp including intronic region accounts for 507 bp and the 
sequence matched (using the BLAST search) a sequence from lama with 96% 
homology. Three different SNPs were identified in the none-coding sequence of C-
peptide intron, 2 in the 3' -UTR and 1 after the termination signal. Across 13 species 
compared with corresponding amino acid sequence, the camel insulin has two unique 
amino acid changes in the signal peptide, one unique amino acid change in the B-chain 
and two changes in the A-chain compared to human (which are observed in some other 
species). Many variations were observed across species in the C-peptide region of camel 
insulin compared to other species. The 3D homology modeling of camel proinsulin 
showed more alpha helical structure compared to the human insulin which may 
influence the molecule stability. Ultimately, the camel insulin gene was mapped to the 
distal (Telomeric) end of the q-arm of camel chromosome 10. 
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. Chapter 4 
Purification, Characterization and Identification of 
Camel Milk Insulin 
. 4.1 Introduction 
In 1922 Insulin was isolated from pancreas for the first time by Banting and Best 
(Banting and Best, 1922). In the same year the isolated insulin was successfully used in 
medical applications. An insulin extract was injected into a 14 year old diabetic patient. 
The extract was effective in reducinR the blood glucose level and improved the patient's 
condition (Banting e/ al., 1922). Ever since there has been considerable research and 
medical interest on the control of insulin expression, the isolation of insulin for medical 
use, and subsequently the expression and purification of recombinant insulin for 
administration to patients. The current state of insulin research is such that so called 
'designer insulin' is now available with tailored medical purposes (Danne and Bolinder, 
2011). 
The discovery of insulin and the subsequent understanding of its role in glucose 
metabolism led to its medical applications and was one of the leading medical 
innovations of the last century. As such, there have been many studies undertaken to 
understand the function, structure, and synthesis of insulin. In the last few decades this 
has become increasingly important with the global rise in the number of people suffering 
from diabetes and who require insulin treatment to control this condition (Mudaliar and 
Edelman, 2001). 
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As described in the introduction chapter of this thesis, the mature insulin molecule is a 
51 amino acid long peptide hormone. The mature insulin hormone consists of two 
polypeptide chains that are covalently attached whereby two disulphide bonds connect 
the A- and B-chains. Like other peptide hormones, insulin matures through a proteolytic 
cleavage modification from proinsulin. The proinsulin molecule consists of three parts; 
the A-, B-chain and C-peptide (see introduction chapter for a more indepth discussion on 
. the molecule). As a result of the proteolytic modification, the C-peptide which is the 
central portion of the proinsulin molecule is cleaved and then released in equimolar 
amounts with the mature insulin (Orci, 1986). As described in the introduction, the 
mature insulin molecule plays a vital role in many metabolic processes by enhancing the 
storage of glycogen in liver and increasing the glucose uptake in muscle and adipose 
tissue which subsequently reduce the blood glucose levels. Insulin is also involved in the 
membrane transport of amino acids and various ions and stimulates the synthesis of 
various RNA and protein molecules (Steiner, 1977; Bhatt et at., 2010). 
Camel milk contains approximately 52 microunits/ml of insulin and it is thought that this 
is probably why there is a lower requirement or dependence for insulin in diabetic 
patients receiving camel milk (Agrawal et at., 2005). These relatively high levels of 
insulin in camel milk and the resulting insulin-like activity are proposed to elicit 
regulatory and immune modulatory effects on beta cells in patients and partially explain 
camel milk anti-diabetic activity (Agrawal et at., 2005). Surprisingly, Agrawal et at. 
(2007a) found that camel milk can help in reducing further destruction of ~-cells in the 
pancreas and may therefore be one of the mechanisms by which camel milk reduces the 
need for insulin in diabetic patients. 
As there are a limited number of studies on camel milk derived insulin, this chapter 
describes the methods used to isolate the insulin protein from camel milk. The camel 
insulin was isolated using a number of different purification techniques, starting with 
milk defatting, then the large molecular weight proteins were separated by ethanol 
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precipitation. leaving insulin and other small molecular weight proteins in the 
supernatant. The insulin then was partially purified by ion exchange chromatography 
and finally isolated using immunoaffinity chromatography. This material was then 
available for further study to characterize the stability and properties of insulin isolated 
directly from camel milk. 
4.2 Aims: 
• To purify the camel insulin protein from camel milk using the following 
methods. 
Defatting of the raw camel milk 
Casein treatment of the defatted milk sample. 
Ion exchange chromatography for the raw and decaseinsed sample 
Immuno-affinity chromatography of· the product of ion exchange 
chromatography. 
• To characterise the isolated protein by: 
liquid chromatography coupled mass spectrometry (LC/MS) analysis of the 
purified sample 
Western blotting 
SDS-PAGE followed by Radioimmuno assay for the separated proteins. 
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4.3 Results 
Camel milk insulin was purified/enriched from camel milk following the purification 
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4.3.1 Isolation and Purification of Camel Milk Insulin from Camel 
Milk 
4.2.1.1 Defatting of Raw Camel Milk 
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The camel milk was obtained fresh as described in the materials and methods section 
~nd hence required defatting. This is required to prevent fouling and blocking of 
subsequent purification steps. In the defatting step a thin fat layer was observed in 
colostrum samples, while in normal milk this layer was thicker and accounted for 
approximately 2-3% of the total milk. 
4.3.1.2 Casein Treatment of Camel Milk 
Treatment of milk and colostrum with rennet· enzyme recovered the highest 
concentration (71%) of insulin as determined by RIA in the whey fraction (see Table 
4.1). When using the acid precipitation technique 89% of total insulin in the samples 
was lost during this step. Figure 4.1 shows the difference between the acid treated and 
untreated samples as shown by SDS-PAGE analysis. By comparison, there was only a 
30% loss in the total insulin activity observed as determined by RIA when using the 
rennet enzyme treatment method (see Table 4.1). The insulin concentration when using 
the ethanol precipitation technique was 50% of the original concentration as determined 
and measured by radioimmunoassay. The concentration of ethanol used in the ethanol 
precipitation method was varied and optimized and the highest recovery obtained from 
an initial 50% ethanol precipitation to precipitate high molecular weight proteins 
(including casein) followed by a second 90% ethanol precipitation step to precipitate the 
insulin. Table 4.1 reports the concentration of insulin recovered using the different initial 
treatment methods. 
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Table 4.1. The concentration of insulin at different treatment stages during purification 
from camel milk 
~ 
Acid precipitation Rennin enzyme Ethanol precipitation 
Fractio method treatment (50"10 followed by 90% Ethanol 
concentration) 
Raw milk 641 .. tIU/mL 98 JlIU/mL 100 JlIU/mL 
Defatted milk 59 ~IU/mL 91 JlIU/mL 92 ~IU/mL 
After treatment 7 JlIU/mL 70 ~IU/mL 50 JlIU/mL 
Figure 4.1. SO -PAGE analysis of acid precipitation method for purification of camel insulin ft'om 
camel milk. Lanes 1- 4 Iwithout casein treatment, Lanes from 5- 10 after casein treatment. Protein 
was loaded and run and then protein bands present visualized using Coomassie blue staining 
reagent. 
4.3.1.3 Determining the Sensitivity of Western Blotting for the Characterisation 
and Detection of Insulin 
In order to follow the purification of camel milk insulin and allow the relative amounts 
in different samples to be ana lysed rapidly via gel electrophoresis without undertaki ng 
RIA, western blotting of samples was investigated. As an antibody spec ifica lly to camel 
insulin was not available, an antibody to human insulin was used instead. As the 
sequence of the A-chain and B-chain of camel and human insulin are similar (see 
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Chapter 3) it was anticipated that the human insulin antibody wou ld be appropriate to 
detect camel insulin. To define the sensitivity of the western blot approach for insulin, 
human insulin at different concentrations were prepared, run on an SDS-PAO ge l, 
transferred to a PDVF membrane and then western blotted for insulin using the anti-
human insulin antibody as described in the materials and methods section (Figure 4.2). 
This analysis showed that the minimum concentration of human insulin detected by 
Western blotting was 10 mlU/mL, although the band at this concentration was very 
weak. Hence the western blotting approach cannot be used to analyse and detect insulin 
at concentrations lower than 10 mlU/mL. 
<E:(:--- Insulin Band 
Figure 4.2. Western blotting of serial diluted insulin concentrations, the minimum 
concentration detected is 10 mlU/mL. The concentrations loaded into cach lane are 
indicated. 
4.3.1.4 Use of Gel Filtration to furtber Purify Insulin after Defatting and Ethanol 
Preci pi ta tion 
As insulin is a small molecule, ge l filtration was used as a fir t chromatography step to 
further purify the camel milk insulin whereby larger proteins would be expected to be 
efficiently removed. For this purpose a 0-25 Sephadex bead column was used and the 
insulin in the resulting I mL fractions that were collected deteremined by RIA. The 
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results of the RlA analysis of the gel filtration chromatography fractions collected 
showed that the maximum concentration of insulin was recovered in the 3rd ml of 
washing where 30.4% of total insulin loaded was observed, however 31.6% of the total 
protein loaded was also found in this same fraction (Table 4.2). The 4th ml of washing 
showed the best result in terms of purification where 16.5% of the insulin was recovered 
with only 0.35% of total protein present in this fraction. However, this represents on ly a 
low recovery yield of the total insulin loaded with most being found in farctions 2 and 3 
(Table 4.2). The gel filtration approach was therefore not very efficient at further 
purifying the insulin from the remainig total protein. 
Table 4.2 . Radio immunoassay and total protein concentration results of gel filtration test with G-25 beads 
to purify insulin from camel milk. Total protei n was determined using a western blot, RIA was used to 
measure insulin activity in the various fractions. 
Total 




Decaseinised colo trum sample 89.18 230 2.5 
1st ml washing 30.43 42 I 
2nd m1 washing 85 .56 150 I 
3rd ml washing 70.63 175 I 
4th ml washing 0.79 95 1 
5th ml wa hing 1.44 25 1 
6th ml washing 0.43 11.5 1 
7th ml washing 0.15 8.2 1 
8th ml washing OJ 6.5 I 
9th ml washing 0 5.5 I 
10th ml washing 0.05 4.6 I 
11th ml \\ashing 0.04 4 1 
12th ml washing 0.07 3.7 I 
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4.2.1.5 Ion Exchange Chromatography as an Alternative for Purification and 
Recovery oflnsulin from Camel Milk 
Ion exchange chromatography was also investigated as a means to rapidly purify insulin 
from camel milk. The results of ion exchange chromatography using A-25 DEAE 
ephadex beads as determined by analysing the insulin activity recovered by RIA is 
presented in Tables 4.3-4.9 and confirmed good binding (as little insulin activity was 
found in the flow through samples) and subsequent good recovery of the bound insulin. 
Tables 4.3 and 4.4 report the results of ion exchange chromatography of decasieni ed 
colostrum samples diluted and from the stock respectively. This purification approach 
recovered approximately 62% of the camel insulin when the sample was eluted with 
buffer that contained 500 mM or more NaCI as determined by RIA. As an alternative to 
using decasienated milk, defatted raw milk was also subjected to ion exchange 
chromatography. However, when this approach was used 46% of insulin activity was 
found in the 500 mM elution fraction and 14% of the activity was recovered in the I M 
elution fraction. When both elutions were merged a total of 60% recovery was obtained 
using the defatted raw milk (Table 4.5). 
Table 4.3. Ion exchange chromatography of diluted decaseinised colostrum (3/11) colostrum / 
(equilibration Buffer + H20) with A-25 DEAE Sephadex beads in 5 mL column. 
Fractions Total Protein Insulin RIA Volume (mL) 
(mg/mL) (IlTU/mL) 
Decaseinised colostrum sample 89.18 180 3 
I st Flow through 6.72 5 4 
I2nd Flow through 16.82 5.2 4 
3rd Flow through 18.43 4.5 4 
~th Flo~ through 18.65 5.5 4 
Washing with 10 mM NaCI 3.89 4.8 6 
Elution with 50 mM NaCI 0.2 1 4.7 10 
IElution with 250 mM NaCI 1.59 6.2 10 
Elution with 1 M NaCI 0.8 28 12 
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Table 4.4. Ion exchange chromatography decase inised colostrum using 1\-25 DEAE Sephadex beads 
in 5 mL column. 
Fractions 
Total Protein Insulin RIA Volume 
(mg/rnl) (IlIU/mL) (ml) 
Decaseinised colostrwn sample 89 230 II 
Flow through 80.75 13.6 II 
Washing with 100 mM NaCI 4.9 55 15 
Elution with 500 mM NaCI 1.42 80 20 
Elution with 1 M NaCI 0.17 4 20 
Elution with Acetic Acid 0.1 0.8 20 
T.able 4.5. Ion exchange chromatography of defatted raw whole milk trial with A-25 DEAE Sephadex 
beads in 5 mL column 
Fractions 
Total Protein Insulin RIA Volume 
(mg/mt) (IlIUlmL) (ml) 
Raw milk Sample 35.3 20 45 
Flow through 26.9 I 13 
Flow through 25.1 1.4 13 
Flow through 30.4 1.9 15 
Last drop of flow through 32 1.6 N/A 
I st wash 50 mM NaCI 15.8 2.8 5 
2nd wash 50 mM NaCI 0.53 5 10 
3ra wash 50 mM NaCI 0.93 6 5 
Elution with 250 mM NaCI 1.89 5.5 20 
Elution with 500 mM NaCI 0.63 21 20 
Elution with 1M NaCI 0.18 6.3 20 
As these small scale preliminary results were promising in terms of recovering insulin 
activity, a purification trail was attempted using 100 L of milk. The milk was initially 
defatted using centrifugation and then the milk was loaded onto aIL DEAE A-25 
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Sephadex bead column. After applying more than 10 column volumes of sample the 
column became saturated such that after I hour of loading the insulin concentration in 
the flow through returned to the original concentration as shown in Table 4.6 Thus, no 
additional insulin was binding at this time. 
Table 4.6. Ion exchange chromatography, the trail of scale started with 100 L of partially defatted raw 
'Ik . h A r DEAE S h d b d . I L I ml ' Wit - ) . epra ex ea Sin co umn. 
Fractions 
Total Protein Insulin RIA Volume 
(mg/ml) (~JU/ml) (L) 
Raw milk - 72 100 
Flow through during I st hour - 18 -
Flow through during 2M hour - 69 -
Flow through during 3ro hour - 68 -
Flow through during 4U1 hour - 69 -
Flow through during 5tn hour - 70 -
Flow through during 6th hour - 71 -
Flow through during 71n hour - 68 -
Flow through during 8uI hour - 69 -
Flow through during 9tn hour - 67 -
Flow through during 10tnhour - 69 -
Flow through during] I tnhour - 68 -
Wash with 0.2 M NaCI 0.18 6 3 
1 sl Elution 1 M NaCI 1.21 4 2 
2no Elution 1 M NaCI 1.55 5 2 
3ro Elution 1 M NaCI 0.53 4 2 
After elution wash 0.9 2 3 
Further, purification approaches were undertaken with rennet enzyme casein treated 
sample, but in this case intermediate column washes were included in the protocol. 
However, the column again became saturated in this case with 5 co lumn volumes of 
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milk when the casein treated milk with rennet enzyme was used to load the co lumn as 
shown in table 4.7. Other pre-treatments of the camel milk were also investigated in 
terms of the activity of insulin recovered following ion-exchange chromatography. Table 
4.8 and 4.9 report the insulin activity and profile following ion exchange of defatted raw 
milk samples when treated with 50% ethanol and shows the recovery improved from 
36% in table 4.8 to 68% in table 4.9 whereby a 20 mL column was used in the later 
study and a 5 mL column in the first. An example chromatogram showing the 
absorbance profile at A280 nm across the purification procedure is shown in figure 4.3. 
The majority of the bound insulin was eluted in the 2nd and 3rd elution fractions (figure 
4.3) as determined by the RIA activity assay (see table 4.9) where 61 % of the total 
activity loaded was found. 
Table 4.7. Ion exchange chromatography of defatted decaseiniscd raw whole mi lk trial using A-25 DEAl:: 
h d b d . h . d· h·· - L I sepi a ex ea s WIt mterme late was tng tn ) m co umn. 
Fractions 
Total Protein Insulin RIA 
Volume (ml) 
(mg/ml) (~IUlmL) 
Decaseinised raw milk 7.54 69 250 
Flow through 30 mL 6.23 35 -
Flow through 75 mL 6.94 43 -
Flow through 125 mL 6.73 46 -
Flow through 200 mL 7.07 56 -
Flow through 250 mL 7.18 68 -
Wash 50 mM 1.23 15.2 30 
Elution 250 mM NaCI 0.23 13 20 
Elution 1 M NaCI 1.02 34 20 
Elution 1 M NaCI 0.76 33 50 
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Table 4.8. Ion exchange chromatography o f 50% ethanol treated defatted raw milk tri al using A-25 DEAE 
Sephadex beads in 5 mL column. 
Fractions 
Total Protein Insulin RIA Volume 
(mg/ml) (~L1U/mL) (ml) 
Defatted raw milk sample 30 107 100 
151 wash 50mM NaCI 2.37 10 10 
2na wash 50mM NaCI 1.43 65 25 
Elution 250mM NaCI I 106 25 
Elution 1 M NaCI 0.5 28 25 
Elution 1 M NaCI 0.11 8 40 
Table 4.9. Ion exchange chromatography of 50% ethanoltrcated defattcd raw milk tria l us ing A-25 DEAE 
Sephadex beads in 20 m L column using LP biologic: 
Total 




Defatted raw milk sample 33 90 100 
Ethanol treated sample 0.74 - 200 
Flow through after 100 ml 0.32 - -
Flow through after 200 m I 0.44 - -
Wash 80 mM NaCI1 51 peak 0.65 6.7 4.5 
Wash 80 mM NaCI 200 peak 0.78 7 5 
Elution 1 M NaCI , 151 peak 2.97 96 6.5 
Elution 1 M NaCI, 2na peak 3.83 750 4.5 
Elution 1 M NaCI, 3r.l peak 4.48 430 5 
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Figur 4.3. I n e change A2 0 run chromatogram of the data reported in table 4.9 generated from data 
viewer of LP biologi aut mated chr matography machine (BioRad, SA). amples were collected 
ace rding to th marked n th chart. The chromatogram how the V curve at A280nm in blue, 
while the red cune i th c ndu ti .ty (m fcm). 
At thi tag a nd purifi ati n a att mpt d at cale tarting with 65L whereby the 
d fatt d milk \ a ubj ted to 50% thanol treatment a described above. Tn thi ca e 
approximatel 2 kg of ream as initially eparated from 65 L of milk and the 
ub quent thanol tr atm nt pr du ed 57 L of clear upernatant containing 59% of the 
in ulin a ti it of th original ampl a deterrnin d by RIA. The re uIt from the 
ub equent in' hang puri fi ati n, r ported in table 4.10, how that the binding wa 
ry effi i nt during th first 1.5 hours but after thi there wa an increase in the in ulin 
acti ity found in th flo through ugg ting breakthrough and material not binding to 
the c lumn du t aturati n able 4.10). Wa bing the column with ethanol free 
wa hing bufti r r ulted in th elution of the majority of the insulin during the wa hing 
t p. The maj rity f the r maining in ulin bound to the column wa eluted in the fir t 
three lution fra ti n v ith 0.7 M a I and increa ing the washing stringency to 1 M 
a I did n t elute more in ulin. 
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Table 4.10. Ion-Exchange chromatography for the supernatant of50% ethanol treated samples of scale 







Raw milk (Defatted) 32 69 65 
Sample 1.62 40.8 57 
Flow through after I.S hour 1.13 1.2 NA 
Flow through after 3 hours 1.23 20 NA 
Flow through after 5 hours 1.38 24.8 NA 
Flow through after 6 hours 1.43 47.2 NA 
Total Flow through 1.09 16 S5 
Wash 1 (80 mM) 5.79 208.32 I 
Wash 2 (80 mM) 2. 19 155 I 
1 st elution (700 mM) 1.76 124 0.5 
2nd elution (700 mM) 3.87 150 0.5 
3rd elution (700 mM) 2.55 77 0.5 
4th elution (700 mM) 0.83 39 0.5 
5th elution (700 mM) 0.49 20 0.5 
6th elution (700 mM) 0.67 17 0.5 
7th elution (700 mM) 0.2 6 0.5 
8th elution (700 mM) 0.22 5 0.5 
9th elution (1 M) 0.64 6 0.5 
10th elution (1 M) 0.22 4 0.5 
11th elution (1 M) 0.09 4 0.5 
12th elution (1 M) 0.08 3 0.5 
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A third purification run was also undertaken using ion-exchange chromatography of 
untreated but defatted camel milk. From 45 L of milk approximately 1.5 kg of cream 
was separated and then the 45 L of untreated defatted milk processed in 6 independent 
batches. In each batch 7.5 L of milk was loaded onto the ion-exchange column and the 
insulin eluted and after each batch the column was regenerated. The resulting RIA 
analysis of insulin activity, detailed in table 4.11, show that much of the insulin was not 
binding to the column and was passing straight through the column. 
4.3.2 Concentration of Insulin Purified by Chromatography 
Following purification ofthe insulin and determination of those fractions that contained 
insulin by RIA, it was necessary to concentrate the purified material. The high insulin 
activity fractions from the second and third purification runs were therefore combined 
together and resulted in 5 L of sample. After filtering the entire 5 L sample using an 0.2 
J.lm filter, the sample was concentrated using a 5 kDa cut off cassette to reduce the 
. volume to 145 mL. The 145 mL sample concentration as determined by RIA was 12000 
J.lIU/ml. This material was then subjected to further purification using imunoaffinity 
chromatography. 
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Table 4.1 t. Insulin purification by lon-Exchange chromatography for deratted milk sample run in 6 
batches. Insulin activit) was determined across all fractions by RIA. 
Sample Batch 
[liS ulin Volume 
(J.tlUlmL) (L) 
Defatted milk Total 94 45 
last 10miofflowthrough before washing (2nd batch) 2nd batch 132 0.01 
last 10 ml ornowthrough before washing (3rd batch) 3rd batch 180 0.01 
last 10 ml of flow through before washing (4th batch) 4th batch 143 0 .01 
last 10 ml of flow through before washing (6th batch) 6th batch 156 0 .0 1 
Wash with 2 liters lor each batch (50mM Nacl) Total 88 13 
Elution with 200 mM Nacl Istbatch 162 1 
1st Elution with 500 mM NaCI 1st batch 135 0 .5 
2nd Elutioll .. vith 500 111M NaCI 1st batch 92 0.5 
3rd Elution with 500 mM NaCI Istbatch 62 0.5 
4th Elution with 500 mM NaCI 1st batch 33 0.5 
5th Elution with 500 111M Nael 1st batch 18 0 .5 
Elution with 200 mM NaCI 2nd batch 100 I 
1st Elution with 500 mM Nael 2nd batch 103 0.5 
2nd 1 ~lution -.vith 500 mM j'\]aCI 2nd batch 107 0 .5 
3rd Elution with 500 111M Nael 2nd batch 78 0.5 
4th Elution with 500 mM NaCI 2nd batch 51 0.5 
5th Elution with 500 mM NaCI 2nd batch 3 1 0.5 
Elution with 200 111M Nael 3rd batch 45 I 
1st L1ution with 500 rnM NaCI 3rd batch 62 0.5 
2nd Elution with 500 mM Nael 3rd batch 63 0.5 
3rd Elution -.vith 500 mM Nael 3rd batch 48 0.5 
4th Elution with 500 rnM Nael 3rd batch 28 0.5 
5th Elution with 500 mM NaCI 3rd batch 20 0.5 
Elution with 200 mM NaCI 4th batch 16 I 
1st Elution -.vith 500 mM NaCI 4th batch 14 0.5 
2nd Elution -.vith 500 mM NaCi 4th batch 17 0.5 
3rd Flution with 500 mM Nacl 4th batch 16 0.5 
4th L1ution with 500 mM NaCi 4th batch 10 0.5 
5th Elution with 500 mM NaCi 4th batch 8 0.5 
Elution with 200 mM NaCI 5th batch 95 I 
1st Elution ... vith 500 111M Nnel 5th batch 85 0.5 
2nd Elution with 500 mM NaCI 5th batch 76 0.5 
3rd [Iution with 500 111M NaCI 5th batch 52 0.5 
4th Elution with 500 mM NaCI 5th batch 31 0.5 
5th Elution with 500 111M Nael 5th batch 19 0.5 
Elution with 200 111M Nael 6th batch 63 I 
1st Out ion -.vith 500 111M NaCI 6th batch 70 0.5 
2nd Elution with 500 mM NaCI 6th batch 67 0.5 
3rd Elution -.vith 500 mM NaCi 6th batch 46 0.5 
4th Elution with 500 mM Nae) 6th balch 28 0.5 
l 'ilh r-I, ,iron viII, "()() ",M N"rl hlh h,,'rh 17 (), 
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4.3.3 Immunoaffinity Chromatography Purification of Insulin following lon-
Exchange Chromatography and Concentration of Insulin Containing Fractions. 
To further purify the camel milk insulin following ion-exchange chromatography, the 
concentrated insulin was subjected to immunoaffinity chromatography purification. The 
immunoaffinity chromatography was undertaken using a 3 ml column that containing an 
anti-human insulin antibody linked to Sepharose 4 beads. An initial trail was undertaken 
using thi s co lumn and decasienised colostrum to load onto the column (so as not to use 
the ion-exchange purified material on optimisation studies) and this work showed that 
after elution from the immunoaffinity chromatography column approximately 87% of 
the total insul in loaded was recovered as detected by RIA (Table 4.12). The RIA activity 
data from the fractions collected from this experiment showed that the majority of the 
insulin activity was found in the 4th and 5th elution fractions when lIsing 1.5 M NaCI in 
the elution buffer. 
Table 4.12. Immuno affinity chromatography of decasienised colostrum in 3 mL co lumn. 
Total 




Decasenised colostrum sample 92 540 22 
15t elution fraction 1.5 M NaCI 0.01 6.3 2 
2nd elution fraction J.5 M NaCI 0.01 6.5 2 
3rd elution fraction 1.5 M NaCI 0.85 15 2 
4th elution fraction 1.5 M NaCI 4.65 2300 2 
5th elution fraction 1.5 M NaCI 3.2 2100 2 
6th elution fraction 1.5 M NaCI 0.62 640 2 
ih elution fraction 1.5 M NaCI 0.15 124 2 
Following demonstration that the affinity chromatography column approach was 
working, the concentrated camel milk insulin from the ion-exchange purification was 
1281 a g ~ 
Molecular Identification and Characterization of Camel Milk Insu lin Motasem Ismail 
subjected to immunoaffinity chromatograph with the 145 mL of sample being processed 
in two batches, one of 80 mL and one of 65 mL. Table 4. 13 reports on the RIA insulin 
activity results from the immunoaffinity chromatography of 80 ml of the concentrated 
product from the ion-exchange runs described and reported in in table 4. 10 and 4.11. 
The highest insulin activity/concentration was observed in (a) the 3rd fraction where 0.18 
IU of insulin was eluted, this amount equals 8.19 ~g of protein, and (b) the 41h fraction 
which contained 0.48 IU (2.2 ~g) of insulin. The insu lin binding to the column was 
efficient as less than 0.4% of the insulin activity was detected in the flow through (Table 
4.13). The remaining 65 ml of sample was then run in a second batch (table 4.14) where 
most of the insulin activity was in the 2nd and 3rd fraction where 0.14 IU (6.3 ~g) was 
detected. Less than 0.5% of the insulin activity was in the flow through (Table 4.14). 
Table 4.13. Im munoaffinity chromatography of the ion-exchange puri fi cation concentrated sample in 3 
mL column (80 ml) 
Fractions 
Total Protein Insulin RIA 
Volume (m!) 
(mg/ml) (~ru/mL) 
Sample 23.25 12000 80 
I st Flow Through 19.65 48 40 
2nd Flow Through 24.82 27 40 
151 elution fraction 0.5 M NaCI 0.18 640 2 
2nd elution fraction 0.5 M NaCI 0.1 670 2 
3rd elution fraction 0.5 M NaCI 0.93 90000 2 
4th elution fraction 0.5 M NaCI 0.34 24000 2 
5th elution fraction 0.5 M NaCI 0.09 2850 2 
6th elution fraction 0.5 M NaCI 0.05 1300 2 
i h elution fraction 0.5 M NaCI 0.04 900 2 
8th elution fraction 0.5 M NaCI 0.04 800 2 
9th elution fraction 0.5 M NaCI 0.03 700 2 
10th elution fraction 0.5 M NaCI 0.01 60 2 
Table 4.14. Immunoaffinity chromatography of the ion-exchange purification concentrated sample in 3 
mL column (65 ml). 
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Total Protein Insulin 
Volume(ml) Sample ID 
(mg/ml) RIA(J.1IU/ml) 
Sample 23.25 12000 65 
1 st Flow Through 21.36 56 50 
2nd Flow Through 24.07 61 15 
1st Elution 0.5 M NaCI 0.04 4 2 
~nd Elution 0.5 M NaCI 0.4 10600 2 
3rd Elution 0.5 M NaCI 0.44 68800 2 
14th Elution 0.5 M NaCI 0.11 3700 2 
5th Elution 0.5 M NaCI 0.03 600 2 
16th Elution 0.5 M NaCI 0.03 400 2 
7th Elution 0.5 M NaCI 0.01 300 2 
8th Elution 0.5 M NaCI 0.02 150 2 
~th Elution 0.5 M NaCI 0.04 100 2 
10th Elution 0.5 M NaCI 0.02 80 2 
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4.3.4 Characterisation of the Purified and Isolated Camel Milk Insulin 
The protein recovered after the ion-exchange and immunoaffinity purification procedure 
was then analysed. To do this 10 III of the elution product from fraction no 2, 3, 4 and 5 
in table 4.14 above were loaded onto a 12% SDS-PAG E system and after running 
blotted onto PVDP membrane. Human insulin was also run as a control. The resulting 
membrane was then western blotted using the anti-human insulin antibody and the 
resulting blot is shown in Figure 4.4. As can be seen in Figure 4.4, in the contro l lane 
containing human insulin a clear single band was detected, however no slIch 
corresponding band was observed in the fractions eluted from the immunoaffinity 
column. Instead a number of bands were observed at a much higher molecular weight in 
all the elution fractions whilst there was no band at the monomer insulin size expected 
(see figure 4.4). It was possible that these higher molecular weight bands were 
multimers of insulin that were covalently linked via disulphide bridges scrambled during 
purification. They could not be non-covalently associated, as these would have been 
destroyed in the presence of the SDS. 
Lane I Lane 2 Lane 3 Lane 4 LaneS 
'.d «.·0 ... · •• 
• .. nlo n 
~ +-- Insu lin Band 
Figure 4.4 Western blotting analyses of elution fractions from the immunoaffinity chromatography 
fractions reported in table 4.14. Lane I = 2nd elution fraction. Lane 2 = 3rd elution fraction, Lane 3= 4'h 
elution fraction, Lane S= S'h elution fraction, Lane 6= Insulin control. The arrow indicates the position of 
insulin on the blot. 
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As no insulin band was clearly visualize and identified by western blotting, and in order 
to confirm the size ofthe purified insulin when analysed on the SDS-PAGE gel, the gel 
was cut into horizontal sections as shown in figure 4.5. The protein was then eluted from 
each horizontal gel section and subjected to RIA analysis to determine the regions of 
insulin activity. The resulting RIA data indicated the presence of active insulin in the gel 
section between 3-6 kDa (see Figure 4.5). Thus, active camel milk insulin was present in 
the region where the control human insulin was detected by western blotting and there 
was little to no activity where the higher molecular weight species were observed. The 
higher molecular weight species are therefore either not insulin and are simply cross-
reactivity with the antibody, or contain inactivated insulin which is not detected by the 
RIA technique. The antibody used for RIA detection was raised against the insulin B-
chain and the. samples were mixed with loading buffer containing a reducing agent, so 
the results indicate the size of insulin B-chain only. The'same amount of the 3rd elution 
fraction from table 4.13 was loaded in the two gels shown in Figure 4.5 below. The RIA 
results show that more insulin was recovered from the gel (46-fold greater) in figure 
4.5B where 3:2 H20/isopropanol method was used to recover the insulin in comparison 
with the passive diffusion method used to recover the insulin from the gel used in figure 
4.5A. 
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Figure 4.5. 0 -P AG analy i of the 3rd immunoaffinity elution fraction de cribed in table 4. 13. The 
re ulting gel wa th n ection d into horizontal section and the protein in each section recovered and 
ubjected to insulin acti ity analy ed by Rl . In (A) protein wa recovered from the gel by using a pas ive 
diffu ion method while in (8) the protein pre ent in the exci ed ections were recovered with a 1:2 
H20 /i opropanol olution method . 
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4.3.5 Mass Spectrometry Analysis of the Purified Insulin Material 
A further method used to characterize the isolated protein was mass spectrometry 
analysis. One mL of the fraction obtained from the insulin purification experiment (3rd 
elution fraction table 4.13) where the insulin concentration was 90000 J,lIU/ml was 
divided into two equal portions, and each half was concentrated to a volume of 10 J,ll and 
then separated by SDS-PAGE. The bottom part of the gel was divided into 4 horizontal 
sections. Each gel section was digested with trypsin and analysed by liquid 
chromatography-mass spectrometry using a micrOTOF-Q mass spectrometry instrument 
(Bruker Daltonics) and the electrospray ionization mass spectrometry technique. In all 
gel sections that were analysed there were no insulin peptides detected, which could be 
due to loss of the low concentration insulin peptides during the in-gel digestion 
processing. This is discussed in the following section. However, a number of 
contaminant proteins from milk were identified confirming that the insulin fraction was 
not 100% pure as might be expected. 
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4.4 Discussion 
The isolation of proteins from natural sources such as milk is not an easy process. This is 
due to the presence of other proteins present in large quantities and often the low 
abundance of the target protein as in the case of this study. For the isolation of insulin 
from camel milk different purification steps were used including defatting, casein 
treatment, ion exchange chromatography and immunoaffinity chromatography. Such 
steps are commonly used in the chromatographic purification of target proteins from 
natural sources such as milk. 
The casein treatment of the camel milk with rennet enzyme was shown to be very 
inefficient, although in the initial trails the rennet treatment was very effective and 
produced a clear whey fraction. Even when using newly manufactured enzyme the 
casein treatment did not improve the subsequent purification steps. This may be due to 
seasonal changes in camel milk components (Haddad in et al., 2007), which can affect 
the curdling process. The initial trial was performed in winter while the trails where the 
treatment was not efficient were undertaken in summer. 
The casein treatment using acid precipitation methods resulted in an approximate 89% . 
loss of insulin in the whey fraction. In the early insulin isolation trails in 1923, Doisy 
developed a method for insulin isolation (Doisy et al .• 1923). The method was based on 
a proteins property to precipitate at a pH value near the isoelectric focusing point (pI) 
and hence where insulin precipitated under slightly acidic conditions. Reducing the pH 
in the studies here by using acid precipitation of casein reduced the insulin solubility and 
precipitated most of the insulin with the casein. 
An alternative precipitation method was also investigated, the use of ethanol. When 
radioimmunoassay was used to monitor the fate of insulin upon ethanol precipitation, 
these data showed that ethanol precipitation did not precipitate the majority of the 
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insulin at 50% and the insulin was precipitated at 90%. This was useful as at 50% many 
other proteins precipitated and hence were purified away from the camel milk insulin 
and also suggested, as expected, that the camel milk insulin was a small molecular 
weight protein as for human insulin. These results were in agreement with other 
previous studies where in earlier insulin isolation attempts it was found that the 
precipitate formed from 90% concentration alcohol contained the majority of the insulin 
protein that was being attempted to be recovered (Rosenfeld, 2002). 
Gel filtration using G-25 beads was used to try and remove large proteins from the small 
insulin molecule. Using this methodology the insulin was eluted late, indicating that the 
insulin entered the beads pores and was of a small size as expected. The gel filtration 
method can be used for insulin polishing but is probably not appropriate as a main 
purification procedure. It is reported that insulin can go through irreversible aggregation 
in the aqueous environment. The aggregation reactions are influenced by pH, the 
presence of ions including Zn2+ and Cu2+, the buffer used, temperature, ionic strength 
and the protein concentration while at equilibrium it is reported that insulin can exist as 
dimers, tetramers, and hexamers in the aqueous environment (Jeffrey PD and Coates 
1966; Pekar and Frank 1972; Darrington and Anderson, 1994; Darrington and Anderson, 
1995; Birnbaum et 01., 1997). This association is likely to be caused by hydrophobic 
interactions between insulin molecules (Yu et 01., 2006; Yu et 01., 2008). Furthermore, 
in gel filtration ~eth6d the sample needed to be loaded in small fractions and eluted with 
large amounts of elution buffer, making this method not very practical for a large scale 
purification. 
As stated above, insulin is a small molecular weight protein and is negatively charged at 
neutral pH. For this reason ion-exchange was investigated as part of the purification 
methodology. The A-25 DEAE Sephadex beads (GE healthcare, USA) combine the 
benefits of ion exchange chromatography with gel filtration chromatography as the 
beads are positively charged and have small pores. The use of A-25 DEAE Sephadex as 
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both an anion exchanger and gel filtration bead system has been previously described for 
the purification and isolation of insulin from other sources (Chen et al., 1995) and hence 
was investigated in this study. 
It has been reported that eluting the insulin from an ion exchange chromatography 
column gives high insulin recovery when using 10 mM ammonium acetate (pH 8) as an 
elution buffer (Dave et al., 2008). Using such a buffer in the large-scale isolation of 
insulin from milk might not be efficient for several reasons. Firstly, the acidic elution 
may result in denaturing traces of casein inion the column which may block the column. 
Secondly, in the large-scale purification, keeping the isolated insulin at low pH 
conditions for long time may' alter the structure of the isolated protein and lead to 
aggregation or the generatio,n of misfolded material. 
Immunoaffinity chromatography has been reported in the literature as a method to 
isolate and then study the insulin from samples that contain insulin at low concentrations 
such as urine and serum (Kuuranne et al., 2008; Hes et al., 2012). Kuuranne and 
colleagues (2008) successfully isolated horse insulin and recombinant insulin from 
racing horse urinary samples and then differentiated between the two insulins by mass 
spectrometry. Hess and co-workers (2012) also managed to isolate and analyse traces of 
insulin and insulin analogues from human serum using the immunoaffinity 
chromatography purification technique. The anti-insulin antibody in the immunoaffinity 
column used in this project is different than the one used by Hess et al. (2012). The 
antibody used in this study has previously been shown to have good binding ability to 
camel milk insulin in the insulin RIA kit (Diasource, Belgium). 
The A-25 DEAE Sephadex bead ion-exchange methodology provided purification in 
initial smaller scale trails with decaseinised milk, but this was not reflected in the first 
purification run which started with 100 L milk. The first purification failed for two main 
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reasons. Firstly, the fat content in the milk could not all be stripped out due to the large 
sample volume and the lack of a defatting machine at that time, and hence a white layer 
of fat accumulated over the column and blocked the beads. Secondly, the large quantity 
of casein protein in the milk can bind to A-25 DEAE Sephadex beads (Yaguchi & Rose 
1971) and saturate them rapidly. Further, rennet enzyme treated milk samples which had 
small amounts of the leftover digested casein can result in the casein binding to beads 
more than in the untreated samples; these smaller casein molecules can enter the beads 
pores and bind more specifically and saturate the column rapidly rendering it unable to 
bind the much less concentrated insulin in the sample. Casein treatment and ethanol 
precipitation with 50% ethanol can help elevate this problem by not only removing the 
casein but also by precipitating the large molecular weight proteins. 
The second ion-exchange purification (scale started with 65L of milk) combined the 
ethanol precipitation with ion exchange chromatography. In this approach the column 
binding capacity improved and there was almost full insulin recovery during the first 90 
min of sample loading through the column. In this second purification run, most of the 
insulin was eluted during the washing step; the bed volume of DEAE A-25 Sephadex 
beads in the ion exchange chromatography column was increased during the washing 
step. The loaded sample had 50% ethanol, however the washing was undertaken with 
ethanol free buffer. 
Following the recovery of insulin by ion-exchange chromatography, the insulin 
containing fractions were combined and concentrated. These were then applied to an 
affinity chromatography column which resulted in high binding efficiency and good 
recovery of the insulin. The purification of the insulin by a combination of ion exchange 
chromatography using A-25 DEAE Sephadex and immunoaffinity chromatography with 
an anti-human insulin antibody (Diasource diagnostics, Belgium) resulted in a good 
recovery of the purified insulin from the initial sample. 
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The purified material was then analysed by western blotting. The western blotting 
method was optimised using human insulin and the anti-human insulin antibody. The 
western blotting sensitivity of human insulin using the anti- human insulin antibody was 
tested and the lowest activity/concentration of insulin that could be detected was at 10 
mIU/ml insulin concentration. Although more than this amount of camel insulin was 
obtained, the camel insulin band was not observed, even at the highest concentration of 
90 mIU/ml. However, higher molecular weight bands were observed. It was not 
determined if these were insulin aggregates that were inactive but this appeared to 
represent the majority of material recovered. It is possible that the human anti-insulin 
antibody may not recognize the camel insulin due to the small changes in amino acid 
sequence as described in Chapter 3 although this seems unlikely as the insulin obviously 
bound to the immunoaffinity column. It seems more likely that much of the insulin 
aggregated and was inactivated and little monomer was left in solution. 
To determine the location of the isolated insulin protein the SDS-PAGE gel was excised 
in strips and each strip was analysed by RIA according to size. The RIA showed insulin 
activity in a position matching the human insulin control, proving that the isolated 
protein was insulin. How~ver, there was no significant activity observed in the area 
corresponding to the higher molecular weight bands. 
To further characterize the purified insulin, mass spectrometry analysis was undertaken 
on the purified sample. The purified material was subjected to tryptic digestion and then 
analysed by LC-MSIMS. The LCIMS results of the in-gel tryptic digested isolated 
product didn't show any of the expected insulin fragments, however a number of milk 
proteins were identified as being present in the purified material. The lack of any insulin 
protein being observed is probably due to the tryptic digestion reducing the insulin 
molecule to very small pieces and the low abundance of insulin compared to some of the 
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contaminating proteins that remained in the solution. This observation has been 
described and explained by Muller and colleagues (2010) who describe the reasons for 
failing to detect low molecular weight (LMW) proteins by mass spectrometry (Muller et 
a/., 2010). They described that this can be due to the low numbers of proteolytic 
peptides formed by tryptic digestion as well as the propensity of the protein to be lost in 
protein separation, concentration and desalting procedures. Protein loss may also happen 
during destaining, by adsorption on surfaces of pipette tips and digestion tubes, by 
drying of samples in the speedvac (vacuum concentrator) and incomplete recovery of 
peptides from the gel after digestion (Speicher, 2000 and Stewart, 2001). 
4.5 Conclusion: 
It can be concluded that combining ethanol precipitation, ion exchange and immuno-
affinity chromatography was efficient in isolating insulin from camel milk. 
Approximately 17 Ilg of camel insulin was purified using the above mentioned methods. 
The purified camel insulin was similar in size as the control human insulin after 
separating the sample by SDS-PAGE and analysing the separated protein by 
Radioimmuno assay. The conditions of in-gel digestion need to be optimised for camel 
insulin analysis. 
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Chapter 5 
Production of Recombinant Camel Insulin and 
Investigations into Camel Milk Insulin Stability 
5.1 Introduction 
For many years insulin purified from porcine and bovine pancreas has been used to treat 
diabetes (Kumar and Bhat, 2003). Purification was achieved in Canada by Banting, Best, 
Macleod and Collip in 1921 (Banting et al., 1922). Limitations in insulin production, 
supply and a concern about the transfer of viruses and incomplete removal of 
contaminating additional protein, encouraged sci~ntists to find alternatives. In the 1960s 
human insulin was chemically synthesized by peptide synthesis of the A- and B-chains 
independently. The synthesis process was followed by random combination and folding 
of the two synthetic chains to try and produce 'native' human insulin. However, there 
were low yields in these intial efforts to obtain correctly folded insulin protein from the 
direct oxidative assembly of the synthetic A- and B-chains' (Meienhofer et aI., 1963, 
Kung et al., 1966; Katsoyannis et al., 1966). Since these initial investigations, much 
research has been undertaken in the intervening years to develop thiol protection, 
cleavage and oxidation schemes for the stepwise formation of the correct disulphide 
bonds to form native insulin (Sieber et al., 1974, Akaji et al., 2002 Moroder et al., 2003 
). The first landmark report into insulin chemical synthesis was performed by the 
successful production of correctly folded human insulin using regioselective cysteine-
pairing procedures (Akaji et al., 1993). 
Human insulin for medical purposes is now produced by recombinant DNA technology. 
This technology was initially utilised by cloning the DNA fragments of the human 
insulin A- and B-chains into two separate vectors then transforming the vectors into 
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Escherichia coli (E.cob) cells. The insulin chains are then harvested and assembled to 
generate the appropriate disulphide bonds to yield native human insulin (Goeddel et al., 
1979). 
An alternative to the production of insulin in E.coli is to use yeast based technology. 
Yeast based technology offers structural and protein folding advantages over the use of 
E.coli. These include the fact that yeast is a eukaryotic cell that contains an ER and the 
correct chaperone machinery to fold and assemble insulin that E.coli lacks. The 
technology is based upon producing a folded proinsulin protein which is then converted 
into mature insulin by enzymatic cleavage to generate insulin (Markussen et al., 1986). 
An alternative to yeast technology is the use of mammalian cells for the production of 
insulin. Approximately 70% of the recombinant therapeutic proteins are made using 
mammalian cell biotechnology and cell culture whereby the product of interest is 
secreted into the cell culture media (Reichert et af., 2005). For mammalian cell 
technology the Chinese hamster ovary (CHO) cell line is the most extensively used 
mammalian cell type which can produce glycosylated and correctly folded recombinant 
proteins (Walsh, 2006, Peter and David, 2008). 
This chapter describes· attempts at the production of recombinant camel insulin using 
mammalian cell biotechnology and the chemical synthesis of the insulin peptides using 
solid phase peptide synthesis. 
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5.2 Aims: 
• To generate camel cDNA from pancreatic RNA. 
• To amplify the preproinsulin and pro insulin from camel cDNA 
• To clone both amplified preproinsulin and pro insulin (with and without stop 
codon) into both pcDNA3.lv5His and pcDNAS FRT vectors. 
• To transiently transfect the cloned pcDNA3.1 v5His vectors (preproirisulin 
and pro insulin with and without stop codon) in Chinese's hamster ovary 
(CHO) cell line. 
• To stably transfect the cloned pcDNAS FRT vectors (preproinsulin and 
proinsulin with and without stop codon) in CHO cell line using the 
commercially available flp-in system. 
• To chemically synthesis the camel insulin A and B chains by solid phase 
peptide synthesis technique using the peptide synthesiser machine. 
5.3 Results 
5.3.1 Cloning of Camel Insulin Gene 
5.3.1.1 Cloning of the camel insulin gene using synthetic DNA fragments 
In order to generate recombinant camel insulin, the insulin A- and B-chains were 
initially cloned into both the pcDNA3.1 vSHis and pcDNAS FRT commercially available 
mammalian expression vectors. The sense and anti-sense strands of A- and B-chains 
were commercially synthesised by I st BASE Custom Oligos and were successfully 
annealed as shown in figure S.I. Figure S.l shows the synthetic DNA strands as 
analysed on a 2% agarose gel before and after annealing. After annealing it was 
observed that the size of the band observed was slightly shifted as expected (Figure S.1). 
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Figure 5.1. garose gel electrophoresis 
analysis of synthetic A- and B-chain D A 
fragments. Lane 2 is sense strand of insulin 
A-chain. lane 3, the antisense A-chain. Lane 
4 the annealed A-chain fragment. Lane 5 
sense strand of B-chain. Lane 6 antisense B-
chain, Lane 7 annealed B-chain fragment. 
Molecular size marker of 100 bp size was 
loaded in I" and 8th lanes. 
500 bp 
100 bp 
Figure 5.2. Agarose gel electrophoresis 
analysis of I igation reaction products. The 
pcD A5 FRT/A-chain, pcDNAS FRT/B-
chain, pcDNA3.1 V5 Ili s/A-cha in and 
pcDNA3.1 v5 Ili s/B-chain were loaded 
respectively into the 4 lanes. 
The pcDNA3.1 v5His and pcDNA 5FRT vectors were digested with Xhol and Nott 
restriction enzymes and then gel purified before being used in a subsequent ligation 
reaction. The ligation reaction was analysed on a 1.5% agarose ge l and the result is 
sho~ n in figure 5.2 and shows 4 different bands for each reaction which indicates the 
presence of super coiled, linear, wild type and recombinant vectors (Figure 5.2). 
After transformation there were numerous colonies observed on all LB/ampicillin 
culture plates. Thirty colonies from each transformation were sub-cultured in 5 ml 
LB/ampicillin. To identify the po itive subcultures, DNA from all sub-cultures was 
crudely extracted and then P R amplified using T7 and BGH primers. PCR screening of 
the sub-cultures showed an increase in the size of the PCR product in some of the clones 
which was indicative of positive ligation. However, the recombination rate of this 
approach to include the target DNA sequence was low. From the thirty sub-cultures 
screened,onl one positive vector construct was obtained of the pcDNA5 FRT/A-chain 
(Figure 5.3) and pcDNA3.I/B-chain (Figure 5.4), while two positive constructs were 
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found with pcDNA3.1 v5His/A-chain (Figure 5.5) and pcDNA5 FRT/8-chain (Figure 
5.6). 
Figure 5.3. P R amplification screening of clones aller the transformation of pcDNA 5 FRT/A-chain 
ligation. Lane II shows one positive clone, 100 bp molecular size marker was loaded in lane 9 and 18. 
Figure 5.4. P R amplification screening of clones after the transformation of pcDNA 5 FRT/B-chain 
ligation. Lane 3 and 5 show two positive clones, 100 bp molecular size marker was loaded in lane 9 and 
18. 
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Figure 5.5 PCR amplification screening of clones after the transformation of pcDNA 3. 1 V51lis/A-chain 
ligation. Lane 12 and 17 show two positive clones, 100 bp molecular weight marker was loaded in lane I 
and 23. 
Figure 5.6. PCR amplification screening of clones after the transformation of pcDNA 3. 1 V5HislB-chain 
ligation. Lane 16 shows one positive clone, 100 bp molecular size marker was loaded in lane I and 28. 







pcDNA5 FRT/A- chain 
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pcDNA3 . 1V5/A-chain 
Insulin A-chain 
Consensus atgggcatcgt agca tgctgcgccagcgtctgctcgctctaccagctggagaactactgcaactag 
Figure 5.7 The alignment of the sequencing results of the A-chain constructs with the camel insulin sequence obtained and 
reported in Chapter 3 of this thesis using DNAMAN software. The second construct of pcDNA3.1 v5/ A-chain shows a mutation in 
the Ith and 13 th nucLeotides. The 18th nucleotide was also missing and hence this construct was discarded. 
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Figure 5.8 The alignment of the sequencing results of the B-chain constructs with the camel insulin gene sequence obtained and 
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The positive clones as shown in Figures 5.3-5.6 were sequenced using a forward T7 
primer and the sequencing results were also confinned by another sequencing reaction 
with a reverse BGH primer. The forward and reverse sequences matched each other in 
all cases. The sequencing results of the constructs were aligned using DNAMAN 
software (version 5.2.2) the result was resembled to the camel insulin sequence reported 
in chapter 3 and the results are shown in figure 5.7 and 5.8. 
From the sequencing results it was found that one of the pcDNA3.1v5His/A-chain 
constructs contained a mutation in the 12th and 13th nucleotides, two guanine nucleotides 
were replaced with two adenine nucleotides, the 18th nucleotide was also missing thus 
this construct was excluded. The successful and correct vector constructs were then 
purified ~rom the positive sub-cultures having the correct sequence using the 
commercially available Wizard® Plus SV Minipreps DNA Purification System 
(Prom ega, USA) and approximately 10 Jlg of vector DNA was purified from each 
construct. 
5.3.1.2 Cloning of camel insulin using a PCR product 
As an alternative to using synthetic oligos to clone and produce recombinant camel 
insulin, a peR product was also generated and used. Nine micrograms of total RNA 
isolated from camel pancreatic tissue with TRIzol reagent. eDNA was then prepared 
from this RNA using the commercially available ImProm-II Reverse transcription 
system. Preproinsulin and pro insulin DNA fragments were amplified from the pancreatic 
cDNA described above. Based on the designed primers the amplified products were such 
that they either contained a stop codon of were without a stop codon and hence would 
read into the V5 tag of the vector and produce a tagged version of the protein. 
The cloning of the insulin gene into the pcDNA3.1v5His and pc DNA FRT vectors was 
undertaken into two restriction mUltiple cloning sites. The first cloning attempt was to 
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insert the PCR product into the Notl and XhoI restriction sites, however the cloning 
efficiency was very low. A second attempt was undertaken to clone the peR product 
into the HindllT and XhoI restriction site using a new set of primers that gave a Hindlll 
overhang. 
5.3.1.2.1 Cloning of the camel insulin gene using the NotI and XhoI restriction sites 
The peR primers used were designed to have a NoH restriction site in the forward 
primer and a XhoI restriction site in the reverse primer. The primers included 3 extra 
nucleotides in each primer prior to the restriction site in order for the restriction enzyme 
to cut efficiently. A single band of approximately 350 bp (the actual band size is 353 bp 
which includes 333 bp from the preproinsulin and 20 bp for the restriction sites and the 
extra 3 bases added to each end) was observed from the peR for the preproinsulin when 
analysed by agarose gel electrophoresis (Figure 5.9). The proinsulin primers produced a 
fragment of size around 280 bp following peR (the actual band size is 284 bp which 
includes 261 bp from the proinsulin, 3 bp for the start codon and 20 bp for the restriction 
sites and the extra 3 bases added to each end). Figure 5.9 shows the analysis of the 
amplified PCR products of pre pro insulin and proinsulin with and without stop codon by 
agarose gel electrophoresis. 
Figure 5.9 Analysis by agarose gel electrophoresis of the PCR ampli {jed fragments of preproinsulin and 
proinsulin with and without stop codon from camel pancreatic eDNA. 
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As a fir t step to verify the specificity and correct amplification of the desired target of 
the peR, the peR product was digested with the Smal restriction enzyme. The Sma l 
enzyme will cut the preproinsulin in two places, cutting the preproinsulin DNA fragment 
at posi tion 67 and 215 to produce 3 digest fragments of size 77, 127 and 148 bp. 
Although the Smal restriction enzyme digests at position 67, the observed product in this 
case is 77 bp in size due to the presence of the additional nucleotides. Figure 5. 10 shows 
the restriction digestion of the preproinsulin peR product with Smal when analysed by 
agarose gel electrophoresis. The 127 and 148 bp bands are clearly visible but diffused, 
however the 77 bp band and a faint band of undigested product are also observed (Figure 
5.10). 
undigested PCR Product ~ 
1::7 aJld148bp hllds (Diffused) ~ 
77l1p ~ 
Figure 5.10. Restriction digestion of preproinsulin fragment with Sma I enzyme for sequence 
confirmation. In 15• column the digested product, 2nd column preproinsulin fragment and 3rd column is 100 
bp molecular size marker. 
The vector and peR products were then double digested with the Not! and Xhol 
enzymes and gel purified. The preproinsulin and proinsulin fragments with and without 
stop codon were then ligated into both the pcDNA3.1 vSHis and pcDNA5 FRT vectors. 
As a result 8 different constructs were prepared which were; pcDNA3 .1 v5His Proinsulin 
with stop codon, pcDNA3 .1 v5His Proinsulin without stop codon, pcDNA3.1 v5His 
Preproinsulin with stop codon, pcDNA3. lv5His Preproinsulin without stop codon, 
pcDNA5 FRT Proinsulin with stop codon, pcDNAS FRT proinsulin without stop codon, 
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pcDNAS FRT Preproinsulin with stop codon and pcDNAS FRT/Preproinsulin without 
stop codon. 
After transformation numerous colonies were observed on all culture plates and a 
number of colonies were sub-cultured in LB-broth. The DNA from the sub-cultured 
colonies was crudely extracted and screened using peR with T7 and BGH primer set. 
Initially, 48 colonies were sub-cultured from each of the 8 vector combinations. From 
the 48 sub-cultures of each of the vector combinations, only one positive vector 
construct was found in pcDNAS FRT Preproinsulin without stop codon (Figure 5.11). 
Figure 5.11. creening by P R for positive clones containing the preproinsulin insert with pcDNA 3.1 
FRT vector without a stop codon (9th lane positive clone). In the last lane 100 bp molecular size marker. 
Forty eight more colonies from each of the remaining 7 construct combinations were 
also sub-cultured and screened for the presence of the correct insert by peR. From this 
large screen only one further positive vector construct for the pcDNA3.1 VS His 
Preproinsulin without stop codon was found (Figure 5.12). Below the expected band a 
further band was also pre ent (Figure 5.12). Both bands (the expected size band and the 
band below it) were gel purified and sequenced. The sequencing results of the weak 
band confirmed that it was a nonspecific peR product. 
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_".'0;:- 500 bp 
100 bp 
Figure 5.12. peR screening for presence of correct insulin gene sequence into vector contnlcts. In 
lane I is a positive vector construct of pc DNA 3.1 VS Preproinsulin without stop codon. The weak band in 
lane I, below the band of interest (- 3S0 bp band) is a non-specific PCR product as confirmed by 
sequencing. One hundred base pair molecular size marker is loaded in the last lane. 
One final screen of an additional 48 colonies from each of the remaining 6 potential 
constructs were then sub-cultured and analysed by PCR screening for the presence of the 
correct insert. Among all the sub cultures, only one further positive vector construct was 
found - the pcDNA5 FRT Proinsulin without stop codon. Figure 5.13 shows the screen 
that identified this positive clone, the size of the positive construct PCR band being more 
than 260 bp higher than the wild type vector. 
Figure 5.13. peR screening of colonies for the presence of correct insulin gene inserts. In the 13'h lane is 
a positive vector construct of pcDNAS FRT Proinsulin without stop codon. One hundred base pair 
molecular size marker is loaded in the last lane. 
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To further confirm the correct seqeunce was present in the positive vector constucts, the 
cloning site and insert of the 3 positive vector constructs were sequenced using a 
forward T7 primer. The sequencing results were confirmed by another sequencing 
reaction with a BOH reverse primer. The sequence of camel preproinsulin which was 
obtained and described in chapter 3 was aligned with the sequencing results from the 
preproinsulin positive vector constructs of pcDNA5 FRT and pcDNA3.1 V5 His using 
DNAMAN software version 5.2.2. The seqencing and alignment showed no sequence 
differences between the cloned gene and the genomic DNA sequence obtained in 
chapter 3 confirming the presence of the correct seqeunce (Figure 5.14). 
The 3 positive vector constructs were sub-cultured in 10 ml LB-broth. Approximately 10 
Jlg of DNA of each of the 3 sub cultures was then subsequently purified using the 
commercially available Wizard® Plus SV Miniprep DNA Purification System 
(Prom ega, USA). Based on the low number of positive colonies obtained from screening 
many colonies, the recombination rate using the Not! and XhoI restriction sites is most 
likely very low under the conditions used during this study. 
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5.3.1.2.1 Cloning of the camel insulin gene using HindIII and XhoI restriction sites 
Cloning using the Notland XhoI restriction sites was inefficient and large numbers of 
colonies had to be screened to find any positive, peR insert containing colonies. The 
restriction enzymes may not work efficiently if the two restriction sites are very close to 
each other. This may leave many acceptor vectors cut at only a single site and the single 
digested vectors are religated during the ligation reaction. This reduces the 
recombination efficiency and results in many of the observed colonies being of the wild 
type vector after transfonnation. The XhoI and NotI restriction sites are next to each 
other on the multiple cloning site of pcDNA3.1 V5His and pcDNA5 FRT vectors. In an 
attempt to increase the recombination efficiency, the Not! cloning site was not used and 
instead the HindIII site was used. According to the vector sequence of the circular 
pcDNA3.1 VSHis and pcDNAS FRT, the distance between HindIII and XhoI restriction 
sites is 68 bp in the pcDNA5 FRT. The distance betWeen the two sites in the circular 
pcDNA3.1 V5 His vector is approximately 50 bp. This should allow the two enzymes 
(Hind III and XhoI) to cut efficiently and remove any potential limitations resulting from 
using neighbouring restriction sites. 
In addition to changing the cloning sites used, the new primers for Hind III and XhoI 
cloning of the insulin gene were designed to have 6 extra nucleotides prior to the 
restriction site instead of the 3 nucleotides previous used to increase the digestion 
efficiency of the peR products. The peR was undertaken using the pancreatic cDNA 
template which been prepared previously. Figure 5.15 shows the camel pancreatic 
cDNA amplified fragments of preproinsulin with stop codon and the pro insulin with and 
without stop codon. A band of size approximately 350 bp (the actual size is 337 bp 
including the 333 bp from the preproinsulin and 24 bp for the restriction sites and the 
extra bases added to each end) was observed for the preproinsulin peR product. The 
proinsulin primers produced a fragment approximately 280 bp (the actual size is 288 bp. 
261 bp from the proinsulin, 3 bp from the start codon and 24 bp for the restriction sites 
and the extra bases added to each end). 
.-. 
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J 
------ 500 bp ----
100 bp 
Figure 5.15. The peR amplified fragments of proinsulin with stop codon in lane I, proinsulin without stop 
codon in lane 2, preproinsulin with stop codon in lane 3. PCR products were amplified from camel 
pancreatic cD A. In the 4th lane is the 100 bp molecular size marker. 
The acceptor vector and peR products were double digested with Hind'" and Xhol 
enzymes and subsequently gel . purified . The preproinsulin with stop codon and the 
proinsulin fragments with and without stop codon were then cloned into both 
pcDNA3.1 vS His and pcDNAS FRT vectors. Thus, the constructs prepared using this 
cloning strategy/set of restriction sites were; pcDNA3.1 v5 His Proinsulin with stop 
codon, pcDNA3.1 v5 His Proinsulin without stop codon, pcDNA3.1 v5 His Preproinsulin 
with stop codon, pcDNA5 FRT Proinsulin with stop codon and pcDNAS FRT 
Preproinsulin with stop codon. 
After transformation only a few colonies were observed on all culture plates and these 
were sub-cultured in LB-broth. The DNA from the sub-cultured colonies was crudely 
extracted and then screened using peR with the T7 and BGH primer set. The 
recombination efficiency was much higher than observed with the NotllXhol restriction 
combination. Figure 5.16 shows the results of the cloning using H indlIl and Xhor 
restriction sites as determined by peR screening of colonies for the presence of the 
inserts. 
To verify the correct inserts were present in the clones obtained, peR products from 2 of 
each of the positive vector constructs were treated with exonuclease and shrimp alkaline 
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phosphatase to remove the extra primers and dntp's and then directly sequenced from 
both directions using T7 forward primer and BGH reverse primer. The resulting 
sequences were compared with the sequence of the full insulin gene obtained in chapter 
3 and all sequences were found to be correct. One colony from each of the verified 
(sequenced) colonies was selected and sub-cultured in 250 ml LB-Broth. The vector 
constructs were then isolated using the commercially available Maxi-prep Kit (Qiagen). 
Around 50 Ilg of vector DNA were isolated from each ofthe five vector constructs. 
Figure 5.16. PCR screening of colonies fTOm the cloning ofpcDNA3.1 VS and pcDNAS FRT Ycctors with 
proinsulin and preproinsulin using HindIlI and Xhol restriction sites. 
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5.3.2 The expression of camel insulin in the Chinese hamster ovary 
(CHO) cell line 
In this project the expression of recombinant camel insulin from CHO cells was 
attempted. Three different transfection experiments were performed, two transient 
transfections - one with insulin A- and B-chains and the other with proinsulin and 
preproinsilin; and one stable transfection with proinsulin and preproinsulin. 
5.3.2.1 Transient transfection and expression of camel milk insulin 
5.3.2.1.1 Transient transfection of insulin A- and B-chains 
Four expression vectors consisting ofpcDNA3.1VS and pcDNAS FRT vector constructs 
with insulin A- and B-chains were transiently transfected in Chinese hamster ovary 
(CHO) cells using Lipofectamine 2000 (Invitrogen) transfection reagent in 6 well culture 
plates. The transfections of A- and B-chains were setup separately in either the 
pcDNA3.1 or pcDNAS fonnat. As these chains do not contain signal sequences they 
would be expected to be synthesised in the cytosol and not secreted out of the cell. 
Western blotting analysis was perfonned to determine whether the insulin chains were 
being produced in the transiently transfected cells. The transfected cells were trypsinised 
and then lysed in RIP A buffer 48 hours after transfection. The cell lysate and its 
respective cell culture media were analysed by western blotting using an anti-insulin 
antibody (Diasource, Belgium). Figure S.17 shows the results of western blotting where 
no signal was observed matching the control insulin using this approach. This agreed 
with the results from the purification of insulin from camel milk whereby the low levels 
of insulin present were not detected but could be detected by radioimmunoassay (RIA). 
RIA was therefore also used to detennine if the insulin chains were being produced and 
to measure the insulin concentration in the cell lysate and the respective culture media. 
The sensitivity of the radioimmuno assay is higher than western blotting and can detect 
as little as 1 ~IU/ml of insulin. 
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The RIA results are presented in Table 1 and confirm the lack of insulin chain 
production in the cell lysate and cell culture medium in the all transfected cell lines. 
Table 5.1: The concentration of insulin as determined by radioimmunoassay for the transiently transfected 
cell lines with pcD A3.1 5 and pcD AS FRT vector constructs with camel insulin A- and B-ehains. 
Transient transfection Vector Source 
Insulin 
(",IV/mt) 
Insulin A-chain pcDNA 3.1 V5 Cell lysate 2 
Insu lin B-chain pcDNA 3.1 V5 Cell lysate I 
In ulin A-chain pcDNA 5 FRT Cell culture media 2 
In ulin B-chain pcDNA 5 FRT Cell culture media 2 
Untran fected cells control NA Cell lysate I 
ntransfected cell control NA Cell culture media 2 
234 567 8 9 
Figure 5.17: Western blotting analysis using anti-insulin antibody or the 4 transiently transrected 
experiments ~ ith pcD A3. J V5 and pcD AS FRT vector constructs with insulin A- and B-chains. Lane's 
1-4 cell culture media, Lane's 5-8 cell lysate. lane 9 is insulin positive control. 
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5.3.2.1.2 Transient transfedion and expression of camel proinsulin and 
preproinsulin in CliO cells 
Four expression vectors of pcDNA3.1 V5 vector constructs consisting of preproinsulin 
and proinsulin with and without stop codon were transiently transfected into an Chinese 
hamster ovary (CHO) cell line using Lipofectamine 2000 (Invitrogen) transfection 
reagent in 6 well culture plates .. Western blotting was used to deteremine whether insulin 
production was present in the transiently transfected cells. Forty eight hours after 
transfection culture media was aspirated and the transfected cells were scraped and lysed 
in extraction buffer. The cell lysate and its respective cell culture media were analysed 
by western blotting using a commercially available anti-insulin antibody (Diasource, 
Belgium). As with the A- and B-chain experiment, no signal was observed matching the 
size of the control insulin although a higher molecular weight band was observed 
(Figure 5,18). 
RIA was also used to determine whether the insulin chains were produced and to 
measure the insulin concentration in the cell lysate and the respective culture media. The 
RIA results presented in table 5.2 confirmed the presence of insulin production in the 
cell culture. The produced insulin was below the level of detection by western blotting, 
hence explaining why no insulin was detected using this method. The low level of 
insulin in the cell lysate may be due to the presence of an insulin degrading enzyme in 
the cell which degrades the produced insulin. Further work would need to be undertaken 
to confirm this. Regardless, this data shows, for the first time, that it is possible to 
express camel insulin from CHO cells. 
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Table 5.2. The concentration of insulin as determined by radioimmuno assay for the transiently 
transfected cell lines with pcD A 3.1 V5 vector constructs with Proinsulin and Preproinsulin. 
Tran ient transfection Vector Source 
Insulin 
~IU/mll 
Proinsulin with stop codon pcDNA 3.1 V5 Cell lysate 2 
Pro insulin without stop codon pcDNA 3.1 V5 Cell lysate 2 
Proinsulin with stop codon pcDNA 3.1 V5 Cell culture media 47 
Proinsulin without stop codon pcDNA3.1 V5 Cell culture media 42 
Preproinsulin with stop codon pcDNA 3.1 VS Cell lysate I 
Preproinsulin without stop codon pcDNA3.1 V5 Cell lysate 3 
Preproinsulin \: ith stop codon pcDNA 3.1 V5 Cell culture media 18 
Preproinsulin without stop codon pcDNA 3.1 VS Cell culture media 70 
Untransfected cells control NA Cell lysate 2 
Untransfected cells control NA Cell culture media I 
1 2 3 4 5 6 7 8 9 10 
Figure 5.18. Western blotting analysis using anti insulin antibody of the 4 transiently transfected cell lines 
with pcD A3 .1 V5 vcctor constructs of Proinsulin and Preproinsulin with and without stop codon. Lane's 
I, 2. 5 and 6 the cell I) sate, Lane's 3. 4. 7 and 8 cell culture media, lane 9 is the negative control cell 
lysate and in lane 10 is insulin posith'e control. 
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5.3.2.2 Stable transfection of CHO cells with proinsulin and preproinsulin 
Whilst the transient studies described above continned that camel insulin could be 
expressed in CHO cells, the amounts observed were low and therefore as an alternative 
to transient expression stable cell lines were generated. To generate stable cell lines 
which expressed camel insulin constitutively, four expression vectors of pcDNAS FTR 
vector with preproinsulin and proinsulin with and without (to read through to the tag) 
stop codon were stably transfected into the Chinese hamster ovary (CHO) Flp-In cell 
line along with the pOG44 vector using Lipofectamine 2000 (Invitrogen) transfection 
reagent in T25 culture flasks. Hygromycine selection was then applied to the transfected 
cells to select for those transfected cells that had the plasmid DNA inserted into the 
recombination site. Distinct cell colonies appeared 6 days after the hygromycim 
selection and 3 days later the transfected cells were trypsinised, pooled ·and cultured in 
T75 flask in the presence of hygromycin. Three days later the cells were transferred to 
T175 tissue culture flasks. 
To continn that the stably transfected and selected CHO cells were producing insulin, 
the culture media was collected during each transfer to a larger flask. The transfected 
cells were also trypsinised and lysed in RIPA buffer to measure for intracellular insulin. 
The cell lysate and its respective cell culture media were analysed by western blotting 
using the commercially available anti-insulin antibody (Diasource, Belgium). 
Encouragingly, a faint band matching the insulin control size was observed (Figure 5.19) 
in the cell lysate but no insulin band was detected in the case of the cell culture media 
when western blotting (Figure 5.20). 
As in the case of the transient studies, RIA was also used to confinn insulin production 
and to measure the insulin concentration in the cell lysate and the respective culture 
media. Table 5.3 reports the results of the RIA measuremenrs. Low levels of insulin 
were detected in both the cell culture and cell lysate, lower than observed in the transient 
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studies. The 10'1' insulin concentration is again probably due to presence of an insulin 
degrading enzyme. The time between sample processing and RIA testing was longer 
than in the tran ient studeis which increases the opportunity for sample degradation even 
in cel l culture. 
Table 5.3. The concentration of camel insulin as determined by radioimmuno assay ror the stably 
transrected cell lines with pcDNA 3. I FRT vector constructs with proinsulin and preproinsulin. 
table tran fection Vector Source 
Insulin 
(IlIU/m1) 
Proinsulin with stop codon pcDNA 5 FRT Cell lysate 3 
Proin ulin without top codon pcDNA 5 FRT Cell lysate 4 
Proinsulin \ ith top codon pcDNA 5 FRT Cell culture media 4 
Proinsulin without top codon pcDNA 5 FRT Cell culture media 5 
Preproinsulin with top codon pcDNA 5 FRT Cell lysate 4 
Preproin ulin without stop codon pcDNA 5 FRT Cell lysate 4 
Preproin ulin with top codon pcDNA 5 FRT Cell cu lture media 5 
Preproinsulin without top codon pcDNA 5 FRT Cell cu lture media 4 
ntran fected cell control NA Cell lysate 1 
ntran fected cells control NA Cell culture media 1 
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1 2 3 4 5 6 7 
In ulin Band ) 
Figure 5.19. We tern blotting using anti-insulin antibody of cell Iy ate of the 4 stably transfected cell lines 
with pcD A 5 FRT vector constructs of proin ulin and preproin ul in with and without stop codon. A faint 
in ulin band (as indicated by the arrow) was present in lanes I , 2, 3 and 5 where the cell lysate of 
proin u1in with stop codon, proin ulin without stop codon, preproinsulin with stop codon and 
preproinsulin without top codon were loaded re pectively. Insulin positive control is in lane 7. 
1 1 3 4 5 
Figure 5.20. We tern blotting using an anti-insulin antibody of cell culture media (lane 1-4) of the 4 
tably tran fected cell lines with pcD A 5 FRT vector con truels of pro insulin and preproinsulin with and 
without top codon. Insulin po itive control i in lane 5. 
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5.3.3 Chemical synthesis of camel insulin peptides 
As an alternative to the production of camel insulin from cultured mammalian cells, 
direct chemical synthesis of the individual chains was also investigated. The A- and B-
chains of human and camel insulin were therefore chemically synthesized using a 
peptide synthesizer. The four different peptides were produced by the solid phase 
peptide synthesis technique. The peptides synthesis process was from the carboxyl 
terminus to the amino terminus. The carboxyl group of the carboxy terminal amino acid 
of each ofthe 4 peptides was covalently bonded to the solid support of NovaSyn®TGT 
resin and the rest of the chain was then synthesised by stepwise addition of the 
appropriate amino acids. The reactive functional group of the amino acids was protected 
with stable Fmoc protecting group to prevent the formation of secondary chains. 
5.3.3.1 Production of tbiol-protected insulin B-chain 
The protected human and camel insulin B-chains were constructed on NovaSyn~GT 
resin by the Fmoc-based solid-phase synthesis method. The thiol group of the cysteine at 
position 7 in the both human and camel insulin B-chain was protected by the acid-stable 
acetamidomethyl (Acm) group. Triphenylmethyl (Trt) as an acid-labile protecting group 
was used to protect the cysteine thio group at position 19 of both peptides. 
5.3.3.2 Production oftbiol-protected insulin A-chain 
For the synthesis of the insulin A-chain, the cysteine thiol group in both camel and 
human chains was protected by the acid labile Trt group at amino acid position number 
20. The tritluroacetic (TF A) stable protecting group Acm was used to protect the 
cysteine at position 7 and another TFA stable protecting group tert-butyl (t~Bu) was used 
at positions 6 and 11. 
5.3.3.3 Peptide cleavage and purification 
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After the synthesis process, the 4 peptides were washed with methanol and then cleaved 
from the resin using TF A and two scavengers; ethanedithiol and triisopropylsilane. The 
TFA cleaved the peptide from the resin while the scavengers preferentially reacted with 
free radical and other reactive species released during the cleavage reaction and washed 
them ofT. De-protection of the 4 synthetic peptides with TF A in the presence of 
scavengers produced insulin A and B-chains with a free thiol group present in the last 
cysteine in all chains. 
Following this, after adding diethyl ether, a white precipitate appeared indicating the 
presence of the peptide. The precipitate was dried after two washes with the diethyl 
ether. The human and camel B-chains were easily reconstituted in 1 ml of 80% 
acetonitrile containing 0.1% TFA. The insulin. A-chain of both human and camel didn't 
dissolve in 1 ml of 80% acetonitrile containing 0.1 % TF A so a further 1 mL of 0.1 % . 
TF A was added. Solid urea was then also added to give an 8 M final urea concentration, 
the urea still only partially dissolving the insulin A-chain. 
The peptides were then analysed and the presence of the correct peptide verified by 
liquid chromatography coupled mass spectrometry (LCIMS). A large and distinct peak 
was observed on the reverse phase HPLC chromatogram for each peptide. In the case of 
the insulin B-chain of both camel and human, the large peak was observed at a retention 
time of 21 min. The subsequent mass specta collected using electrospray ionization mass 
spectrometry confirmed the large peak as the full insulin B-chain peptide. The calculated 
mass of the positively double charged ion of the human insulin B-chain with the 
protecting groups is 1750.37, while the calculated mass for camel B-chain is 1721.35. 
The extracted ion chromatogram (Figure 5.21 (Human) and Figure 5.22(Camel» 
confirmed the presence of the double charged ion of human and camel insulin B-chain at 
the retention time matching the large peak reverse phase HPLC chromatogram. 
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Many peaks were observed on the reverse phase HPLC chromatogram in the case of the 
insulin A-chain of both camel and human (Figure 5.23 and 5.24, respectively). The mass 
spectra obtained using electrospray ionization mass spectrometry confirmed the presence 
of the full insulin A-chain peptide corresponding to one of the many peaks observed in 
the UV trace from the HPLC (Figures 5.23 and 5.24). The calculated mass of the 
positively double charged ion of the human A-chain with the protecting groups is 
1283.59, while the calculated mass for camel A-chain is 1261.58. The extracted ion 
chromatogram shown in Figure 5.23 and 5.24 confirmed the presence of the double 
charged ion of the insulin A-chain of human and camel, respectively, at the retention 
time of 23 min, which matched a small but broad peak on the reverse phase HPLC 
chromatogram. 
Following confirmation- of synthesis of the correct peptide by mass spectrometry, the 
insulin B-chain of camel and human were purified by reveres phase high performance 
liquid chromatography (HPLC). The synthetic peptides were injected onto a CI8 
reversed phase preparative column for this purpose and then eluted with acetonitrile. The 
retention time of the large peak corresponding to the insulin B-chain in the case of the 
preparative column was 27 min. The fraction of the large peak was collected. Fractions 
from ten HPLC runs were pooled and Iyophilised by freeze drying. From the purification 
and Iyophilisation approximately 12 mg of camel and human insulin B-chain peptide 
was produced. The Iyophilised product was then stored at -20°C until required for 
further use. 
The A-chain insulin peptides were very insoluble and could not be purified by HPLC. 
Due to a lack of time the A-chain could not be correctly purified and solubilised and 
hence the process of in vitro insulin folding was not performed and the stability study on 
insulin was carried out with the insulin from camel milk isolated. The details of insulin 
isolation from camel milk are described in detail in chapter 4. 
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Figure 5.21. Rever e phase HPLC chromatogram and the extracted ion chromatogram at mass 1750.37 of 
human in ulin 8-chain. The extracted ion chromatogram confirms the presence of human insulin 8-chain 
at the HPL retention time of21 min. 
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Figure 5.22. Rever e pha e HPLC chromatogram and the extracted ion chromatogram at mass 172 1.35 of 
camel insulin B-chain. The extracted ion chromatogram confirms the presence of the camel insulin B-
chain at HPLC retention time of21 min. 
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Figure 5.23. Rever e phase HPL chromatogram and the extracted ion chromatogram at mass 1283.59 of 
human insulin A-chain. The extracted ion chromatogram confirms the presence of the human insulin A-
chain at HPLC retention time of 23 min. 
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Figure 5.24. Rever e pha e HPLC chromatogram and the extracted ion chromatogram at mass 1261 .58 of 
camel insulin A-chain. The extracted ion chromatogram confirms the presence of camel insulin A-chain at 
HPLC retention time of 23 min. 
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5.4 Discussion 
In order to try and produce camel insulin from an in vitro cultured mammalian cell line, 
mammalian cell vectors (pcDNA3.1 v5His and pcDNA 5 FRT) were used as acceptor 
vectors to clone the camel insulin gene and insulin peptide DNA fragments. The cloning 
using the Xhol and NotI restriction sites in the multiple cloning site was difficult and 
very low recombination efficiency was observed. The XhoI and Not! restriction sites are 
close to each other in the vector (figure 5.26). This reduces the efficiency of double 
digestion with the restriction enzymes. The single digested vectors can religate easily 
without the in ert and result in many wiJd type vector colonies after transformation . 
After replacing the upstream cloning site with HindIll instead of NotI, the cloning 
efficiency increa ed and a few colonies were observed on plates. Furthermore, adding 
additional ba e to the primer allowed the restriction enzymes to cut more completely. 
~ ~ )'-"'~- IPu .... ~."" 
761 CCCATTOACO CAAATGGGCG GTAGGCGTGT ACGGTGGGAG GTCTATATM GCAOAOCTCT CTGGCTAACT AOAOAACCCA 
T7 ....... "1pWrino _ _II I(pn I _,., 
841 CTOCTTACTO OCTTATCGAA ATTMTACGA CTCACTATAO GdAOACCc.v. GC'I'OOCTAO'r TAAGCTTGOT Ac!cOAOCTed 
_ I Emil V &s/)( I Net I 
821 GATCCACTAG TCCAc:TcrdG TGGAAT'TGCC CT G GGC MT Tel' GCA GAT' ATC CAG CAC IIGT Ged 
ACCTTAACGG r~~ S'i~ n~ ~~ AH Aap 11. Gln lib se. G Y 
~. I I ~. ~I~. ~I , V51!i!ap! 
8Ir GOC CGC TCG AGT CTA OAG GGC cco COG T'!'C GM GG MG CCT ATe CCT MC CCT CTC CTC GOT erc 
Gl y AC9 ~.r G4r L.u Glu Oly p~o Atq Ph. Cl~ e l y Lya Pro 11. p~ A~~ Peo Leu Leu ely t.u 
___ --.; .,1 • ~...,.., I ~t , IGHR.wrse 
1053 GAT TCT ACO CGT ACC GOT CAT CAT CAC CAT CAC CAT TGA GTTTAAACCC GCTGATCAGC CTCGACTGTG 
lUll'S •• Th. 111 Tll r Gly Hia H1a R1. lli s IU. Rl* • •• 
Figure 5.26. The pcD A3.1 v5Hi vector multiple cloning site. From the Invitrogen website 
http://tool.invitrogen.com/content! fs/manual Ipcdna3.1 topota_man.pdf 
The CHO cell line was initially transiently transfected with insuJin A and B-chains and 
subsequently transiently and stably transfected with proinsulin and preproinsulin. The 
production of insulin from mammalian cells turned out to be a difficult process and 
many attempt failed to produce large amounts of recombinant insulin from insulin 
transfected mammalian cells. Such difficulty in expressing insulin from mammalian cell 
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lines has been previously reported by others (Groskreutz et al., 1994; Quin et al., 1991 
and Vollenweider et al., 1992). 
The main reason given for the low yield of insulin from mammalian cell lines is due to 
the presence of the insulin degrading enzyme in mammalian cells. Insulin degrading 
enzyme is a neutral thiol metalloprotinases which is involved in switching off the insulin 
signal by rapidly degrading the excess insulin (Duckworth, 1988). To confirm this was 
indeed the issue, siRNA knockdown experiments could be undertaken to knockdown the 
levels of this enzyme and determine whether this results in increased levels of insulin 
being observed. If this was the case, potentially a knockout cell line could be made to 
produce insulin in the absence of the degrading enzyme. 
The first transfection attempt was undertaken with vectors cloned with insulin A- and B-
synthetic chains without the signal sequence. The signal peptide directs the nascent 
polypeptide emerging from the ribososome to the endoplasmic reticulum (ER) apparatus 
for post-translational modification and secretion. For the protein to be secreted from a 
eukaryotic cell, the protein should first enter the endoplasmic retiCulum then be transport 
into the Golgi apparatus. The signal peptide at the beginning of the proteins directs the 
molecule to the endoplasmic reticulum lumen via binding to the signal recognition 
particle, SRP. The signal recognition particle then binds to the SRP then binds to the 
SRP receptor on the surface of the ER and passes the polypeptide to the Sec61 
translocon which transports the peptide into the ER. The signal peptide is cleaved off by 
signal peptidase after· serving its purpose of directing the protein to endoplasmic 
reticulum and is notpresent in the mature protein (Stem et al., 2007). 
The subsequent transfections were performed with preproinsulin and pro insulin cloned 
-
vectors. Pro insulin is the precursor of insulin and consists of the insulin B-chain, C-
peptide and A-chain while preproinsulin is pro insulin with the signal peptide. For each 
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vector construct one was made with a stop codon and the other was without. That 
without should read through to a stop further downstream with a his tag between the end 
of the insulin and new stop. The tag could have been used for purification purposes 
should sufficient insulin have been made in the mammalian system. " 
The RIA results of transient transfection with preproinsulin and proinsulin indicated the 
presence of insulin in culture media more than the cell lysate. The reduced amount of 
insulin in the lysate may be due to the presence of insulin degrading enzyme in the cell 
lysate being at a higher concentration. The western blotting results didn't show an insulin 
specific band, most likely due to the insulin concentration being below the detection 
level of insulin. Despite this, the RIA result show that insulin can be produced in CHO 
cells but that degradation likely rap~dly occurs afterwards. 
The CRa cell line was used to" successfully produce stably transfected cells with 
preproinsulin and proinsulin using the commercially available flp-in system. Using this 
system, healthy cells were observed one week after transfection. The expression level of 
insulin from the transfected cells is likely to be higher than the amount detected by RIA 
and western blotting due to a number of reasons including: 
Low post-translational modification from proinsulin to insulin; the antibody used 
in the RIA kit and western blotting is specific to the mature insulin. 
Low secretion levels of insulin, the intracellular insulin is probably degraded 
rapidly. 
The insulin degrading enzyme my also be secreted out of the cell and de"grade the 
secreted insulin. Even if it is not secreted, many proteins are released into the 
media during cell death and as such it is likely to be released into the media and 
result in insulin degradation. 
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Potential for technical problems, for instance; the samples were stored at -20°C 
before the RIA test instead of -80°C and they been shipped to the hospital for 
RIA analysis at 4°C.' 
Several methods could be used to enhance the level of the expressed insulin: 
Transfect the insulin gene in a cell line generated from p-cells of pancreas. 
- Collect the culture media of the insulin transfected cells after 24 hours of 
culturing. The insulin peak concentration was found 24 hours after culturing the 
cells in other studies (pak et al., 2002) 
Include bacitracin antibiotic with the culture media. Bacitracin is an antibiotic 
which also inhibits the. insulin degrading enzyme. This antibiotic was used by 
Pak and colleagues in 2002, after the bacitracin treatment the level of the 
recombinant insulin produced by CHO transfected cells was enhanced. 
Knockdown the degrading enzyme by RNAi to reduce/eliminate the potential 
problem. Ultimately generate a knockout of the enzyme of the knockdown 
approach was shown to be viable. This is likely to be the best solution for the 
long term elimination of the potential problematic enzyme. 
As an alternative to production from mammalian cells, solid phase peptide synthesis was 
successfully used to synthesise the insulin peptides (A and B-chains). LCIMS verified 
the correct peptides had been synthesised. The broad A-chain peak in the HPLC and the 
extracted ion chromatograms were due to the low solubility of the insulin A-chain in the 
acidic conditions used which proved problematic in the purification and handling of the 
peptide. Although the A-chain peptide was solubilised by pH adjustment to basic 
condition before LCIMS analysis, the HPLC purific'ation requires acidic buffers 
including acetonitrile containing triflouroacitic acid. 
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5.5 Conclusion: 
From the results of this chapter it can be concluded that the camel insulin can be 
produced by Chinese's hamster ovaries cell lines using the transient and stable 
transfection techniques but in limited amount due to the presence of the insulin 
degrading enzymes in the mammalian cens. The camel insulin production using solid 
phase peptide synthesis is hard due to the difficulties in purifying the camel insulin A-
chain after synthesis. 
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Chapter 6 
Investigating the thermal stability of camel insulin and 
insulin from other species in camel milk 
6.1 Introduction: 
Camel milk proteins have been reported to be remarkably stable Elagamy (2000). 
Previous studies suggested that camel milk insulin is more stable than insulin from other 
species (Wernery el a1., 2006a). From the work described in chapter 3, there are a few 
but potentially important changes in the amino acid sequence of camel insulin compared 
to human which may account for some of this enhanced stability as described in chapter 
3. However, the stability of camel milk insulin could be due to the amino acid makeup 
of insulin alone or due to other factors in the milk that protect the insulin in the camel 
milk. 
In this chapter, the stability of camel, bovine and human insulin in camel and bovine 
milk was studied under different thermal conditions to determine the relative thermal 
stability of the insulin from these species and to determine if camel milk itself offered 
any thermal protect to the insulin proteins. 
6.2 Aims: 
• To investigate the biophysical properties of camel milk insulin and the protective 
nature of camel milk on insulin upon temperature stress. 
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• To study the thermal stability of camel, bovine and human insulins in camel and 
bovine milk under different temperatures. 
6.3 Results: 
Insuli.n from bovine and human. along with camel insulin isolated from camel milk were 
spiked into camel and bovine milk and the thermal stability of the insulin molecules 
investigated. To do this the samples were divided into three groups; the first was used as 
. . 
a control, the second was heated at 600e for one hour and the third group was incubated 
at noe for one hour. The plain milk (unspiked) samples were also treated under the 
same conditions to determine the stability of the milk insulin itself. The insulin 
concentration remaining was then measured by radioimmunoassay. 
The results from this study (Tables 6.1 and 6.2) show that the reduction of camel and 
bovine insulin concentration (10% and 12% respectively) was much less than human 
insulin (31%) in camel milk after incubating the samples at 600 e for one hour. This 
suggests that both camel and bovine insulin are more stable than human insulin. There 
was no further reduction in the insulin concentration after incubating the human insulin 
(34%) with camel milk at noe fo~ one hour in comparison with 600 e incubation. 
However the camel and bovine insulin (21 % and 22% reduction, respectively) showed 
higher insulin concentrations being maintained than the human insulin. 
Interestingly, when the camel insulin was in bovine milk it maintained higher insulin 
concentrations (10% reduction) after incubating the sample at 600 e for one hour and the 
percentage of reduction was similar to that with camel milk and less than the other two 
insulin's investigated. The bovine and human insulin showed a similar reduction 
percentage in bovine milk (32% and 31 % respectively) after being at 600 e for one hour. 
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The camel, bovine and human insulin concentrations dropped drastically when they 
were incubated at noc for one hour in bovine milk. These data suggest that the camel 
insulin is the most stable of the insulins investigated and is the most thermal resistant as 
shown in the bovine milk suggesting that the amino acid differences between camel and 
the other insulins provide some of the additional stability. However, it is also apparent 
that the camel milk itself provides some protection or 'stability' to the different insulin 
molecules and hence the results here suggest that the enhanced thermal stability of camel 
milk insulin is due to both the amino acid makeup of the camel insulin molecule and the 
presence of unknown factors that provide stability in the camel milk. 
The changes in insulin concentrations in the plain milk samples after the thermal 
treatment were close to the changes that occurred with the insulin spiked milk samples. 
Tables 6.1 and 6.2 summarise the results obtained of insulin concentrations before and 
after incubating the samples at 60°C and noe. Figure 6.1 illustrates the results obtained 
in a chart format. 
Table 6.1 Insulin concentrations and the reduction of insulin before and after thermal treatment at 60°C 
for one hour in either camel or bovine milk 
Insulin 
Reduction 
Original Insulin concentration 
percentage after 
Milk Insulin Concentration after incubation 
incubation at 
(IlIU/ml) at 60°C / Ih 
60°C / Ih (%) (,.lIV/ml) 
Camel 307 276 10 
Camel Human 262 181 31 
Milk Bovine 292 256 12 
Milk 60 56 7 
Camel 260 235 10 
Bovine Human 227 157 31 
Milk Bovine 256 173 32 
Milk 36 26 28 
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Table 6.2 Insulin concentrations and the reduction of insulin before and after thermal 
treatment at noc for one hour in either camel or bovine milk. 
Insulin 
Reduction 
Original Insulin concentration 
percentage after 
Milk Insulin Concentration after incubation 
(11IU/ml) at noe / lb incubation at 
(J1IU/ml) 
noe Ilb (%) 
Camel 307 243 21 
Camel Human 262 173 34 
Milk Bovine 292 228 22 
Milk 60 48 20 
Camel 260 10 96 
Bovine Human 227 6 97 
Milk Bovine 256 8 97 
Milk 36 3 92 
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F igure 6.1 The change in insulin concentration after the thennal treatment of different 
insulin in either camel or bovine milk. A is original sample without treatment (denoted 
a 100%), B i the percentage of in ulin remaining after incubating at 60°C for one hour, 
is the in ulin concentration remaining after incubating at n oc for one hour. TIle large 
reduction in the in ulin concentration after the n oc incubation time point in bovine 
milk is very clear. 
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6.4 Discussion: 
To study the thermal stability of camel insulin, camel and bovine milks were spiked with 
camel, bovine and human insulin's and then thermally treated at 60°C and 72°C for one 
hour. It is noted that there is only a single amino acid difference between camel and 
bovine insulin, while four amino acid differences are present between the camel and the 
human insulin. 
After thermal treatment at 60°C for one hour, camel insulin appeared to be slightly more 
thermal stable than bovine insulin in bovine milk and all insulin's were more thermal 
stable in camel milk. Among the three insulin's, camel insulin was the most thermal 
stable and the human insulin was the less thermal stable. This reflects the amino acid 
changes between the species insulin molecules which seems to account for some of the 
difference in thermal stability observed, but not all. 
Camel milk appeared to offer stability to the insulin molecules, even at 72°C thermal 
treatment for one hour, whilst the bovine milk lost any ability to stabilise insulin at this 
temperature and time. The camel insulin appears to be stabilised by both amino acid 
variants in comparison to human (mild effect) and by unknown properties of camel milk 
itself (major factor). Bovine insulin, where only a single amino acid difference with the 
camel insulin is present, was the next most thermal stable of the insulin molecules whilst 
human insulin was the least stable and is the most different at the amino acid level. The 
insulin stability results therefore suggest that the camel milk insulin thermal stability is 
largely a property of the camel milk but that the amino acid composition also adds to the 
observed thermal stability, although this has a minor effect compared to the effect of the 
camel milk itself. 
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Similar to the findings presented here, Elagamy (2000) studied the effect of heat 
treatment on camel, bovine and buffalo milk. In this research he used a radial immune 
diffusion assay to quantify the· concentration of lysozyme, lactoferrin and 
immunoglobulin G (IgO) following thermal insult and showed that heating milk at 65°C 
for 30 min had no significant effect on lysozyme and lactoferrin concentration. 
However, the activity of IgGs was significantly reduced in the three milk types. The 
total activity of IgO in cow and buffalo milk was lost at 75°C for 30 min while the loss 
was only 68.7% of the total activity of camel IgG. The complete activity of lactoferrin 
was lost at 85°C after 30 min incubation in all types of milk, but at this temperature, the 
reduction in the activity of the lysozyme was 56% for camel and 74% and 81.7% for 
cow and buffalo milk, respectively (Elagamy, 2000). On the other hand Omidfar and 
colleagues (2007) investigated the thermal denaturation stability using ELISA and 
Circular Dichrosim (CD) spectra analysis to study the thermal stability of camel 
antibodies at different temperature to determine the reversibility and binding activity 
after heat denaturation. The VHH of the camel nanobodies and both IgG2-IgG3 
displayed good binding ability even at 90°C. At 90°C the protein maintained up to 50% 
of its activity due to its moderately stable conformation and preservation of more than 
50% of its secondary structure. Conesa and colleagues (2008) also found that the 
lactoferrin in camel was the most active lactoferrin against E. coli 0157:H7, while alpaca 
and human lactoferrins had minimum activity. The antimicrobial activity was calculated 
by measuring the minimum bactericidal concentrations (MBCs), this result was obtained 
after testing the lactoferrin of sheep, goat and elephant as wel,I. 
The results presented in this chapter, and other published results, therefore strongly 
suggest that camel milk proteins in general are more heat resistant than the proteins of 
human and other species like cow. The exact reason for this is not clear at this stage. In 
the case of insulin the amino acid makeup of the protein appears to play some part in this 
increased thermal stability, but the major role is played by unknown factors in the camel 
milk. In the future further studies to investigate the constituents of camel milk that might 
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be responsible for this stability or 'protection' would be interesting. Identification of 
these constituents could help in the engineering of more thermal stable proteins or allow 
for the use of these constituents to protect other proteins from thermal stress, including 
the formulation of biotherapeutic proteins and live vaccines for use in 3rd world 
countries and in hot climates. 
6.5 Conclusion: 
From the results obtained from this chapter it can be concluded that camel insulin seems 
to be stabilised due to the amino acid variants in comparison to human insulin 
furthermore this study also -suggested that the components of camel milk itself gives 
greater thermostability in comparison with bovine milk. Thus, the greater thermal 
stability of camel milk insulin is due to both, the amino acid composition of the camel 
insulin protein and also the existence of unknown factors that provide higher stability in 
camel milk. 
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Chapter 7 
Final Discussion 
Diabetes is a condition associated with a patient's inability to control their glucose levels 
- -
as a result of insulin deficiency. This is usually treated by regular application of 
recombinant insulin produced in E.coli cells. As described earlier in this thesis, a 
number of studies have now reported on the observation that diabetic patients who are 
regular drinkers of camel milk have a reduced dependency on insulin and that in some 
communities the incidence of diabetes is zero amongst regular camel milk drinkers 
(Agrawal el af., 2007b). Compared to the milk from other species, camel milk has a high 
concentration of insulin and it has been suggested that this can even help activate B cells 
in camel milk drinkers in addition to providing insulin (Agrawal et al., 2007a). There is 
currently an overwhelming and exponential increase in type II diabetics in the Middle 
East area and beyond which shows no sign of abating at present. As camel milk insulin 
has high thermostability and is a widely taken dietary supplement across the Middle 
Eastern population, the consumption of camel milk may help prevent, reduce andlor 
even treat diabetics. 
The prevalence of diabetics in the Middle East is amongst the highest in the world and 
the rate is increasing rapidly, contributing to the concern of limiting the epidemic arid 
. the financial burden of health care of the countries in this area (FAO, 2010). The 
prevalence rate of the disease in most of these countries, especially in the gulf council 
countries (GCC), is such that they rank between the 2nd and 12th in the world in terms of 
the incidence within the population with the United Arab Emirates being the 2nd in the 
world in terms of diabetes prevalence within the population (Alhyas et al., 2012). The 
treatments for this diseases costs these countries many millions of dollars and requires 
many medical staff: The disease also contributes to other serious and costly 
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complications, such as early stage eye disease, heart attack, coronary heart disease and 
non-traumatic lower limb amputation (Ringborg et al., 2009). Therefore, it is considered 
to be extremely important that these countries, and the world overall, find new 
preventive methods and treatments/cures for this disease which do not just rely upon 
recombinant insulin treatment 
For many years, insulin has remained the best and most widely used treatment for 
diabetes. Many diabetic patients require multiple injections of insulin daily. Patients 
often resist taking insulin therapy in the early stages of their disease for a variety of 
reasons including a belief that the need for insulin reflects personal failure and concerns 
that insulin therapy will be complicated, hypoglycaemic consequences correlated with 
the inject~on, and the usage inconvenience. Many disadvantages of injectable insulin 
therapy could overcome, such as these social issues, by using alternative methods of 
delivering recombinant insulin, oral delivery being the most preferred method (Polonsky 
and Jackson 2004; Brunton et al., 2006; Meece, 2006; Brod et al., 2009). However, to 
date a reliable oral delivery system for insulin has not been devised. 
Diabetes is a genetic and immunological disorder and it is unfeasible to change the 
genetics of a population; however it is feasible to change the lifestyle of the population 
as in many cases lifestyle issues, particularly diet, underpin the development of the 
disease. Thus, alongside a change.of diet, encouraging the consumption of camel milk as 
a regular dietary supplement across the Middle East could be an important step in 
combating diabetes in the area. This thesis set out to investigate the properties of camel 
insulin in more detail and to try and understand why camel milk has higher insulin 
concentrations than other species and if this was potentially a property of the camel 
insulin molecule or a property of the milk itself. Camel and camel milk are available 
widely in the Middle East and so a further understanding of the insulin within this that 
contributes to a positive diabetic benefit will aid in understanding the mechanism behind 
this observation. It has been shown in this thesis that the insulin in camel milk is more 
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thennostable under harsher elevated temperature conditions compared to the insulin 
found in cow or human. To further investigate why this is the case, the genomic DNA 
sequence of the camel insulin gene was deduced and compared to other species. The 
sequencing results were confinned after sequencing 32 camels. 
Although AI-Swailem and colleagues sequenced camel pro insulin in 2008 the start 
region of the sequence was not of camel origin (AI-Swailem et al., 2008). This was due 
to their choice ofprime~, which were driven from the human insulin sequence. Initially, 
using the primers from this study and subsequently by designing new primers from the 
BAC clone of lama pacos number CH246-515B 17 flanking region of the insulin gene, 
the full sequence of camel insulin was obtained. The result of the new primers showed 
sequence differences with the published data (AL-Swaile.m et al., 2008). The 
comparison of the sequences of the 32 sequenced camels showed five single nucleotide 
polymorphisms within the insulin gene, three of which are in the intronic region of the 
C-peptide and two which were found in the 3' untranslated region of the gene after the 
stop codon and before the tennination sequence. These two SNP's found in the 3' -UTR 
may playa role in gene expression although this has not been investigated in this study. 
The sequencing showed, as expected, that the camel insulin gene sequence is highly 
conserved between individuals. However, when comparing the insulin gene of camel 
with human and bovine counterparts, this revealed a number of non-sense differences at 
the DNA level of the A- and B-chains while in the signal ~nd C-peptides there were 
changes distributed across the sequence. This suggests that the A- and B-chains, which 
constitute the final active insulin molecule are still highly conserved at the amino acid 
level and reflect insulin function and its importance, whilst the remainder of the gene 
and prepro-molecule is less well conserved, these section of the protein not being part of 
the final functional insulin protein molecule. 
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The predicted amino acid sequence from the camel insulin gene showed a number of 
unique differences at the amino acid level when compared with other species as shown 
in figure 3.8 One of the major differences between camel insulin and other species is the 
amino acid change of valine in all other species investigated to alanine in the 2nd amino 
acid of the B-chain of the camel. This change could well contribute to the increased 
thermostability for the camel insulin molecule shown in this thesis compared with other 
species. This hypothesis is supported by work from Dao-Pin et al. (1990) that showed 
the substitution of valine to alanine has implications for high thermostability in the T4 
phage lysozyme protein (Dao-Pin et al., 1990). In addition to this Lyu and co-workers 
(1990) reported the variation in stability of an alpha heli~~l structure after performing a 
substitution of a single residue in a polypeptide sequence ~ith different amino acids 
using a chemical peptide synthesis technique. The authors showed in this study a higher 
. stability of alpha helical structure in alanine cont.aining helides than in valine containing 
, . 
helices. Thus, this unique amino acid change in camel insulin might result in a more 
stable insulin molecule than in other species and explain the higher thermostability of 
camel insulin when compared with the human and bovine insulins under different 
thermal conditions. This could be simply tested by mutating the alanine reside back to 
valine recombinantly, and then assessing the effect on thermostability of the resulting 
molecule. 
In comparison with human insulin (B-chain and A-chain), camel insulin has 4 amino 
acid differences; furthermore three out of the four are changes to alanine residues. The 
. first substation is in the 2nd residue of the B-chain as discussed above, and is a change 
from valine to alanine. The second and third differences are in the last amino acid of the 
B-chain and in 8th residue of the A-ch~in, both being threonine to alanine substitutions. 
According to Lyu et al. (1990), alanine residues are more alpha helically stable than 
valine and threonine. Camel insulin contains three additional alanine residues compared 
to the human insulin sequence. Thus, a molecule containing more alpha helical stable 
" 
residues could increase the stability of camel insulin. The predicted 3-D structure of 
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camel proinsulin also predicts more alpha helical structure than beta sheet in comparison 
with the human proinsulin structure (Figure 5.10) which may further explain the greater 
stability of camel insulin compared to its human counterpart. Proinsulin is the precursor 
of insulin and plays an important role in controlling the structure of the mature insulin 
protein (Wahren et al., 2000) and if the camel insulin has a more stable precursor 
molecule this may result is in more mature insulin with correct folding. 
The protein isolation process used in this project was efficient in purifying and 
concentrating the insulin protein. Combining three different isolation methods facilitated 
the purification of insulin from a natural source rich with other proteins using large 
. quantity of milk. Ethanol purification was initially used to remove large molecular 
weight proteins and casien, whilst ion exchange ~hromatography was used to bind and 
purify negatively charged proteins, insulin being one of these proteins. Finally, 
immunoaffinity chromatography using human anti i~sulin antibodies was eff~ctive in 
purifying the insulin protein form most of the remaining proteins carried through the 
previous steps. SDS-PAGE and radioimmuno assay confirmed that the isolated protein 
contained insulin whereby the RIA results showed insulin activity in a position matching 
the human insulin control and there was no significant activity observed in the area 
corresponding to the higher molecular weight bands. Despite this, other contaminant 
proteins were still clearly present as shown by cross-reaction on western blots and from 
mass spectrometry analysis of the purified material. 
To further study camel insulin and to produce it in a larger quantity, the recombinant 
expression of camel insulin was investigated. To overcome the incorrect folding 
problems and lack of, or less human like post-translational modifications associated with 
bacterial and yeast production systems (O'Callaghan and James, 2008), the camel 
insulin gene was cloned into a mammalian expression vector and transiently and stably 
transfected into a Chinese hamster ovary (CHO) cell line. The transfected cell line did 
successfully produce camel insulin but at very low concentrations. The reason behind 
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the limited production of insulin by mammalian cells is most likely due to the 
production of insulin degrading enzyme in such cells as explained by Pak et al. (2002). 
Potentially, transfecting the camel insulin in a cell line derived from pancreatic cells or 
into a knockout cell line whereby the insulin degrading enzyme has been removed could 
result in enhanced production of insulin in the absence of the degrading enzyme. 
This project confirmed the previously published data by Wernery et al. (2006a) that 
camel milk insulin is a highly thermostable molecule,· Further, in this study it has been 
shown that camel milk components appear to have the greatest effect on the stability of 
camel milk insulin, contributing more to the relatively (relativ·e to the thermostability of 
insulin from other species) high thermostability of the camel insulin molecule than the 
changes at the amino acid level. The thermostability study investigated camel, bovine 
and human insulin and their1hermostability under different thermal conditions in bovine 
and camel milks. The results, after heating the spiked bovine and camel milks with 
different insulin samples at 600 e for one hour, conflrmeds that among the three 
insulin's, camel insulin was the most thermal stable whilst the human insulin was the 
least thermal stable. This strongly suggests that amino acid changes between the insulin 
species accounts for some of the difference in thermal stability observed. Camel milk 
appeared to confer thermostability to all three of the insulin molecules, even after 
heating at noe for one hour, whereas the bovine milk lost any ability to stabilise insulin 
at this temperature and time. Generally, camel insulin appears to be stabilised by 
unknown properties of camet milk components and to a lesser degree by the amino acid 
variants in comparison to human and bovine insulin. 
The thermostabiIity studies also showed that bovine insulin, where only a single amino 
acid difference with the camel insulin is present, was the next most thermal stable of the 
insulin molecules whilst human insulin was the least stable and is the most different at 
the amino acid level. This again suggests that whilst camel milk insulin thermostability 
is a property of the camel milk itself, the amino acid composition also contributes to the 
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observed thennal stability, even though this has a lesser effect in comparison with the 
etTect of the camel milk itself. 
In the future, the camel milk components could be fractionated by different 
chromatographic, filtration and ultra-filtration techniques and then each fraction of milk 
mixed with insulin then heat stressed to find the milk fraction(s) conferring this 
stabilising effect. Each fraction could then be further investigated to identify the makeup 
of this fraction in order to try and identify the components responsible. These could be 
protein in nature or lipid based. The stability could be due to the interaction with other 
milk proteins or due to the minerals (e.g. trace metal ions) available in the milk. 
Finding and identifying the componeilt(s) which stabilise insulin in camel milk could 
help the insulin and generally. recombinant protein industry in a variety of ways. First, 
such a component could be added to recombinant insulin vials to help in stabilising the 
insulin during shipping and transport. Second, as previously reported by Agrawal et al. 
(2007a, 2007b) where drinking camel milk helped in reducing the blood glucose level, 
insulin could be produced in a tablet form with the stabilising agent and given to 
diabetics orally. This would help millions of diabetic patients who sutTer from insulin 
injections. Thirdly, understanding the mechanism(s) by which these components 
stabilise insulin may help in the development of stabilisation formulations and 
approaches for ~ther recombinant protein molecules and/or vaccines for use globally. As 
such, there are still many exciting opportunities for the improvement of insulin therapy, 
diabetic treatment and development of stabilisation approaches for other therapeutics 
that might arise from the study of camel milk and camel insulin. 
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Appendices: 
Appendix t: The Sequence of camel insulin Gene using CAM-INS-F2 and CAM-INS-
R2 Primers: 
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Appendix 2: The protocol used for solid phase peptide synthesis on PSSM-8 peptide 
synthesizer from SHIMADZU Corporation 
:. 
I • ' ,9: ,. , .' . . ,. 
, .. 
Protocol ,: 
". : ":, 
.=a:===c========::;;'=~===+======= +==-==========:d ==== +='~~_==:== .~::.= ==?~.=~.~ ~-== ~~ ~ .. :'. 
step" ' ' times ' v?lume (micro,-L) ' 'bubbling tim~ (set) ; "~ 
=====z=======~==:====::z+=== = ==:;+============== .===+==.::;:~== T:=~ ====~'====:::~ '~ ... ~: 
INITIAL RESIN ' WASH 1 DMF 600 : , 180 ;' ,", ':, 
_________ ~ __ ~ ________ t-------t- - --------~-~----t---~-- ~ --~--~--~- ~ -- : 
DeBLOCK 2 PIP 500 450 '; 
----- - ------~ ----- ---t---- - - - + -- - - -------------+- - - - - --- -- - ------~ - -
NEEDLE ~IASHlPIP) ON(l) 
~ ______ ___ ____ _______ t - ---- - - t ----------------- t ----- - - --- ----- ~- ~ - -
REMOVE PIP 5 DMF 600 6,0 . 
- - - -~ - - -- - ----~----- - ~- ------t- - - - - - - - - - --- ----t--- - ---- - -- --. --: . --
ACTIVATE' AA ' iso 
---- --- -------- ------ t - ------ t - - ------- - --- ---- t------i--- --~-- - ~ - - - , 
COUPL,ING 45 (mi n) 
------------ p-- - - - -- -t - - - - - - -t -- - ------- - - - - ---t -- -- -- ------- ~ ---~-~ 
NEEDLE WASH (AA) 'ON (1 ) , 
---------------------t -- -- -- - t -- -- - - --- -- --- - - - t--------- - ---- - --- ~ - . 
REMOVE EXCESS AA 5 DMF 600 60 
- --------------------t--- ~~- -t------- -- -- - -----t-------~----- ~ -~~ - -- ~ 
----------- - --- - -----t-- - - -- - + ---- -------- - -- - -t - - - ~-------- - -- -----
DUMMY RESIN WASH , DMF 500, " .' 
- - - - .. - - .. - - .. - - - ~ - - - - - - + - - - - - - - + - - - - - - - - - - - - - - - - - + - - - ~ '. - ~ - .: - - - ~ - '. - .:. - - - I 'j-': '; . 
EXCESS VOLUME' 5 . 0 (mL) , , ";: .- -
=Z;.~=z======·=======.===+=======+=================+::=~============~=~ -=1 ,~ : , ' '. 
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ppendix 3: Solid Phase peptide synthesis calculation sheet for Camel insulin B-cbain. 
Strategy Fmoc/ HBTU .. . 
, , 
. . 
Peptide Camel B Chai n 
, S-equence Phe-Ala -Asn~Oln-Hi -L u- y -0 y-S r-Hls-L u - V l ~~l u -A 
• 
Leu-Tyr- L u - 1-
Lys-Ala-OH 
~ :ryr-Th~. -Pro-
71 . 7 ) 
• H r ) 
Resin TGT ( CoT rm AA n ) 
ReSln sub~titu i n 
Resin quam.icy 
Free pepti 





















.( 1) 21 
( 2) 22 
( 3) 23 
( 4) 24 
( 5) 25 
( 6) 26 
( 7) 27 
( 8) 28 
( 9)' 29 
Fro - L sIB --- ---- -----
Fmoc-Pr - H ---- -. -- - ----
FmO - Th tBu - \I - ---- ------------
Fm c-Tyr (tBu - H --- - -----------
Fro c - Ph - H - - - - - - - - - - . - - - - - - - -
Fm c - ph - H ----- ---- ------- ----- -
Fm -Gl y- H ----- ----- --
Fmoc-Arg(Pm l" \:: - ----- ----- -
Fm -Glu( 
Fn -Gly- H -------- ---- -
Fmoc-Cy (Tr ) - H - ---------------- -
Fmoc - al- H - ---- ---------------- -
Fmoc -Leu - H - ------- -- ----------- --
Fmoc -Tyr(tBu) - \I ---- - ---- - - ---~ ---
Fmo -L u- H --- --- - ---- -- ---- -- - - .-
Fro -Al - H - - ------ -- --- -------'---
Fmoc -Glu(OtBu)- H -----------------
Fmoc- Val-OH -- ------------------- - -
Fn~c -Leu-OH ---- ----------------- --
Fmoc-His(Trt)- H -- - - ----- - -: - -- -.- -
Fmoc-Ser (Trt )-OH - - ----- --- - - - - - - --
Fmoc-Gly-OH - -- --------- - -------.- , -
Fmoc-CyS(Acm) -OH ----- ~ -- - ------~--
Fmoc-Leu-OH ----- - - ----- -- - --------
Fmoc-His(Trt)-OH --- - --------- - ----
Fmoc -G1n(Trt)-OH ------- - ----------
Fmoc-Asn(Trt)-OH ------------------Fmoc-A1a-OH -- -- ---- ---- __________ _ 
Fmoc-Phe-OH -------- --- ___________ _ 
4 _5 . -\ S , ' 
- . 3 54.31 
5 .4 56 . 55 
619 . 7 - --- 99 .16 
5 . 6 ---- ·9 0 . 99 
91 . 31' ':" .:- - 4.7·, 57 · 
41:1. S --;-- 66 . 32 , 
353 ;4 --~- 5 ; 5s 
619. 7" -;--- 99\.11.6' . 
610.71. - .- ... 97.'7'2 
596.68 . -~-- 95' . 47 
311.34 49 .82 
387. 4 ---- 62 . 00' 
' , ' 
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